SS/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
202.0 |
mmHg |
4.1 |
18.34 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65483 |
611 |
SS.LEW-(D1Rat211-D1Rat18)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
179.0 |
mmHg |
2.9 |
12.97 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65490 |
611 |
SS.LEW-(D1Mco75-D1Rat18)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
193.0 |
mmHg |
4.2 |
18.78 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65492 |
611 |
SS.LEW-(D1Rat211-D1Rat18)/Mco |
heart rate |
controlled sodium content diet (2 %) (between 34 and 38 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
heart pumping trait |
male |
73 days-80 days |
8 |
|
|
404.0 |
beats/min |
5.0 |
14.14 |
intra-aortic abdominal radiotelemetry |
|
10 |
|
0 |
|
|
diurnal difference |
|
65504 |
611 |
SS.LEW-(D1Rat211-D1Rat18)/Mco |
pulse pressure |
controlled sodium content diet (2 %) (between 34 and 38 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
73 days-80 days |
8 |
|
|
49.0 |
mmHg |
0.74 |
2.09 |
intra-aortic abdominal radiotelemetry |
|
10 |
|
0 |
|
|
average of 24 hr |
|
65500 |
611 |
SS/Jr |
absolute change in systolic blood pressure |
controlled sodium content diet (2 %) (between 34 and 38 days) then controlled exposure to darkness then controlled exposure to ambient light |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
73 days-80 days |
8 |
|
|
22.6 |
mmHg |
1.05 |
2.97 |
intra-aortic abdominal radiotelemetry |
|
10 |
|
0 |
|
|
diurnal difference |
|
65497 |
611 |
SS-Mas1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
317.5 |
beats/min |
19.5 |
27.58 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66623 |
717 |
SS-Gpr183em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
148.56 |
mmHg |
5.69 |
17.06 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66641 |
717 |
SS-Gpr183em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.33 |
mmHg |
10.48 |
18.15 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66653 |
717 |
SS-Ets1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
139.33 |
mmHg |
15.68 |
27.15 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66655 |
717 |
SS-Rag1em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
123.14 |
mmHg |
6.08 |
16.08 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66661 |
717 |
SS-Renem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
155.25 |
mmHg |
12.05 |
24.1 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66671 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
124.67 |
mmHg |
2.17 |
5.32 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66681 |
717 |
SS-Gpr183em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
145.0 |
mmHg |
9.6 |
25.4 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66682 |
717 |
SS-Acad10em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.0 |
mmHg |
3.78 |
8.46 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66686 |
717 |
SS-Alms1em1Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
6 |
|
|
7.77 |
mg/d |
1.02 |
2.49 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66692 |
717 |
SS-Mthfrem1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
1 |
|
|
11.47 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66698 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
9.78 |
mg/d |
0.8 |
1.13 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66710 |
717 |
SS-Apoeem7Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
5 |
|
|
11.01 |
mg/d |
0.65 |
1.45 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66718 |
717 |
SS-Nox4em2Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
12.06 |
mg/d |
1.27 |
2.2 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66721 |
717 |
SS-Nox4em2Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
5 |
|
|
10.89 |
mg/d |
0.69 |
1.53 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66730 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
7 |
|
|
11.76 |
mg/d |
0.57 |
1.51 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66742 |
717 |
SS-Acad10em2Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
12 |
|
|
1.51 |
g |
0.03 |
0.12 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66758 |
717 |
SS-Mthfrem1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.63 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66759 |
717 |
SS-Nckap5em1Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
7 |
|
|
1.48 |
g |
0.08 |
0.21 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66762 |
717 |
SS-Nckap5em2Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.71 |
g |
0.05 |
0.14 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66767 |
717 |
SS-Nckap5em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.67 |
g |
0.08 |
0.18 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66780 |
717 |
SS-Alms1em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.47 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66790 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.41 |
g |
0.05 |
0.1 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66793 |
717 |
SS-Tfdp2em2Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.37 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66798 |
717 |
SS-Cybaem1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.52 |
g |
0.11 |
0.15 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66799 |
717 |
SS-Itga9em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.48 |
g |
0.01 |
0.01 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66801 |
717 |
SS-Ncf2em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
6 |
|
|
11.43 |
mEq/d |
0.64 |
1.56 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66812 |
717 |
SS-Ube2q2em3Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
1 |
|
|
11.19 |
mEq/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66819 |
717 |
SS-Tgfb1em3Mcwi+/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
11.14 |
mEq/d |
1.82 |
3.16 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66823 |
717 |
SS.LEW-(D1Mco102-D1Mco129)/1Mco |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 36 and 40 days) |
Joe B, et al., Hum Mol Genet. 2009 Aug 1;18(15):2825-38. Epub 2009 May 7. |
arterial blood pressure trait |
male |
66 days-70 days |
20 |
|
serial mean |
172.0 |
mmHg |
1.9 |
8.5 |
tail cuff plethysmography |
|
345600 |
|
0 |
|
Rats warmed to 28 degrees C for measurement. |
|
|
65310 |
565 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., Hum Mol Genet. 2009 Aug 1;18(15):2825-38. Epub 2009 May 7. |
heart mass |
male |
64 days-70 days |
20 |
|
serial mean |
1.32 |
g |
0.01 |
0.06 |
post excision weight measurement |
|
345600 |
|
0 |
|
|
|
|
65314 |
565 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
12 |
|
serial mean |
160.0 |
mmHg |
6.0 |
20.78 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65463 |
151 |
SS.LEW-(D8Rat56-D8Rat51)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 31 and 38 days) |
Ariyarajah A, et al., J Hypertens 2004 Aug;22(8):1495-502. |
arterial blood pressure trait |
male |
66 days-74 days |
9 |
|
|
197.0 |
mmHg |
5.0 |
15.0 |
radiotelemetry |
|
0 |
|
0 |
|
|
|
|
65471 |
589 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (0.4 %) (for 35 days) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renin activity |
female |
95 days
| 7 |
|
|
4.7 |
ng/ml/h |
1.6 |
4.23 |
ex vivo blood analysis |
|
0 |
|
0 |
|
|
|
|
65473 |
151 |
SS/Jr |
mean arterial blood pressure |
controlled sodium content diet (2 %) (for 63 days) |
Moujahidine M, et al., Hypertens Res 2004 Mar;27(3):203-12. |
arterial blood pressure trait |
male |
98 days
| 16 |
|
serial mean |
171.0 |
mmHg |
4.0 |
16.0 |
radiotelemetry |
|
120 |
|
0 |
|
|
average of 6hr |
|
65475 |
610 |
BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (0.4 %) (for 35 days) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renin activity |
female |
95 days
| 11 |
|
|
9.6 |
ng/ml/h |
1.0 |
3.32 |
ex vivo blood analysis |
|
0 |
|
0 |
|
|
|
|
65474 |
151 |
SS-Chr 19SHR/Rkb |
single kidney wet weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
kidney mass |
male |
98 days
| 20 |
|
|
3.1 |
g/kg |
0.06 |
0.27 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
66088 |
669 |
SS-Chr 19SHR/Rkb |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (4 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
heart right ventricle mass |
male |
98 days
| 20 |
|
|
0.57 |
mg/g |
0.03 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
66093 |
669 |
SS-Chr 5BN-Cyp4a2em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
9.13 |
mEq/d |
0.61 |
1.06 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66834 |
717 |
SS-Ncf2em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
5 |
|
|
10.7 |
mEq/d |
0.99 |
2.21 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66831 |
717 |
SS-Apoeem7Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
12.51 |
mEq/d |
2.26 |
3.92 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66836 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
1 |
|
|
12.12 |
mEq/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66835 |
717 |
SS-Cybaem1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
6 |
|
|
9.8 |
mEq/d |
1.62 |
3.97 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66837 |
717 |
SS-Nox4em2Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
5 |
|
|
9.51 |
mEq/d |
0.72 |
1.61 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66853 |
717 |
SS-Renem1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
4 |
|
|
7.2 |
mEq/d |
0.99 |
1.98 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66855 |
717 |
SS-Nckap5em3Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
10.65 |
mEq/d |
0.47 |
0.67 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66867 |
717 |
SS-Mas1em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
10.91 |
mEq/d |
2.02 |
2.85 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66869 |
717 |
SS-Mmp2em1Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
6 |
|
|
24.91 |
mg/d |
4.8 |
11.75 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66875 |
717 |
SS-Nckap5em1Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
7 |
|
|
66.56 |
mg/d |
21.67 |
57.33 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66885 |
717 |
SS-Gpr183em2Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
9 |
|
|
84.78 |
mg/d |
11.45 |
34.35 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66887 |
717 |
SS-Gpr183em3Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
4 |
|
|
56.31 |
mg/d |
13.79 |
27.57 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66904 |
717 |
SS-Nckap5em2Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
2 |
|
|
76.07 |
mg/d |
1.64 |
2.32 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66907 |
717 |
SS-Ets1em1Mcwi-/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
9 |
|
|
14.6 |
mg/d |
3.91 |
11.72 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66917 |
717 |
SS-Itga9em1Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
4 |
|
|
34.92 |
mg/d |
4.36 |
8.71 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66923 |
717 |
SS-Mthfrem1Mcwi-/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
8 |
|
|
73.13 |
mg/d |
19.06 |
53.91 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66929 |
717 |
SS-Acad10em2Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
5 |
|
|
41.87 |
mg/d |
14.26 |
31.89 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66931 |
717 |
SS-Ncf2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
127.17 |
mmHg |
6.48 |
15.88 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66934 |
717 |
SS-Nox4em2Mcwi-/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
2 |
|
|
42.62 |
mg/d |
6.61 |
9.34 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66932 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
124.75 |
mmHg |
5.48 |
10.97 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66935 |
717 |
SS-Mas1em1Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
2 |
|
|
82.56 |
mg/d |
1.95 |
2.75 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66930 |
717 |
SS-Rag1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
127.5 |
mmHg |
4.09 |
8.19 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66938 |
717 |
SS-Ulk4em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
174.25 |
mmHg |
16.92 |
33.84 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66940 |
717 |
SS-Tgfb1em3Mcwi+/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
119.67 |
mmHg |
10.14 |
17.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66945 |
717 |
SS-Ncf2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.2 |
mmHg |
6.27 |
14.03 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66953 |
717 |
SS-Cybaem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
124.0 |
mmHg |
8.62 |
19.27 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66958 |
717 |
SS-Nox4em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
120.67 |
mmHg |
3.38 |
5.86 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66965 |
717 |
SS-Rag1em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.0 |
g |
0.07 |
0.12 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66998 |
717 |
SS-Mthfrem1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
1 |
|
|
1.08 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67003 |
717 |
SS-Ulk4em3Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
4 |
|
|
1.26 |
g |
0.05 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67000 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
2 |
|
|
1.19 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67015 |
717 |
SS-Apoeem7Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.16 |
g |
0.06 |
0.1 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67018 |
717 |
SS-Apoeem7Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
5 |
|
|
1.1 |
g |
0.03 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67023 |
717 |
SS-Tfdp2em2Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.17 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67042 |
717 |
SS-Nox4em2Mcwi-/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
2 |
|
|
1.04 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67054 |
717 |
SS-Gpr183em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
335.5 |
beats/min |
6.5 |
9.19 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67074 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
366.25 |
beats/min |
23.14 |
46.28 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67076 |
717 |
SS-Apoeem7Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
364.0 |
beats/min |
12.29 |
21.28 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67084 |
717 |
SS-Rag1em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
343.0 |
beats/min |
14.92 |
36.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67088 |
717 |
SS-Nox4em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
374.33 |
beats/min |
5.7 |
9.87 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67087 |
717 |
SS-Gpr183em3Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
345.67 |
beats/min |
10.27 |
17.79 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67086 |
717 |
SS-Nckap5em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
341.0 |
beats/min |
11.0 |
15.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67089 |
717 |
SS-Rag1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
353.0 |
beats/min |
22.92 |
45.83 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67093 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
360.67 |
beats/min |
2.67 |
4.62 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67095 |
717 |
SS-Itga9em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
374.0 |
beats/min |
5.29 |
9.17 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67105 |
717 |
SS.LEW-(D10Chm224-D10Chm6)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 11 |
|
|
2.78 |
mg/g |
0.04 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64886 |
226 |
SS.LEW-(D18Chm91-D18Rat67)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
|
2.7 |
mg/g |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64896 |
226 |
SS.LEW-(D10Chm128-D10Chm169)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 8 |
|
|
2.97 |
mg/g |
0.08 |
0.23 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64914 |
226 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) then controlled exposure to ambient light (for 12 hours) then controlled exposure to darkness (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
42 |
|
continuous mean |
4.5 |
mmHg |
2.0 |
12.96 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
0 |
|
left femoral artery |
increase |
|
64928 |
229 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 39 and 40 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
107 days-109 days |
3 |
|
|
228.2 |
mmHg |
2.6 |
4.5 |
intra-aortic abdominal radiotelemetry |
|
86400 |
|
0 |
|
|
|
|
65047 |
283 |
SS/Jr |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 27 and 28 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
67 days-69 days |
5 |
|
|
125.2 |
mmHg |
3.0 |
6.71 |
intra-aortic abdominal radiotelemetry |
|
86400 |
|
0 |
|
|
|
|
65057 |
283 |
SS.SR-(D3Arb14-D3Mco36)/Mco |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 39 and 40 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
107 days-109 days |
4 |
|
|
157.5 |
mmHg |
3.3 |
6.6 |
intra-aortic abdominal radiotelemetry |
|
86400 |
|
0 |
|
|
|
|
65064 |
283 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 9 and 10 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
76 days-78 days |
5 |
|
|
110.2 |
mmHg |
2.0 |
4.47 |
intra-aortic abdominal radiotelemetry |
|
86400 |
|
0 |
|
|
|
|
65062 |
283 |
SS-Nckap5em3Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
356.5 |
beats/min |
12.5 |
17.68 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67110 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
381.0 |
beats/min |
1.0 |
1.41 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67126 |
717 |
SS-Mthfrem1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
348.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67125 |
717 |
SS-Gpr183em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
379.0 |
beats/min |
13.0 |
18.38 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67134 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
353.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67139 |
717 |
SS-Gpr183em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
373.33 |
beats/min |
14.66 |
25.38 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67142 |
717 |
SS-Tfdp2em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
380.33 |
beats/min |
38.35 |
66.43 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67164 |
717 |
SS-Mthfrem1Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
353.57 |
beats/min |
9.89 |
27.96 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67173 |
717 |
SS-Acad10em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
374.6 |
beats/min |
8.52 |
19.05 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67175 |
717 |
SS-Mas1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
348.5 |
beats/min |
6.5 |
9.19 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67174 |
717 |
LEW/Crl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
2.96 |
beats/min |
11.93 |
26.67 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51680 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-11.7 |
beats/min |
12.08 |
34.18 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51700 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-3.72 |
beats/min |
14.86 |
33.24 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51703 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
-74.95 |
beats/min |
19.95 |
39.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51701 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-90.84 |
beats/min |
15.38 |
37.66 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51711 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
-36.4 |
beats/min |
20.58 |
50.41 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51714 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-21.04 |
beats/min |
12.68 |
28.35 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51725 |
481 |
Hsd:SD |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
11 |
|
|
2.61 |
ml/min |
0.23 |
0.77 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51747 |
481 |
SS/JrHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
21 |
|
|
53.74 |
mg/d |
5.94 |
27.24 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51750 |
481 |
SS-Chr 18BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
8 |
|
|
23.12 |
mg/d |
6.52 |
18.44 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51753 |
481 |
GH/OmrMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
8 |
|
|
15.69 |
mg/d |
3.09 |
8.73 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51756 |
481 |
SHR/NCrl |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
9 |
|
|
24.02 |
mg/d |
3.75 |
11.24 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51755 |
481 |
BN/NHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
10 |
|
|
19.71 |
mg/d |
4.56 |
14.41 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51762 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
17.03 |
mmHg |
2.14 |
4.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51764 |
481 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
21.82 |
mmHg |
4.54 |
12.02 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51784 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
30.33 |
mmHg |
2.51 |
5.03 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51778 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
7.38 |
mmHg |
3.34 |
10.01 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51786 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
15.53 |
beats/min |
17.94 |
50.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51795 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
8 |
|
|
1.77 |
ml/min |
0.16 |
0.45 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51803 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
116.75 |
mmHg |
1.54 |
4.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51820 |
481 |
SS-Chr 20BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
9 |
|
|
1.75 |
ng/ml/h |
0.31 |
0.92 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51834 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
13 |
|
|
0.43 |
ng/ml/h |
0.08 |
0.29 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51833 |
481 |
SS-Chr 9BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
14 |
|
|
1.08 |
ng/ml/h |
0.12 |
0.45 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51840 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
5 |
|
|
4.01 |
ng/ml/h |
1.09 |
2.43 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51843 |
481 |
BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
3 |
|
|
2.06 |
ng/ml/h |
0.69 |
1.19 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51844 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-25.56 |
beats/min |
21.49 |
48.06 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51847 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
-26.49 |
beats/min |
16.87 |
44.63 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51849 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
22.21 |
beats/min |
6.03 |
17.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51855 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
-8.33 |
beats/min |
29.02 |
82.09 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51856 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
-7.05 |
beats/min |
10.76 |
21.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51858 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
12 |
|
|
16.35 |
mmHg |
2.77 |
9.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51869 |
481 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
10 |
|
|
10.9 |
mEq/d |
0.8 |
2.54 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51894 |
481 |
F344/DuCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
7 |
|
|
0.29 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51896 |
481 |
F344/DuCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
9 |
|
|
0.22 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51898 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.31 |
mg/dl |
0.02 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51902 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
2 |
|
|
21.3 |
beats/min |
54.9 |
77.64 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51921 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
15 |
|
|
-30.67 |
beats/min |
12.69 |
49.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51925 |
481 |
SS-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
6 |
|
|
2.03 |
ml/min |
0.15 |
0.38 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51935 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
1 |
|
|
1.05 |
ml/min |
|
|
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51934 |
481 |
SS-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
4 |
|
|
1.44 |
ml/min |
0.11 |
0.22 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51933 |
481 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
14 |
|
|
1.64 |
ml/min |
0.17 |
0.64 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51944 |
481 |
SS-Chr 20BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
12 |
|
|
0.96 |
ml/min |
0.09 |
0.3 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51945 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
5 |
|
|
1.39 |
ml/min |
0.1 |
0.23 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51947 |
481 |
SS-Chr 9BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
13 |
|
|
1.13 |
ml/min |
0.2 |
0.73 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51948 |
481 |
SS-Chr 9BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
14 |
|
|
0.77 |
ml/min |
0.16 |
0.61 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51951 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
24.43 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51965 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
25.27 |
mmHg |
3.22 |
12.48 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51966 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
-0.9 |
mmHg |
1.72 |
4.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51967 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
13.53 |
mmHg |
3.99 |
10.56 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51969 |
481 |
Crl:CD(SD) |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
6 |
|
|
0.32 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51984 |
481 |
F344/DuCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
5 |
|
|
0.29 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51985 |
481 |
SS-Chr 20BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
14 |
|
|
122.5 |
mmHg |
2.84 |
10.64 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52006 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
137.89 |
mmHg |
7.62 |
15.25 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52007 |
481 |
SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
14 |
|
|
123.13 |
mmHg |
1.84 |
6.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52004 |
481 |
SS-Chr 18BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
13.61 |
mEq/d |
0.49 |
1.38 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52010 |
481 |
SS-Chr 16BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
6 |
|
|
14.22 |
mEq/d |
0.96 |
2.35 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52013 |
481 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
3 |
|
|
12.33 |
mEq/d |
1.71 |
2.97 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52021 |
481 |
WKY/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
9 |
|
|
1.5 |
ml/min |
0.15 |
0.45 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
|
52027 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
1.21 |
mmHg |
4.28 |
11.33 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52024 |
481 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
7 |
|
|
0.31 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52035 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
6 |
|
|
0.35 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52038 |
481 |
F344/DuCrl |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
10 |
|
|
24.49 |
mg/d |
4.28 |
13.53 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
52063 |
481 |
WKY/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-33.41 |
beats/min |
13.0 |
39.01 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52074 |
481 |
WKY/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-73.2 |
beats/min |
18.38 |
55.13 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52078 |
481 |
SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
129.82 |
mmHg |
3.64 |
10.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52082 |
481 |
WKY/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
-35.03 |
beats/min |
21.41 |
56.65 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52081 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
104.93 |
mmHg |
2.81 |
7.93 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52091 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
104.25 |
mmHg |
3.14 |
6.27 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
52092 |
481 |
FHH-Chr 12BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
10 |
|
|
157.28 |
mg/d |
60.1 |
190.06 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52094 |
482 |
FHH-Chr 15BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
9 |
|
|
232.75 |
mg/d |
44.36 |
133.08 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52095 |
482 |
FHH-Chr 8BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
7 |
|
|
65.01 |
mg/d |
9.0 |
23.82 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52096 |
482 |
FHH-Chr 5BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
6 |
|
|
110.21 |
mg/d |
29.1 |
71.27 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52100 |
482 |
FHH/EurMcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
16 |
|
|
170.33 |
mg/d |
49.67 |
198.67 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52097 |
482 |
FHH-Chr 3BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
2 |
|
|
259.8 |
mg/d |
89.85 |
127.07 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52099 |
482 |
FHH-Chr 12BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
11 |
|
|
368.02 |
mg/d |
45.8 |
151.92 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52113 |
482 |
FHH/EurMcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
48 |
|
|
472.36 |
mg/d |
30.23 |
209.46 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52115 |
482 |
FHH-Chr 4BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
9 |
|
|
168.35 |
mg/d |
63.34 |
190.01 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52127 |
482 |
BN/NHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
11 |
|
|
39.43 |
mg/d |
8.21 |
27.23 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52135 |
482 |
SS-Chr 9BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
8 |
|
|
1.85 |
ml/min |
0.19 |
0.55 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52145 |
482 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
8 |
|
|
1.68 |
ml/min |
0.46 |
1.31 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52146 |
482 |
SS-Chr 17BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
5 |
|
|
2.41 |
ml/min |
0.57 |
1.27 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52151 |
482 |
FHH-Chr 5BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
6 |
|
|
23.17 |
mEq/d |
2.06 |
5.05 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52786 |
482 |
FHH-Chr 6BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
8 |
|
|
15.39 |
mEq/d |
2.33 |
6.6 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52791 |
482 |
FHH-Chr 15BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
7 |
|
|
17.44 |
mEq/d |
3.27 |
8.66 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52802 |
482 |
FHH-Chr 16BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
7 |
|
|
8.59 |
mEq/d |
1.43 |
3.78 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52808 |
482 |
FHH-Chr XBN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
7 |
|
|
20.79 |
mEq/d |
0.9 |
2.37 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52822 |
482 |
FHH-Chr 7BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
11 |
|
|
14.23 |
mEq/d |
3.75 |
12.43 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52824 |
482 |
SS-Chr 10BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
10 |
|
|
171.08 |
mmHg |
6.65 |
21.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52829 |
482 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
8 |
|
|
135.4 |
mmHg |
3.37 |
9.54 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52846 |
482 |
SS-Chr 20BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
7 |
|
|
147.43 |
mmHg |
7.77 |
20.57 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52853 |
482 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
20 |
|
|
156.0 |
mmHg |
7.15 |
31.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52872 |
482 |
FHH-Chr 15BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
9 |
|
|
2.92 |
ng/ml/h |
0.71 |
2.13 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52879 |
482 |
FHH-Chr 12BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
7 |
|
|
7.44 |
ng/ml/h |
1.44 |
3.8 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52878 |
482 |
FHH-Chr 6BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
6 |
|
|
3.2 |
ng/ml/h |
0.43 |
1.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52889 |
482 |
FHH-Chr 13BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
7 |
|
|
8.07 |
ng/ml/h |
0.72 |
1.91 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52892 |
482 |
FHH-Chr 20BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
1 |
|
|
1.4 |
ng/ml/h |
|
|
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52893 |
482 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
38 |
|
|
2.57 |
ng/ml/h |
0.36 |
2.21 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52899 |
482 |
FHH-Chr 12BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
10 |
|
|
1.71 |
ng/ml/h |
0.17 |
0.52 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52897 |
482 |
FHH-Chr 1BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
7 |
|
|
3.1 |
ng/ml/h |
0.58 |
1.53 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52907 |
482 |
FHH-Chr 11BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
3 |
|
|
1.02 |
ng/ml/h |
0.4 |
0.69 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52912 |
482 |
FHH-Chr 4BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
8 |
|
|
11.17 |
ng/ml/h |
2.91 |
8.22 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52911 |
482 |
FHH-Chr XBN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
5 |
|
|
4.63 |
ng/ml/h |
0.97 |
2.16 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52920 |
482 |
FHH-Chr 9BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
4 |
|
|
2.48 |
ng/ml/h |
0.69 |
1.38 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52921 |
482 |
SS-Chr 14BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
11 |
|
|
0.88 |
mEq/d |
0.09 |
0.29 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52929 |
482 |
SS-Chr 5BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
8 |
|
|
1.03 |
mEq/d |
0.09 |
0.27 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52940 |
482 |
SS-Chr 5BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
10 |
|
|
1.33 |
mEq/d |
0.09 |
0.28 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52942 |
482 |
SS-Chr 3BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
7 |
|
|
1.04 |
mEq/d |
0.11 |
0.3 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52950 |
482 |
SS-Chr 1BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
20 |
|
|
1.07 |
mEq/d |
0.08 |
0.34 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52958 |
482 |
SS-Chr 20BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
9 |
|
|
0.95 |
mEq/d |
0.07 |
0.2 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52951 |
482 |
SS-Chr XBN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
7 |
|
|
1.27 |
mEq/d |
0.14 |
0.38 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52959 |
482 |
SS-Chr 4BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
7 |
|
|
1.08 |
mEq/d |
0.21 |
0.56 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52962 |
482 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
21 |
|
|
1.14 |
mEq/d |
0.05 |
0.23 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52970 |
482 |
SS-Chr 1BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
19 |
|
|
0.93 |
mEq/d |
0.06 |
0.27 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52961 |
482 |
SS-Chr 19BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
8 |
|
|
0.81 |
mEq/d |
0.08 |
0.23 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52967 |
482 |
SS-Chr XBN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
3 |
|
|
1.6 |
ml/min |
0.34 |
0.59 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52173 |
482 |
SS-Chr 12BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
3 |
|
|
2.21 |
ml/min |
0.03 |
0.06 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52185 |
482 |
SS-Chr 14BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
9 |
|
|
0.3 |
mg/dl |
0.01 |
0.04 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52192 |
482 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
8 |
|
|
0.34 |
mg/dl |
0.04 |
0.1 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52195 |
482 |
SS-Chr XBN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
3 |
|
|
2.43 |
ml/min |
0.72 |
1.25 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52188 |
482 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
9 |
|
|
0.42 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52207 |
482 |
SS-Chr 20BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
7 |
|
|
0.36 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52214 |
482 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
8 |
|
|
0.33 |
mg/dl |
0.03 |
0.09 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52223 |
482 |
SS-Chr XBN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
3 |
|
|
0.4 |
mg/dl |
0.07 |
0.13 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52237 |
482 |
FHH-Chr 15BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
9 |
|
|
0.32 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52244 |
482 |
FHH-Chr 6BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
5 |
|
|
0.38 |
mg/dl |
0.05 |
0.11 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52254 |
482 |
FHH-Chr 1BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
7 |
|
|
0.35 |
mg/dl |
0.03 |
0.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52272 |
482 |
FHH-Chr 9BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
3 |
|
|
0.5 |
mg/dl |
0.2 |
0.34 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52280 |
482 |
FHH-Chr XBN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
6 |
|
|
0.61 |
mg/dl |
0.08 |
0.2 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52278 |
482 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
8 |
|
|
0.24 |
mg/dl |
0.03 |
0.07 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52283 |
482 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80 days-99 days |
7 |
|
|
0.33 |
mg/dl |
0.03 |
0.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52284 |
482 |
LE/BluGill |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
6 |
|
|
2.56 |
ml/min |
0.2 |
0.5 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
52291 |
482 |
FHH-Chr 5BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
6 |
|
|
1.25 |
mEq/d |
0.12 |
0.3 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52298 |
482 |
FHH-Chr 2BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
5 |
|
|
1.34 |
mEq/d |
0.07 |
0.15 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52318 |
482 |
FHH-Chr 1BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
10 |
|
|
0.94 |
mEq/d |
0.09 |
0.27 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52338 |
482 |
FHH-Chr 2BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
5 |
|
|
1.71 |
ml/min |
0.2 |
0.44 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52346 |
482 |
FHH-Chr 20BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
6 |
|
|
2.06 |
ml/min |
0.39 |
0.95 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52357 |
482 |
FHH-Chr 5BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
7 |
|
|
1.6 |
ml/min |
0.12 |
0.32 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52351 |
482 |
FHH-Chr 13BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
10 |
|
|
1.17 |
ml/min |
0.23 |
0.73 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52355 |
482 |
FHH-Chr 3BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
3 |
|
|
0.68 |
ml/min |
0.25 |
0.44 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52362 |
482 |
FHH-Chr 10BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
7 |
|
|
1.82 |
ml/min |
0.35 |
0.94 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52366 |
482 |
FHH-Chr 7BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
7 |
|
|
1.44 |
ml/min |
0.23 |
0.6 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52377 |
482 |
FHH-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
7 |
|
|
1.55 |
ml/min |
0.35 |
0.92 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52384 |
482 |
FHH-Chr 19BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
7 |
|
|
227.43 |
mg/d |
44.77 |
118.45 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52390 |
482 |
FHH-Chr 19BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
8 |
|
|
31.83 |
mg/d |
11.92 |
33.71 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52396 |
482 |
FHH-Chr 18BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
9 |
|
|
48.46 |
mg/d |
29.49 |
88.47 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52406 |
482 |
FHH/EurMcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
48 |
|
|
183.29 |
mg/d |
13.89 |
96.23 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52407 |
482 |
FHH-Chr 1BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
10 |
|
|
68.56 |
mg/d |
16.62 |
52.55 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52415 |
482 |
FHH-Chr 10BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
6 |
|
|
264.36 |
mg/d |
29.33 |
71.84 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52425 |
482 |
FHH-Chr 9BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
5 |
|
|
134.79 |
mg/d |
42.57 |
95.18 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52423 |
482 |
SS-Chr 7BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
9 |
|
|
0.51 |
ng/ml/h |
0.12 |
0.37 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52446 |
482 |
SS-Chr 5BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
7 |
|
|
0.44 |
ng/ml/h |
0.08 |
0.2 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52448 |
482 |
SS-Chr 15BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
7 |
|
|
0.28 |
ng/ml/h |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52453 |
482 |
SS-Chr 13BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80 days-99 days |
17 |
|
|
1.13 |
ng/ml/h |
0.29 |
1.2 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52457 |
482 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
18 |
|
|
0.66 |
ng/ml/h |
0.14 |
0.58 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52478 |
482 |
FHH-Chr 15BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
9 |
|
|
383.93 |
beats/min |
7.94 |
23.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52485 |
482 |
FHH-Chr 20BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
7 |
|
|
386.33 |
beats/min |
10.29 |
27.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52499 |
482 |
FHH-Chr 4BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
5 |
|
|
446.87 |
beats/min |
8.17 |
18.26 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52514 |
482 |
FHH-Chr 11BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
4 |
|
|
431.62 |
beats/min |
7.42 |
14.85 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52518 |
482 |
FHH-Chr 9BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
4 |
|
|
437.66 |
beats/min |
5.03 |
10.06 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52521 |
482 |
FHH-Chr 9BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
4 |
|
|
409.54 |
beats/min |
10.2 |
20.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52527 |
482 |
FHH-Chr 2BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
5 |
|
|
156.33 |
mmHg |
11.05 |
24.71 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52538 |
482 |
FHH-Chr 5BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
7 |
|
|
174.07 |
mmHg |
8.96 |
23.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52543 |
482 |
FHH-Chr 8BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
3 |
|
|
159.61 |
mmHg |
9.53 |
16.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52544 |
482 |
FHH-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
10 |
|
|
188.54 |
mmHg |
5.26 |
16.64 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52547 |
482 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
48 |
|
|
181.54 |
mmHg |
2.9 |
20.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52552 |
482 |
FHH-Chr 1BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
9 |
|
|
166.93 |
mmHg |
4.8 |
14.41 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52560 |
482 |
FHH-Chr 11BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
4 |
|
|
188.98 |
mmHg |
4.83 |
9.66 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52565 |
482 |
FHH-Chr 7BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
9 |
|
|
148.65 |
mmHg |
7.47 |
22.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52569 |
482 |
FHH-Chr 9BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
4 |
|
|
170.24 |
mmHg |
5.85 |
11.71 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52568 |
482 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
8 |
|
|
120.84 |
mmHg |
2.6 |
7.37 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52571 |
482 |
FHH-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
8 |
|
|
165.26 |
mmHg |
12.62 |
35.7 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52576 |
482 |
SS-Chr 5BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
10 |
|
|
27.89 |
mg/d |
5.0 |
15.81 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52595 |
482 |
SS-Chr 20BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
9 |
|
|
44.12 |
mg/d |
8.7 |
26.09 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52604 |
482 |
SS-Chr 4BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
7 |
|
|
53.64 |
mg/d |
9.34 |
24.71 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52615 |
482 |
SS-Chr 4BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
8 |
|
|
11.71 |
mg/d |
2.97 |
8.4 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52621 |
482 |
SS-Chr 2BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
10 |
|
|
73.9 |
mg/d |
13.02 |
41.18 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52628 |
482 |
SS-Chr 7BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
10 |
|
|
413.46 |
beats/min |
4.88 |
15.44 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52645 |
482 |
SS-Chr 5BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
8 |
|
|
396.82 |
beats/min |
6.28 |
17.76 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52644 |
482 |
SS-Chr 20BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
9 |
|
|
410.8 |
beats/min |
6.42 |
19.25 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52647 |
482 |
SS-Chr 11BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
15 |
|
|
401.61 |
beats/min |
7.22 |
27.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52656 |
482 |
SS-Chr 11BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
14 |
|
|
378.79 |
beats/min |
10.47 |
39.16 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52658 |
482 |
SS-Chr XBN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
5 |
|
|
432.4 |
beats/min |
14.46 |
32.33 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52663 |
482 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
9 |
|
|
416.02 |
beats/min |
6.59 |
19.78 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52667 |
482 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
11 |
|
|
396.87 |
beats/min |
4.2 |
13.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52668 |
482 |
SS-Chr 4BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
7 |
|
|
399.08 |
beats/min |
14.32 |
37.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52666 |
482 |
SS-Chr 12BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
7 |
|
|
358.72 |
beats/min |
9.8 |
25.93 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52670 |
482 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
18 |
|
|
384.5 |
beats/min |
7.1 |
30.12 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52677 |
482 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
10 |
|
|
184.5 |
mg/d |
28.5 |
90.11 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52685 |
482 |
SS-Chr 6BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
9 |
|
|
89.78 |
mg/d |
14.56 |
43.68 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52688 |
482 |
SS-Chr 7BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
11 |
|
|
72.57 |
mg/d |
8.11 |
26.89 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52691 |
482 |
SS-Chr 5BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
10 |
|
|
46.14 |
mg/d |
7.31 |
23.12 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52695 |
482 |
SS-Chr YBN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
17 |
|
|
152.58 |
mg/d |
15.5 |
63.93 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52708 |
482 |
SS/JrHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
11 |
|
|
161.82 |
mg/d |
34.64 |
114.9 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52716 |
482 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
12 |
|
|
15.1 |
mEq/d |
1.32 |
4.57 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52732 |
482 |
SS-Chr 17BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
7 |
|
|
20.45 |
mEq/d |
2.52 |
6.66 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52743 |
482 |
SS-Chr 20BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
9 |
|
|
15.96 |
mEq/d |
2.07 |
6.2 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52755 |
482 |
SS-Chr 13BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
16 |
|
|
11.92 |
mEq/d |
1.33 |
5.31 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52757 |
482 |
SS-Chr XBN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
7 |
|
|
16.97 |
mEq/d |
1.49 |
3.94 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52763 |
482 |
SS-Chr 1BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
19 |
|
|
10.57 |
mEq/d |
1.46 |
6.38 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52765 |
482 |
SS-Chr 19BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
8 |
|
|
9.12 |
mEq/d |
2.82 |
7.99 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52771 |
482 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
20.6 |
beats/min |
13.45 |
26.91 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50513 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
388.73 |
beats/min |
6.4 |
20.24 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50527 |
481 |
WKY/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-71.1 |
beats/min |
33.5 |
82.05 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50518 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
3 |
|
|
0.64 |
ng/ml/h |
0.27 |
0.47 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50536 |
481 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
1 |
|
|
0.67 |
ng/ml/h |
|
|
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50539 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
6 |
|
|
9.02 |
ng/ml/h |
1.47 |
3.59 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50537 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
3.0 |
mmHg |
3.86 |
7.72 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50542 |
481 |
WKY/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-53.6 |
beats/min |
20.05 |
49.12 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50553 |
481 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
5 |
|
|
2.8 |
ng/ml/h |
0.87 |
1.94 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50565 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
-34.01 |
beats/min |
27.27 |
81.82 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50580 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
4 |
|
|
-24.45 |
beats/min |
31.16 |
62.33 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50590 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-9.39 |
beats/min |
43.01 |
96.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50594 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
-1.7 |
mmHg |
1.59 |
4.78 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50608 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-0.27 |
beats/min |
11.36 |
27.82 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50616 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
-26.25 |
beats/min |
11.9 |
23.81 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50623 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
-1.4 |
beats/min |
7.97 |
22.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50622 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
3 |
|
|
-2.03 |
mmHg |
7.23 |
12.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50637 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
136.5 |
mmHg |
3.86 |
12.21 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50644 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
411.76 |
beats/min |
26.24 |
52.48 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50667 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
387.4 |
beats/min |
19.95 |
52.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50670 |
481 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
3 |
|
|
118.36 |
mmHg |
3.5 |
6.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50673 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
2 |
|
|
142.46 |
mmHg |
8.89 |
12.57 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50678 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-1.47 |
beats/min |
34.5 |
84.5 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50684 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-5.23 |
beats/min |
21.31 |
56.37 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50686 |
481 |
LEW/Crl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
4 |
|
|
0.29 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50692 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
0.61 |
mmHg |
1.97 |
7.64 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50704 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
0.72 |
mmHg |
2.7 |
7.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50706 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
1 |
|
|
28.48 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50720 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
-25.21 |
beats/min |
19.43 |
54.97 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50728 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
10 |
|
|
149.76 |
mmHg |
4.03 |
12.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50742 |
481 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
101.3 |
mmHg |
2.17 |
6.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50745 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
29.73 |
mmHg |
2.92 |
8.76 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50747 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
32.91 |
mmHg |
5.6 |
13.72 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50752 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
-11.26 |
mmHg |
2.11 |
5.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50766 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
3 |
|
|
-6.83 |
mmHg |
2.51 |
4.35 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50765 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
-0.91 |
mmHg |
3.29 |
9.86 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50770 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
12 |
|
|
4.84 |
mmHg |
2.48 |
8.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50779 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
5.65 |
mmHg |
0.84 |
1.68 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50782 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
40.43 |
mmHg |
1.89 |
4.23 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50789 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
114.24 |
mmHg |
2.67 |
5.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50796 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
140.46 |
mmHg |
4.67 |
12.37 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50795 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
119.61 |
mmHg |
1.83 |
4.85 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50798 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
142.26 |
mmHg |
3.59 |
10.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50799 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
-11.35 |
mmHg |
4.78 |
14.34 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50803 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
-12.57 |
mmHg |
1.76 |
6.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50801 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
-7.15 |
mmHg |
2.83 |
6.32 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50812 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
0.91 |
mmHg |
2.27 |
4.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50818 |
481 |
LEW/Crl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
97.54 |
mmHg |
1.66 |
3.71 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50837 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
0.64 |
mmHg |
2.4 |
5.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50840 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
4.72 |
mmHg |
4.89 |
6.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50843 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
3 |
|
|
21.03 |
mmHg |
14.54 |
25.18 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50841 |
481 |
F344/DuCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
407.31 |
beats/min |
7.86 |
23.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50856 |
481 |
Crl:CD(SD) |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
404.0 |
beats/min |
22.43 |
59.35 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50855 |
481 |
F344/DuCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
385.1 |
beats/min |
13.34 |
32.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50862 |
481 |
Crl:CD(SD) |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
-48.95 |
beats/min |
23.61 |
47.22 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50865 |
481 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
409.57 |
beats/min |
5.76 |
12.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50881 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
35.88 |
mmHg |
3.36 |
8.9 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50875 |
481 |
F344/DuCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
31.24 |
mmHg |
2.72 |
7.19 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50876 |
481 |
SS-Chr 9BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
13 |
|
|
395.28 |
beats/min |
9.37 |
33.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50882 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
393.96 |
beats/min |
5.0 |
14.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50884 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
375.46 |
beats/min |
8.18 |
18.29 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50889 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
6.57 |
beats/min |
9.35 |
22.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50892 |
481 |
Crl:CD(SD) |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
5.44 |
beats/min |
14.96 |
29.92 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50891 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
28.03 |
mmHg |
6.24 |
13.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50901 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
2 |
|
|
23.96 |
mmHg |
20.35 |
28.78 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50903 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
10.88 |
beats/min |
6.24 |
13.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50904 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
15.12 |
beats/min |
28.47 |
49.3 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50908 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
12.14 |
beats/min |
6.37 |
16.86 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50906 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
2.79 |
mmHg |
5.37 |
13.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50922 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
1.42 |
mmHg |
2.41 |
7.24 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50925 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
3.68 |
mmHg |
1.76 |
3.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50928 |
481 |
SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
14 |
|
|
136.07 |
mmHg |
3.1 |
11.61 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50943 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
-12.2 |
beats/min |
20.46 |
50.11 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50953 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
15 |
|
|
35.98 |
mmHg |
2.91 |
11.27 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50962 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
24.17 |
mmHg |
4.29 |
10.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50964 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
14 |
|
|
37.45 |
beats/min |
19.76 |
73.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50986 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
36.95 |
beats/min |
7.33 |
14.67 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50987 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
13.43 |
mmHg |
1.98 |
5.23 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50998 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
5 |
|
|
12.61 |
ng/ml/h |
1.89 |
4.23 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51002 |
481 |
GH/OmrMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
9 |
|
|
3.39 |
ng/ml/h |
0.88 |
2.65 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51005 |
481 |
SS-Chr 9BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
14 |
|
|
2.21 |
ng/ml/h |
0.35 |
1.3 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51010 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
6.8 |
mmHg |
2.91 |
6.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51019 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
10 |
|
|
11.67 |
mmHg |
1.81 |
5.73 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51024 |
481 |
LEW/Crl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
0.07 |
beats/min |
14.92 |
39.49 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51041 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
-20.57 |
beats/min |
11.12 |
29.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51037 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
20 |
|
|
-1.58 |
mmHg |
1.98 |
8.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51038 |
481 |
SS-Chr 20BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
10 |
|
|
1.2 |
ml/min |
0.12 |
0.38 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51061 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
-2.18 |
mmHg |
2.36 |
5.28 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51067 |
481 |
F344/DuCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
117.34 |
mmHg |
1.33 |
3.99 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51077 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
3 |
|
|
15.0 |
beats/min |
17.09 |
29.6 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51070 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
1.42 |
mmHg |
1.42 |
2.0 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51083 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
0.65 |
mmHg |
2.07 |
5.48 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51084 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-4.01 |
beats/min |
12.94 |
31.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51089 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
-11.61 |
beats/min |
15.08 |
26.12 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51098 |
481 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
407.56 |
beats/min |
12.77 |
38.31 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51112 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
12 |
|
|
394.2 |
beats/min |
10.18 |
35.26 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51117 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
12 |
|
|
432.92 |
beats/min |
10.44 |
36.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51119 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
432.28 |
beats/min |
13.8 |
41.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51122 |
481 |
Hsd:SD |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
20 |
|
|
-41.72 |
beats/min |
7.75 |
34.65 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51125 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
-1.56 |
mmHg |
2.17 |
8.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51132 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
137.63 |
mmHg |
3.75 |
11.25 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51139 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
126.1 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51143 |
481 |
SHR/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
139.16 |
mmHg |
4.78 |
13.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51149 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
16 |
|
|
-16.62 |
beats/min |
6.53 |
26.13 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51154 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
-14.82 |
beats/min |
11.3 |
33.9 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51156 |
481 |
F344/DuCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
14.0 |
mmHg |
3.08 |
8.14 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51170 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
7 |
|
|
0.28 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51173 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
7 |
|
|
0.35 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51177 |
481 |
GH/OmrMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
8 |
|
|
0.31 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51182 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
12.46 |
mmHg |
3.39 |
7.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51183 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
10.04 |
mmHg |
3.19 |
9.56 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51186 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-34.31 |
beats/min |
15.69 |
47.06 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51197 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
17 |
|
|
-27.92 |
beats/min |
8.05 |
33.2 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51199 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
-34.17 |
beats/min |
7.73 |
24.44 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51203 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
-60.76 |
beats/min |
16.42 |
46.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51207 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
-69.53 |
beats/min |
11.28 |
27.64 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51225 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
15 |
|
|
10.55 |
beats/min |
16.42 |
63.61 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51233 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
-79.11 |
beats/min |
25.39 |
71.8 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51230 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
15 |
|
|
-21.84 |
beats/min |
4.82 |
18.68 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51236 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-22.66 |
beats/min |
17.34 |
45.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51239 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
15 |
|
|
-15.78 |
beats/min |
13.94 |
54.0 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51238 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
10 |
|
|
399.95 |
beats/min |
7.51 |
23.75 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51253 |
481 |
Crl:CD(SD) |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
18.95 |
beats/min |
7.34 |
17.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51260 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
388.81 |
beats/min |
6.13 |
10.62 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51255 |
481 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
3 |
|
|
0.95 |
mEq/d |
0.15 |
0.26 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51275 |
481 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
18 |
|
|
393.77 |
beats/min |
10.28 |
43.62 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51280 |
481 |
SS-Chr 20BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
15 |
|
|
417.6 |
beats/min |
6.66 |
25.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51281 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
381.9 |
beats/min |
3.85 |
11.54 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51286 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
408.04 |
beats/min |
7.45 |
21.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51291 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.25 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51309 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-7.69 |
beats/min |
11.36 |
30.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51331 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
46.11 |
beats/min |
18.25 |
48.29 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51333 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
19.9 |
mmHg |
4.12 |
10.08 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51339 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-5.36 |
beats/min |
26.01 |
58.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51348 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
-11.5 |
beats/min |
12.54 |
37.62 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51351 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
15 |
|
|
-27.23 |
beats/min |
9.2 |
35.65 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51350 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
10.88 |
beats/min |
4.58 |
12.97 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51378 |
481 |
Crl:CD(SD) |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
109.0 |
mmHg |
4.18 |
8.37 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51390 |
481 |
Crl:CD(SD) |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
103.26 |
mmHg |
5.16 |
10.33 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51392 |
481 |
F344/DuCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
101.06 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51393 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
2.21 |
mmHg |
3.42 |
9.04 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51395 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
36.49 |
mmHg |
4.28 |
11.32 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51422 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
45.65 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51423 |
481 |
SS-Chr 18BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
10 |
|
|
81.8 |
mg/d |
23.56 |
74.51 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51433 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
41.75 |
mmHg |
2.35 |
7.05 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51426 |
481 |
SS-Chr 16BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
12 |
|
|
49.72 |
mg/d |
6.98 |
24.18 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51439 |
481 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
4 |
|
|
1.51 |
ml/min |
0.23 |
0.45 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51448 |
481 |
SS-Chr 18BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
7 |
|
|
3.47 |
mg/d |
0.73 |
1.92 |
automated urine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51454 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
2 |
|
|
0.73 |
ml/min |
0.02 |
0.02 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51451 |
481 |
SS-Chr 20BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
19 |
|
|
6.82 |
mg/d |
0.97 |
4.22 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51467 |
481 |
SHR/NCrl |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
10 |
|
|
0.47 |
mg/d |
0.04 |
0.12 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51474 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
20 |
|
|
9.53 |
mmHg |
1.49 |
6.66 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51479 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
364.9 |
beats/min |
8.85 |
23.41 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51486 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
33.19 |
mmHg |
3.65 |
5.16 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51491 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
20.44 |
mmHg |
5.29 |
11.82 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51490 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
7.05 |
mmHg |
1.68 |
4.12 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51496 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-37.54 |
beats/min |
13.84 |
41.52 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51501 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
7 |
|
|
-28.06 |
beats/min |
17.7 |
46.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51504 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
12 |
|
|
-46.0 |
beats/min |
14.52 |
50.29 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51509 |
481 |
SS-Chr 18BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
7 |
|
|
0.91 |
mEq/d |
0.11 |
0.28 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51519 |
481 |
F344/DuCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-48.94 |
beats/min |
12.72 |
33.65 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51530 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
7 |
|
|
1.45 |
ml/min |
0.17 |
0.46 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51542 |
481 |
SHR/NCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
7 |
|
|
1.08 |
ml/min |
0.08 |
0.2 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51544 |
481 |
GH/OmrMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
3 |
|
|
1.69 |
ml/min |
0.06 |
0.1 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51545 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
9 |
|
|
2.23 |
ml/min |
0.08 |
0.25 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51547 |
481 |
FHH/EurMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
male |
87 days-120 days |
8 |
|
|
59.56 |
mg/d |
16.55 |
46.8 |
automated urine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51558 |
481 |
GH/OmrMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
7 |
|
|
1.34 |
mg/d |
0.47 |
1.24 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51564 |
481 |
SS-Chr 16BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
12 |
|
|
22.08 |
mg/d |
3.69 |
12.78 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51565 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
8 |
|
|
328.06 |
beats/min |
5.66 |
16.02 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51582 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
2.21 |
mmHg |
3.87 |
11.6 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51596 |
481 |
Hsd:SD |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
5 |
|
|
1.65 |
ng/ml/h |
0.44 |
0.98 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51620 |
481 |
FHH/EurMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
122.1 |
mmHg |
1.91 |
5.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51627 |
481 |
F344/DuCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
7.87 |
mEq/d |
1.47 |
4.17 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51640 |
481 |
FHH/EurMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.23 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51643 |
481 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.26 |
mg/dl |
0.01 |
0.02 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51647 |
481 |
SS-Chr 9BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
14 |
|
|
0.26 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51651 |
481 |
SHR/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
6 |
|
|
0.26 |
mg/dl |
0.0 |
0.01 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51652 |
481 |
BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
3 |
|
|
0.28 |
mg/dl |
0.03 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51655 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
2 |
|
|
25.88 |
mmHg |
1.67 |
2.36 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51660 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
15 |
|
|
36.48 |
mmHg |
2.7 |
10.45 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51662 |
481 |
Crl:CD(SD) |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
9 |
|
|
0.59 |
mg/d |
0.08 |
0.25 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51669 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
30.91 |
mmHg |
4.23 |
11.18 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51665 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
31.19 |
mmHg |
2.1 |
4.2 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51667 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
377.14 |
beats/min |
16.4 |
43.39 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50329 |
481 |
SS-Chr 18BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
451.67 |
beats/min |
18.13 |
44.41 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50327 |
481 |
Hsd:SD |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
20 |
|
|
124.48 |
mmHg |
1.9 |
8.48 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50333 |
481 |
Hsd:SD |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
15 |
|
|
114.94 |
mmHg |
1.51 |
5.86 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50334 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
2 |
|
|
-57.41 |
beats/min |
0.99 |
1.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50338 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-48.51 |
beats/min |
15.93 |
42.16 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50339 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-45.24 |
beats/min |
26.63 |
70.44 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50347 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
-47.44 |
beats/min |
16.66 |
49.97 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50353 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
4 |
|
|
-45.27 |
beats/min |
22.01 |
44.02 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50363 |
481 |
SHR/NCrl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
-12.88 |
beats/min |
7.63 |
18.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50364 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
6.33 |
mmHg |
2.64 |
6.46 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50369 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
3.61 |
mmHg |
1.8 |
5.09 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50378 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
6 |
|
|
11.87 |
ng/ml/h |
0.85 |
2.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50389 |
481 |
SHR/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
7 |
|
|
10.95 |
ng/ml/h |
1.24 |
3.28 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50391 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
9 |
|
|
11.85 |
ng/ml/h |
0.69 |
2.08 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50394 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
4.13 |
mmHg |
3.85 |
8.62 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50406 |
481 |
WKY/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
9 |
|
|
0.4 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50409 |
481 |
WKY/NCrl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
5 |
|
|
0.42 |
mg/dl |
0.03 |
0.07 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50412 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
-8.48 |
beats/min |
15.29 |
43.23 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50429 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
-0.61 |
mmHg |
2.07 |
4.64 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50432 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
-0.2 |
mmHg |
4.63 |
12.24 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50434 |
481 |
WKY/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
8 |
|
|
1.16 |
mEq/d |
0.2 |
0.56 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
50439 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
6 |
|
|
410.27 |
beats/min |
18.86 |
46.2 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50446 |
481 |
SS/JrHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
14 |
|
|
0.93 |
ng/ml/h |
0.15 |
0.56 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50456 |
481 |
SHR/NCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
7 |
|
|
0.83 |
ng/ml/h |
0.23 |
0.6 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50464 |
481 |
FHH/EurMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
8 |
|
|
9.0 |
ng/ml/h |
0.76 |
2.15 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50462 |
481 |
GH/OmrMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
400.42 |
beats/min |
13.3 |
39.9 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50473 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
349.08 |
beats/min |
20.02 |
40.03 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50476 |
481 |
FHH/EurMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
6 |
|
|
358.13 |
beats/min |
16.04 |
39.3 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50481 |
481 |
SHR/NCrl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
385.51 |
beats/min |
15.45 |
46.36 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50479 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
19 |
|
|
4.09 |
mmHg |
1.31 |
5.69 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50498 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
15 |
|
|
8.67 |
mmHg |
1.66 |
6.43 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50499 |
481 |
SS/Jr |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 16 |
|
|
12.1 |
g/kg |
0.3 |
1.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64772 |
226 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 5 |
|
|
10.1 |
g/kg |
0.4 |
0.89 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64775 |
226 |
SS.LEW-(D8Rat56-D8Rat51)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 9 |
|
|
11.1 |
g/kg |
0.4 |
1.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64788 |
226 |
SS.MNS-(D2Wox27-Adh1)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 5 |
|
|
10.3 |
g/kg |
0.2 |
0.45 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64796 |
226 |
SS.LEW-(D2Rat18-D2Chm277)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 6 |
|
|
12.2 |
g/kg |
0.3 |
0.73 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64800 |
226 |
SS.MNS-(D2Chm25-Fgg)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 9 |
|
|
2.94 |
mg/g |
0.08 |
0.24 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64950 |
226 |
SS.MNS-(D2Chm51-D2Rat341)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 8 |
|
|
0.62 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64955 |
226 |
SS.LEW-(D2Rat199-D2Mco17)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 8 |
|
|
0.7 |
mg/g |
0.03 |
0.08 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64963 |
226 |
SS.BN-(D13Rat151-D13Rat197)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
49.3 |
mg/d |
3.7 |
12.82 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65249 |
15 |
SS/Jr |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8. |
body mass |
male |
53 days-67 days |
10 |
|
|
297.0 |
g |
5.0 |
15.81 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
66107 |
691 |
SS.SR-(D3Arb14-D3Mco36)/Mco |
heart left ventricle relative wall thickness |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle wall thickness |
male |
109 days-112 days |
7 |
(SWT+PWT)/LVDd |
|
67.0 |
% |
9.0 |
23.81 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65759 |
283 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
heart left ventricle relative wall thickness |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle wall thickness |
male |
109 days-112 days |
6 |
(SWT+PWT)/LVDd |
|
85.0 |
% |
3.0 |
7.35 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65760 |
283 |
SS.SR-Inha/Jr |
heart wet weight |
controlled sodium content diet (2 %) (for 24 days) |
Rapp JP, et al., Genomics 1998 Jul 15;51(2):191-6 |
heart mass |
male |
62 days
| 20 |
|
|
1.25 |
g |
0.01 |
0.06 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65835 |
633 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8. |
arterial blood pressure trait |
male |
67 days
| 10 |
|
|
218.0 |
mmHg |
7.8 |
24.67 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
|
|
66117 |
691 |
SS-Chr 13BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84 days-88 days |
12 |
|
|
15.9 |
mg/d |
2.1 |
7.27 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65203 |
15 |
SS.BN-(D13Rat7-D13Rat60)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
69.4 |
mg/d |
12.6 |
43.65 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65205 |
15 |
SS.BN-(D13Rat20-D13Rat127)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84 days-88 days |
12 |
|
|
21.2 |
mg/d |
4.9 |
16.97 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65216 |
15 |
SS.BN-(D13Rat127-D13Rat77)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
66.5 |
mg/d |
7.3 |
25.29 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65230 |
15 |
SS.BN-(D13Rat57-D13Rat192)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
62.8 |
mg/d |
3.9 |
13.51 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65246 |
15 |
SS/NEisSlc |
plasma aldosterone level |
controlled sodium content diet (8 %) |
Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24. |
blood aldosterone amount |
male |
42 days
| 4 |
|
|
139.3 |
pg/ml |
22.8 |
45.6 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
|
|
67280 |
736 |
SS.BN-(D13Rat7-D13Rat60)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86 days-89 days |
12 |
|
|
148.0 |
mmHg |
3.7 |
12.82 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
5395 |
15 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
not specified |
64 days-71 days |
46 |
|
|
302.0 |
g |
1.8 |
12.21 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64713 |
222 |
SS.LEW-(D10Mit10-D10Mgh1)/Jr |
body weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
not specified |
64 days-71 days |
20 |
|
|
292.0 |
g |
2.1 |
9.39 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64725 |
222 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
not specified |
64 days-71 days |
40 |
|
|
304.0 |
g |
1.6 |
10.12 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64716 |
222 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
not specified |
64 days-71 days |
20 |
|
|
290.0 |
g |
1.9 |
8.5 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64718 |
222 |
SS.SR-(D3Arb14-D3Mco36)/Mco |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
7 |
|
|
54.0 |
% |
3.0 |
7.94 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65750 |
283 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
velocity of circumferential fiber shortening |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
7 |
|
|
848.0 |
%/s |
50.0 |
132.29 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65755 |
283 |
SS/Jr |
velocity of circumferential fiber shortening |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 29 days) then controlled sodium content diet (4 %) (between 40 and 41 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart left ventricle end-diastolic diameter |
male |
109 days-112 days |
6 |
|
|
548.0 |
%/s |
59.0 |
144.52 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65753 |
283 |
SS/JrSeac |
body weight |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
body mass |
not specified |
126 days
| 5 |
|
|
273.0 |
g |
6.26 |
14.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67256 |
733 |
SS/HsdMcwiCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.15 %) (for 21 days) then dihydrocapsaicin (30 ug/kg) and pentobarbital (50 mg/kg) |
Gao F and Wang DH, Hypertension. 2010 Apr;55(4):1018-25. Epub 2010 Mar 1. |
arterial blood pressure trait |
male |
35 days-56 days |
0 |
|
|
-28.0 |
mmHg |
4.0 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
DR strain is from Charles River Laboratory, Wilmington, MA |
67262 |
731 |
SS/JrHsdMcwi |
kidney glomerulus diameter |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
kidney glomerulus size trait |
female |
97 days-101 days |
16 |
|
|
117.0 |
um |
3.8 |
15.2 |
ex vivo light microscopy |
|
0.0 |
|
0 |
|
plasma creatinine analysis |
glomerular diameter |
|
67286 |
151 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
|
serial mean |
27.0 |
mmHg |
2.0 |
8.94 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67299 |
151 |
SS/JrHsdMcwi |
ratio of change in renal blood flow rate to kidney weight |
controlled sodium content diet (0.4 %) (for 16 hours) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renal blood flow trait |
female |
97 days-101 days |
13 |
|
|
-2.4 |
ml/min/g |
0.6 |
2.16 |
electromagnetic flowmetry |
|
0.0 |
|
0 |
|
electromagnetic flowmetry |
|
|
67308 |
151 |
BN/NHsdMcwi |
ratio of change in renal blood flow rate to kidney weight |
controlled sodium content diet (0.4 %) (for 16 hours) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renal blood flow trait |
female |
97 days-101 days |
21 |
|
|
-1.4 |
ml/min/g |
0.3 |
1.37 |
electromagnetic flowmetry |
|
0.0 |
|
0 |
|
electromagnetic flowmetry |
change in renal blood flow rate |
|
67305 |
151 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
20 |
|
|
222.0 |
mmHg |
5.01 |
22.41 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67311 |
749 |
SS.SR-(D13Mit9-D13Mit1)/Jr |
systolic blood pressure |
controlled sodium content diet (8 %) (between 62 and 69 days) then controlled exposure to darkness |
St. Lezin EM, et al., J Clin Invest 1996 Jan 15;97(2):522-7 |
arterial blood pressure trait |
female |
56 days-63 days |
8 |
|
serial mean |
122.0 |
mmHg |
2.0 |
5.66 |
intra-aortic abdominal radiotelemetry |
|
604800.0 |
|
0 |
|
5 s every 5 min nightly for a week |
|
|
11707 |
119 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 28 days) |
Cicila GT, et al., Mamm Genome 1999 Feb;10(2):112-6. |
heart mass |
male |
65 days
| 20 |
|
|
1.29 |
g |
0.02 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11777 |
145 |
SS/Jr |
heart wet weight |
controlled sodium content diet (1 %) (for 30 days) then controlled sodium content diet (0.2 %) (for 40 days) |
Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902. |
heart mass |
male |
100 days
| 21 |
|
|
1.28 |
g |
0.02 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11783 |
146 |
SS.SR-(Cyp11b1)/Jr |
body weight |
controlled sodium content diet (1 %) (for 30 days) then controlled sodium content diet (0.2 %) (for 40 days) |
Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902. |
body mass |
male |
100 days
| 16 |
|
|
336.7 |
g |
6.7 |
26.8 |
body weighing method |
|
|
|
0 |
|
|
|
|
11786 |
146 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 42 days) |
Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902. |
arterial blood pressure trait |
male |
79 days
| 20 |
|
serial mean |
231.4 |
mmHg |
7.2 |
32.2 |
tail cuff plethysmography |
|
|
|
0 |
|
|
|
|
11789 |
146 |
SS.SR-(Cyp11b1)/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 42 days) |
Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902. |
arterial blood pressure trait |
male |
79 days
| 20 |
|
serial mean |
198.1 |
mmHg |
5.7 |
25.49 |
tail cuff plethysmography |
|
|
|
0 |
|
|
|
|
11790 |
146 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
body mass |
male |
68 days-70 days |
20 |
|
|
298.2 |
g |
4.2 |
18.78 |
body weighing method |
|
|
|
0 |
|
|
|
|
11799 |
147 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
arterial blood pressure trait |
male |
68 days-70 days |
20 |
|
serial mean |
230.6 |
mmHg |
4.7 |
21.02 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11807 |
147 |
SS.SR-(D7Uia1-D7Mco7)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
arterial blood pressure trait |
male |
68 days-70 days |
20 |
|
serial mean |
205.0 |
mmHg |
1.8 |
8.05 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11814 |
147 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
body mass |
male |
68 days-70 days |
20 |
|
|
289.8 |
g |
3.2 |
14.31 |
body weighing method |
|
|
|
0 |
|
|
|
|
11817 |
147 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
body mass |
male |
68 days-70 days |
20 |
|
|
297.7 |
g |
2.5 |
11.18 |
body weighing method |
|
|
|
0 |
|
|
|
|
11823 |
147 |
SS.SR-(D7Mco7-D7Wox19)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
arterial blood pressure trait |
male |
68 days-70 days |
20 |
|
serial mean |
209.0 |
mmHg |
2.2 |
9.84 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11820 |
147 |
SS.MNS-(D10Mco14-D10Mit11)/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 25 and 28 days) |
Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35. |
arterial blood pressure trait |
not specified |
64 days-68 days |
20 |
|
serial mean |
175.0 |
mmHg |
1.7 |
7.6 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11832 |
148 |
SS.SR-(D7Rat16-D7Rat176)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) |
Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. |
arterial blood pressure trait |
male |
68 days-70 days |
19 |
|
serial mean |
223.7 |
mmHg |
4.0 |
17.44 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11826 |
147 |
SS.MNS-(Aldoc-D10Mco1)/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 25 and 28 days) |
Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35. |
arterial blood pressure trait |
not specified |
64 days-68 days |
38 |
|
serial mean |
210.0 |
mmHg |
2.7 |
16.64 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11842 |
148 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 25 and 28 days) |
Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35. |
heart mass |
not specified |
64 days-68 days |
20 |
|
|
3.95 |
g/kg |
0.05 |
0.22 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11839 |
148 |
SS.WKY-(D2N35-Mme),MNS-(D10Mit11-D10M11Mit119)/Mco |
systolic blood pressure |
controlled sodium content diet (0.2 %) (between 15 and 18 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Rapp JP, et al., J Clin Invest 1998 Apr 15;101(8):1591-5. |
arterial blood pressure trait |
male |
70 days-76 days |
24 |
|
serial mean |
170.0 |
mmHg |
1.4 |
6.86 |
tail cuff plethysmography |
|
|
|
0 |
|
|
|
|
11848 |
150 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-92 days |
21 |
|
serial mean |
174.0 |
mmHg |
6.0 |
27.5 |
vascular indwelling catheter method |
left femoral artery |
|
|
0 |
|
3 hrs (during inactive phase) 3 consecutive days, and 4 extra hrs (during active phase) next day |
|
|
11854 |
151 |
SS.MNS-(D2Rat183-D2Chm113)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
8 |
|
|
145.0 |
mmHg |
4.0 |
11.31 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11934 |
226 |
SS.LEW-(D3Got33-D3Chm68)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
10 |
|
|
156.0 |
mmHg |
6.0 |
18.97 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11943 |
226 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
7 |
|
|
150.0 |
mmHg |
2.0 |
5.29 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11956 |
226 |
SS.LEW-(D17Rat65-D17Chm2)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
5 |
|
|
171.0 |
mmHg |
8.0 |
17.89 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11963 |
226 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
4.39 |
g/kg |
0.05 |
0.24 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11987 |
221 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
4.09 |
g/kg |
0.03 |
0.14 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
11994 |
221 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
35 |
|
continuous mean |
167.0 |
mmHg |
4.0 |
23.66 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
12002 |
229 |
SS.LEW-(D10Mco38-D10Mgh1)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
3.89 |
g/kg |
0.03 |
0.15 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12008 |
221 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.1 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-94 days |
42 |
|
continuous mean |
127.0 |
mmHg |
3.0 |
19.44 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
|
|
12006 |
229 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
heart mass |
male |
64 days-66 days |
0 |
|
|
1.32 |
g |
0.01 |
|
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12011 |
205 |
SS.LEW-(D2Rat18-D2Chm277)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 6 |
|
|
311.0 |
g |
20.0 |
48.99 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12014 |
226 |
SS.LEW-(D10Mco84-D10Rat58)/Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
heart mass |
male |
64 days-66 days |
0 |
|
|
1.45 |
g |
0.01 |
|
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12023 |
205 |
SS.MNS-(D2Wox27-Adh1)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 5 |
|
|
352.0 |
g |
15.0 |
33.54 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12032 |
226 |
SS.LEW-(D3Rat52-D3Rat130)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 7 |
|
|
390.0 |
g |
6.0 |
15.87 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12037 |
226 |
SS.MNS-(D10Rat13-D10Rat12)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
4.19 |
g/kg |
0.05 |
0.22 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12044 |
221 |
SS.MNS-(D10Mco62-D10Mit1)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Hypertension 2001 Oct;38(4):779-85 |
heart mass |
male |
64 days-69 days |
20 |
|
|
3.82 |
g/kg |
0.03 |
0.12 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12047 |
221 |
SS.LEW-(D10Mco84-D10Mco143)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
heart mass |
male |
64 days-66 days |
0 |
|
|
4.06 |
g/kg |
0.06 |
|
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12053 |
205 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 7 |
|
|
375.0 |
g |
5.0 |
13.23 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12061 |
226 |
SS.LEW-(D10Chm128-D10Chm169)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 8 |
|
|
369.0 |
g |
6.0 |
16.97 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12063 |
226 |
SS.LEW-(D10Mco84-D10Mco129)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
heart mass |
male |
64 days-66 days |
0 |
|
|
4.32 |
g/kg |
0.01 |
|
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12056 |
205 |
SS.LEW-(D17Chm14-D17Rat181)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 5 |
|
|
377.0 |
g |
9.0 |
20.12 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12069 |
226 |
LEW |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 6 |
|
|
372.0 |
g |
9.0 |
22.05 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12080 |
226 |
SS.WKY-(D2N35-Mme)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 25 and 28 days) |
Deng AY, et al., Hypertension 1997 Aug;30(2 Pt 1):199-202 |
arterial blood pressure trait |
male |
65 days-68 days |
27 |
|
|
161.9 |
mmHg |
2.45 |
12.73 |
tail cuff photoplethysmography |
tail |
|
|
0 |
|
average of 4 days, 3 to 4 consistent readings each day, IITC |
|
|
12105 |
231 |
SS.LEW-(D8Rat56-D8Rat51)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 9 |
|
|
4.7 |
g/kg |
0.4 |
1.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12107 |
226 |
SS.LEW-(D17Rat65-D17Chm2)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 5 |
|
|
3.6 |
g/kg |
0.2 |
0.45 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12118 |
226 |
SS.LEW-(D16Got3-D16Rat112)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 9 |
|
|
3.43 |
g/kg |
0.06 |
0.18 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12116 |
226 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 16 |
|
|
4.1 |
g/kg |
0.1 |
0.4 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12124 |
226 |
SS.LEW-(D17Chm9-D17Rat97)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 10 |
|
|
3.9 |
g/kg |
0.1 |
0.32 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12119 |
226 |
SS.MNS-(D10Mco30-D10Got112)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
arterial blood pressure trait |
male |
64 days-68 days |
20 |
|
|
190.0 |
mmHg |
2.55 |
11.4 |
tail cuff plethysmography |
tail |
345600 |
|
0 |
|
warm up to 28 C |
Average of 3-4 consistent measurements taken each day over 4 consecutive days |
|
12135 |
232 |
SS.MNS-(D10Mco30-D10Got91)/1Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
arterial blood pressure trait |
male |
64 days-68 days |
20 |
|
|
206.0 |
mmHg |
5.06 |
22.63 |
tail cuff plethysmography |
tail |
345600 |
|
0 |
|
warm up to 28 C |
Average of 3-4 consistent measurements taken each day over 4 consecutive days |
|
12138 |
232 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
body mass |
male |
64 days-68 days |
20 |
|
|
312.0 |
g |
3.22 |
14.4 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12143 |
232 |
SS.MNS-(D10Mco30-D10Got91)/3Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
arterial blood pressure trait |
male |
64 days-68 days |
20 |
|
|
193.0 |
mmHg |
3.5 |
15.65 |
tail cuff plethysmography |
tail |
345600.0 |
|
0 |
|
warm up to 28 C |
Average of 3-4 consistent measurements taken each day over 4 consecutive days |
|
12140 |
232 |
SR/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 112 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
arterial blood pressure trait |
male |
147 days
| 10 |
|
serial mean |
132.0 |
mmHg |
3.1 |
9.8 |
tail cuff plethysmography |
tail |
0 |
|
0 |
|
|
|
|
12165 |
222 |
SR/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 56 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
arterial blood pressure trait |
male |
91 days
| 10 |
|
serial mean |
159.0 |
mmHg |
2.0 |
6.32 |
tail cuff plethysmography |
tail |
0 |
|
0 |
|
|
|
|
12168 |
222 |
SR/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 28 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
arterial blood pressure trait |
male |
63 days
| 10 |
|
serial mean |
150.0 |
mmHg |
3.5 |
11.07 |
tail cuff plethysmography |
tail |
0 |
|
0 |
|
|
|
|
12167 |
222 |
SR/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 168 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
arterial blood pressure trait |
male |
203 days
| 10 |
|
serial mean |
156.0 |
mmHg |
4.0 |
12.65 |
tail cuff plethysmography |
tail |
0 |
|
0 |
|
|
|
|
12170 |
222 |
SR/Jr |
body weight |
controlled sodium content diet (0.2 %) (for 28 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
male |
63 days
| 10 |
|
|
238.0 |
g |
4.7 |
14.86 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
12180 |
222 |
SR/Jr |
body weight |
controlled sodium content diet (0.2 %) (for 112 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
male |
147 days
| 10 |
|
|
379.0 |
g |
5.7 |
18.02 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
12182 |
222 |
LEW/NCrl |
body weight |
controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 28 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
male |
63 days
| 8 |
|
|
286.0 |
g |
4.4 |
12.45 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
12194 |
222 |
SS.MNS-(D10Mco62-D10Mco30)/Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
1.37 |
g |
0.03 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12205 |
232 |
SS.MNS-(D10Mco30-D10Got91)/3Mco |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
3.77 |
g/kg |
0.02 |
0.09 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12215 |
232 |
SS.SR-(D3Mco36-D3Got166)/Jr |
heart wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
heart mass |
male |
70 days-72 days |
40 |
|
|
1.12 |
g |
0.02 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12255 |
237 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
heart mass |
male |
70 days-72 days |
40 |
|
|
1.15 |
g |
0.01 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12279 |
237 |
SS.SR-(D3Mco39-D3Got130)/Jr |
heart wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
heart mass |
male |
70 days-72 days |
39 |
|
|
1.08 |
g |
0.01 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12277 |
237 |
SS/Jr |
both kidneys wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
kidney mass |
male |
70 days-72 days |
20 |
|
|
2.9 |
g |
0.05 |
0.23 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12316 |
237 |
SS.SHR-(D8Uia1-D8Rat90)/Mco |
body weight |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
body mass |
male |
84 days
| 12 |
|
|
366.0 |
g |
4.3 |
14.9 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12332 |
246 |
SS.SHR-(D13Rat63-D13Mit1)/Mco |
both kidneys wet weight |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
kidney mass |
male |
84 days
| 12 |
|
|
2.79 |
g |
0.05 |
0.18 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12340 |
246 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
arterial blood pressure trait |
male |
64 days-66 days |
0 |
|
|
221.0 |
mmHg |
3.95 |
|
tail cuff plethysmography |
|
|
|
0 |
|
warm up to 28 C |
Average of 3-4 consistent measurements taken each day over 4 consecutive days |
|
11913 |
205 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
body mass |
male |
68 days-70 days |
20 |
|
|
303.0 |
g |
2.86 |
12.79 |
whole body digital scale |
|
0 |
|
0 |
|
|
|
|
12688 |
282 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
4.26 |
g/kg |
0.07 |
0.3 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12707 |
282 |
SS.LEW-(D10Rat24-Igfbp4)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 50 days) |
Chauvet C, et al., J Hypertens. 2008 May;26(5):893-901. |
arterial blood pressure trait |
male |
66 days-78 days |
7 |
|
serial mean |
177.0 |
mmHg |
6.0 |
15.87 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
1036800 |
|
0 |
|
telemetry probe model PA-D70, Data Sciences, St. Paul, MN |
average of 24 hour averages over 12 days |
|
12739 |
304 |
SS.LEW-(D10Mco15-D10Mgh1)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 50 days) |
Chauvet C, et al., J Hypertens. 2008 May;26(5):893-901. |
arterial blood pressure trait |
male |
66 days-78 days |
6 |
|
serial mean |
180.0 |
mmHg |
6.0 |
14.7 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
1036800 |
|
0 |
|
telemetry probe model PA-D70, Data Sciences, St. Paul, MN |
average of 24 hour averages over 12 days |
|
12742 |
304 |
SS.LEW-(D10Chm10-D10Chm14)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 50 days) |
Chauvet C, et al., J Hypertens. 2008 May;26(5):893-901. |
arterial blood pressure trait |
male |
66 days-78 days |
5 |
|
serial mean |
168.0 |
mmHg |
6.0 |
13.42 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
1036800 |
|
0 |
|
telemetry probe model PA-D70, Data Sciences, St. Paul, MN |
average of 24 hour averages over 12 days |
|
12743 |
304 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
64 days-66 days |
20 |
|
|
195.0 |
mmHg |
3.27 |
14.62 |
tail cuff plethysmography |
|
4 |
|
0 |
|
semi- automatic equipment from IITC, Woodland Hills, CA |
average of 2-3 readings/day over 4 days |
|
12807 |
313 |
SS.LEW-(D1Mco36-D1Rat131)/2Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
64 days-66 days |
20 |
|
|
170.0 |
mmHg |
2.33 |
10.42 |
tail cuff plethysmography |
|
4 |
|
0 |
|
semi- automatic equipment from IITC, Woodland Hills, CA |
average of 2-3 readings/day over 4 days |
|
12818 |
313 |
SS.LEW-(D1Mco36-D1Mco77)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
64 days-66 days |
20 |
|
|
184.0 |
mmHg |
3.07 |
13.73 |
tail cuff plethysmography |
|
4 |
|
0 |
|
semi- automatic equipment from IITC, Woodland Hills, CA |
average of 2-3 readings/day over 4 days |
|
12819 |
313 |
SS.LEW-(D1Mco36-D1Rat131)/1Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
arterial blood pressure trait |
male |
64 days-66 days |
20 |
|
|
178.0 |
mmHg |
2.22 |
9.93 |
tail cuff plethysmography |
|
4 |
|
0 |
|
semi- automatic equipment from IITC, Woodland Hills, CA |
average of 2-3 readings/day over 4 days |
|
12817 |
313 |
SS.SHR-(D9Mco72-D9Mco93)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 35 and 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
arterial blood pressure trait |
male |
75 days-79 days |
5 |
|
serial mean |
146.0 |
mmHg |
1.44 |
3.22 |
intra-aortic abdominal radiotelemetry |
lower abdominal aorta |
172800 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 12 4-hour averages over 48 hours using 5 or 6 rats |
|
13030 |
305 |
SS.SHR-(D9Mco74-D9Rat64)/Mco |
diastolic blood pressure |
controlled sodium content diet (2 %) (between 35 and 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
arterial blood pressure trait |
male |
75 days-79 days |
5 |
|
serial mean |
108.0 |
mmHg |
1.32 |
2.95 |
intra-aortic abdominal radiotelemetry |
lower abdominal aorta |
172800 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 12 4-hour averages over 48 hours using 5 or 6 rats |
|
13033 |
305 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
arterial blood pressure trait |
male |
64 days-70 days |
44 |
|
serial mean |
190.0 |
mmHg |
1.61 |
10.68 |
tail cuff photoplethysmography |
tail |
345600 |
|
0 |
|
|
average of 4 daily averages of 3-4 measurements/day |
|
13116 |
282 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
arterial blood pressure trait |
male |
64 days-70 days |
30 |
|
serial mean |
206.0 |
mmHg |
2.23 |
12.21 |
tail cuff photoplethysmography |
tail |
345600 |
|
0 |
|
|
average of 4 daily averages of 3-4 measurements/day |
|
13125 |
282 |
SHR/Fub |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
28 days
| 11 |
|
|
0.03 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13282 |
335 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
|
221.0 |
mmHg |
3.44 |
15.38 |
tail cuff plethysmography |
|
|
|
0 |
|
average of 3-4 consistent readings |
|
|
12454 |
266 |
SS.LEW-(D1Mco87-D1Rat71)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
|
207.0 |
mmHg |
2.87 |
12.84 |
tail cuff plethysmography |
|
|
|
0 |
|
average of 3-4 consistent readings |
|
|
12461 |
266 |
SS.LEW-(D1Uia2-D1Rat49)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
|
187.0 |
mmHg |
2.42 |
10.82 |
tail cuff plethysmography |
|
|
|
0 |
|
average of 3-4 consistent readings |
|
|
12465 |
266 |
SS.LEW-(D1Uia8-D1Rat18)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
|
191.0 |
mmHg |
2.24 |
10.02 |
tail cuff plethysmography |
|
|
|
0 |
|
average of 3-4 consistent readings |
|
|
12471 |
266 |
SS.LEW-(D17Rat65-D17Chm2)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 43 and 47 days) |
Grondin M, et al., Physiol Genomics 2005 Mar 21;21(1):112-6. Epub 2005 Jan 4. |
arterial blood pressure trait |
male |
88 days-92 days |
5 |
|
|
173.0 |
mmHg |
8.0 |
17.89 |
intra-aortic abdominal radiotelemetry |
|
|
|
0 |
|
|
measure every 2 min for 24 hrs |
|
12472 |
261 |
SS.LEW-(D1Mco87-D1Rat71)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
329.0 |
g |
2.27 |
10.15 |
body weighing method |
|
|
|
0 |
|
|
|
|
12494 |
266 |
SS.LEW-(D1Uia8-D1Rat124)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
298.0 |
g |
2.53 |
11.31 |
body weighing method |
|
|
|
0 |
|
|
|
|
12506 |
266 |
SS.LEW-(D1Uia8-D1Rat213)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
277.0 |
g |
5.53 |
24.73 |
body weighing method |
|
|
|
0 |
|
|
|
|
12507 |
266 |
SS.LEW-(D1Mco36-D1Rat49)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
3.74 |
g/kg |
0.04 |
0.17 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12561 |
266 |
WKY |
heart weight to body weight ratio |
controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
heart mass |
male |
360 days
| 4 |
|
|
2.5 |
g/kg |
0.1 |
0.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12593 |
268 |
WKY |
heart weight to body weight ratio |
controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
heart mass |
female |
360 days
| 4 |
|
|
2.8 |
g/kg |
0.1 |
0.2 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12596 |
268 |
SS/Jr |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 21 and 25 days) |
Roman RJ, et al., Am J Physiol Renal Physiol. 2006 Jun;290(6):F1463-71. Epub 2006 Jan 5. |
arterial blood pressure trait |
male |
82 days-86 days |
69 |
|
serial mean |
187.0 |
mmHg |
|
|
vascular fluid filled catheter |
femoral artery |
345600 |
|
0 |
|
connected to solid-state transducer (Argon Medical Technologies, Athens, TX) |
5 hr recording session - 1 min. averages, averaged over 4 days |
|
12613 |
272 |
SS.LEW-(D18Rat67-D18Rat55)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hum Mol Genet. 2005 Dec 15;14(24):3877-84. Epub 2005 Nov 8. |
arterial blood pressure trait |
male |
56 days
| 6 |
|
|
132.0 |
mmHg |
8.0 |
19.6 |
intra-aortic abdominal radiotelemetry |
aorta |
|
|
0 |
|
|
|
|
12608 |
269 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
body mass |
male |
64 days-66 days |
30 |
|
|
328.0 |
g |
2.61 |
14.3 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12866 |
313 |
SS.LEW-(D1Mco99-D1Rat49)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
body mass |
male |
64 days-66 days |
20 |
|
|
302.0 |
g |
1.89 |
8.45 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12879 |
313 |
SS.LEW-(D1Mco36-D1Rat131)/1Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
20 |
|
|
3.84 |
g/kg |
0.03 |
0.15 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12897 |
313 |
SS.LEW-(D1Mco36-D1Mco101)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
30 |
|
|
3.82 |
g/kg |
0.02 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12902 |
313 |
SS.LEW-(D1Mco2-D1Rat49)/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.14 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12525 |
266 |
SS.LEW-(D1Rat196-D1Mco36)/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.17 |
g |
0.01 |
0.03 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12533 |
266 |
SHRSP |
body weight |
controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
body mass |
female |
360 days
| 4 |
|
|
160.4 |
g |
4.05 |
8.1 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12539 |
268 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
heart mass |
male |
68 days-70 days |
20 |
|
|
4.35 |
g/kg |
0.05 |
0.22 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12553 |
266 |
SHR |
heart wet weight |
controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
heart mass |
male |
360 days
| 4 |
|
|
0.88 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12572 |
268 |
SHRSP |
heart weight to body weight ratio |
controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
heart mass |
female |
360 days
| 4 |
|
|
4.8 |
g/kg |
0.5 |
1.0 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12571 |
268 |
SHR |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 63 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
arterial blood pressure trait |
female |
91 days
| 4 |
|
serial mean |
152.2 |
mmHg |
6.0 |
12.0 |
tail cuff photoplethysmography |
|
0 |
|
0 |
|
UR1000; Ueda |
average of 3 consistent readings |
|
12583 |
268 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.26 |
g |
0.05 |
0.21 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12675 |
282 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
316.0 |
g |
3.93 |
17.58 |
body weighing method |
|
|
|
0 |
|
|
|
|
12942 |
305 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
343.0 |
g |
5.2 |
23.26 |
body weighing method |
|
|
|
0 |
|
|
|
|
12948 |
305 |
SS.SHR-(D9Wox16-D9Rat76)/Mco |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
366.0 |
g |
3.96 |
17.71 |
body weighing method |
|
|
|
0 |
|
|
|
|
12953 |
305 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
6 |
|
|
1.39 |
g |
0.03 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12964 |
305 |
SS.SHR-(D9Mco72-D9Mco93)/Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
6 |
|
|
1.14 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12972 |
305 |
SS.SHR-(D9Wox16-D9Rat76)/Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.5 |
g |
0.02 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12969 |
305 |
SS.SHR-(D9Mco74-D9Rat64)/Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
5 |
|
|
1.11 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12971 |
305 |
SS/Jr |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 21 and 37 days) |
Dutil J, et al., Hypertension 2005 Apr;45(4):557-64. Epub 2005 Feb 28. |
arterial blood pressure trait |
male |
56 days-72 days |
18 |
|
|
170.0 |
mmHg |
4.0 |
16.97 |
intra-aortic abdominal radiotelemetry |
|
|
|
0 |
|
|
|
|
12354 |
242 |
SS.SHR-(D8Uia1-D8Rat90)/Mco |
serum triglyceride level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood triglyceride amount |
male |
28 days-84 days |
8 |
|
|
45.0 |
mg/dl |
1.4 |
3.96 |
automated blood analysis |
|
|
|
0 |
|
|
|
|
12400 |
246 |
SS.LEW-(D5Rat130-D5Rat72)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (for 14 days) |
Roman RJ, et al., Am J Physiol Renal Physiol. 2006 Jun;290(6):F1463-71. Epub 2006 Jan 5. |
arterial blood pressure trait |
male |
80 days
| 6 |
|
serial mean |
195.0 |
mmHg |
|
|
radiotelemetry |
femoral artery |
|
|
0 |
|
connected to solid-state transducer (Argon Medical Technologies, Athens, TX) |
5 hr recording session - 1 min. averages, averaged over 4 days |
|
12651 |
272 |
SS.LEW-(D10Mco84-D10Got93)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
arterial blood pressure trait |
male |
64 days-70 days |
30 |
|
serial mean |
189.0 |
mmHg |
2.28 |
12.49 |
tail cuff photoplethysmography |
tail |
345600 |
|
0 |
|
|
average of 4 daily averages of 3-4 measurements/day |
|
13136 |
282 |
SHR/Fub |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
196 days
| 11 |
|
|
2.6 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13285 |
335 |
SS/Jr |
plasma sodium level |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
blood sodium amount |
male |
43 days-52 days |
12 |
|
|
147.0 |
mmol/l |
2.0 |
6.93 |
sodium ion-selective electrode method |
|
|
|
0 |
|
sodium ion-selective electrode |
|
|
13322 |
344 |
LEW/Crlc |
plasma potassium level |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
blood potassium amount |
male |
43 days-52 days |
8 |
|
|
5.0 |
mmol/l |
0.3 |
0.85 |
potassium ion-selective electrode method |
|
|
|
0 |
|
potassium ion-selective electrode |
|
|
13323 |
344 |
LEW/Crlc |
plasma chloride level |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
blood chloride amount |
male |
43 days-52 days |
8 |
|
|
103.0 |
mmol/l |
2.0 |
5.66 |
chloride ion-selective electrode method |
|
0.0 |
|
0 |
|
chloride ion-selective electrode |
|
|
13327 |
344 |
SS.SHR-(D9Mco72-D9Mco109)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
0 |
|
|
188.0 |
mmHg |
3.21 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67514 |
749 |
SS.SHR-(D9Mco72-D9Mco106)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
0 |
|
|
176.0 |
mmHg |
5.24 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67520 |
749 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
body mass |
not specified |
0 days
| 0 |
|
|
307.0 |
g |
4.93 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67527 |
749 |
SS.SHR-(D9Rat7-D9Rat84)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
body mass |
not specified |
0 days
| 0 |
|
|
339.0 |
g |
3.37 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67538 |
749 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
1.38 |
g |
0.02 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67550 |
749 |
SS.SHR-(D9Mco72-D9Mco105)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.3 |
g/kg |
0.16 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67569 |
749 |
SS.SHR-(D9Rat7-D9Mco91)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.16 |
g/kg |
0.06 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67576 |
749 |
SS.SHR-(D9Mco72-D9Mco105)/Mco |
urine total protein excretion rate |
controlled sodium content diet (2 %) (between 30 and 33 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
total urine protein amount |
not specified |
78 days-83 days |
0 |
|
|
212.0 |
mg/d |
14.66 |
|
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
67587 |
749 |
SS/Jr |
urine total protein excretion rate |
controlled sodium content diet (2 %) (between 30 and 33 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
total urine protein amount |
not specified |
78 days-83 days |
0 |
|
|
94.0 |
mg/d |
7.54 |
|
pyrogallol red-molybdate complex-based urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
67584 |
749 |
SS-Chr 16BN/Mcwi |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
7 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
167.62 |
% |
15.92 |
42.13 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
17915 |
381 |
SS.LEW-(D10Mit10-D10Mgh1)/Jr |
heart wet weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
heart mass |
not specified |
64 days-71 days |
20 |
|
|
1.1 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64763 |
222 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
heart mass |
not specified |
64 days-71 days |
19 |
|
|
1.21 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64764 |
222 |
SS/JrHsdMcwi |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
10 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
148.65 |
% |
12.89 |
40.77 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
17922 |
381 |
SS.LEW-(D18Rat30-D18Chm29)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 8 |
|
|
3.5 |
g/kg |
0.1 |
0.28 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64802 |
226 |
SS.LEW-(D18Rat30-D18Chm29)/Ayd |
body weight |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
body mass |
male |
98 days
| 8 |
|
|
378.0 |
g |
9.0 |
25.46 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
64803 |
226 |
SS/Jr |
heart rate |
controlled sodium content diet (2 %) (for 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart pumping trait |
male |
75 days-79 days |
5 |
|
|
378.0 |
beats/min |
9.18 |
20.53 |
intra-aortic abdominal radiotelemetry |
|
172800 |
|
0 |
|
|
|
|
64986 |
305 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 23 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
arterial blood pressure trait |
male |
56 days-60 days |
8 |
|
|
137.0 |
mmHg |
0.71 |
2.0 |
radiotelemetry |
|
86400 |
|
0 |
|
|
two 24 hours widely separated periods, data represent averages of all readings over the 24-h measurements |
|
64999 |
542 |
LEW |
body weight |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
body mass |
male |
77 days
| 14 |
|
|
299.2 |
g |
6.76 |
25.3 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
65004 |
542 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
body weight |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
body mass |
male |
77 days
| 5 |
|
|
318.8 |
g |
9.03 |
20.2 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
65010 |
542 |
SS/Jr |
heart rate |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart pumping trait |
male |
77 days
| 40 |
|
|
414.0 |
beats/min |
4.27 |
27.0 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65013 |
542 |
SS.BN-(D13Rat7-D13Rat127)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
173.0 |
mmHg |
5.4 |
18.71 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65162 |
15 |
SS.BN-(D13Rat20-D13Got22)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86 days-89 days |
12 |
|
|
184.0 |
mmHg |
6.2 |
21.48 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65165 |
15 |
Hsd:SD |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
15 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
141.14 |
% |
5.99 |
23.18 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
17018 |
381 |
Hsd:SD |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82 days-99 days |
15 |
%change=VE during7-9 min hypoxia/control during standard conditions |
|
138.6 |
% |
6.48 |
25.11 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
17019 |
381 |
FHH-Agtr1bm1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
12 |
|
|
40.63 |
cm |
0.89 |
3.08 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63662 |
529 |
FHH-F10m1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
10 |
|
|
38.45 |
cm |
0.22 |
0.69 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63676 |
529 |
FHH-F10m2Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
11 |
|
|
38.5 |
cm |
0.38 |
1.25 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63690 |
529 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
6 |
|
|
33.42 |
cm |
0.27 |
0.66 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63693 |
529 |
FHH-Adipoqm3Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
7 |
|
|
37.86 |
cm |
0.51 |
1.35 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63707 |
529 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
4 |
|
|
37.38 |
cm |
0.69 |
1.38 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63725 |
529 |
FHH-Adipoqm1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
10 |
|
|
0.52 |
g |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63727 |
529 |
FHH-Adipoqm2Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
15 |
|
|
0.63 |
g |
0.05 |
0.18 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63728 |
529 |
FHH-Agtr1bm1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
15 |
|
|
0.64 |
g |
0.01 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63734 |
529 |
FHH-Adipoqm1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
8 |
|
|
0.73 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63744 |
529 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
8 |
|
|
0.4 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63758 |
529 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
6 |
|
|
0.38 |
g |
0.01 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63765 |
529 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
1 |
|
|
0.6 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63766 |
529 |
FHH/EurMcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
28 |
|
|
0.53 |
g |
0.01 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63770 |
529 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
4 |
|
|
0.37 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63775 |
529 |
FHH-Adipoqm3Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
7 |
|
|
0.55 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63779 |
529 |
FHH/EurMcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
172 |
|
|
0.7 |
g |
0.01 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63781 |
529 |
FHH-Tlr4m1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
male |
70 days-84 days |
13 |
|
|
0.66 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63785 |
529 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
2 |
|
|
0.37 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63787 |
529 |
LE/BluGill |
percent change in ventilation |
controlled sodium content diet (0 %) then controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82 days-99 days |
13 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
|
151.33 |
% |
5.57 |
20.09 |
stop flow air displacement plethysmography |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
19309 |
381 |
SHR.SS-(D13Rat1-D13Mgh6)/Mco |
serum total cholesterol level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood cholesterol amount |
male |
84 days
| 8 |
|
|
40.0 |
mg/dl |
1.8 |
5.09 |
automated blood analysis |
|
0 |
|
0 |
|
|
|
|
64809 |
246 |
SS.BN-(D13Rat91-D13Got45)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86 days-89 days |
12 |
|
|
169.0 |
mmHg |
4.4 |
15.24 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65176 |
15 |
SS.BN-(D13Rat178-D13Got45)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
190.0 |
mmHg |
2.8 |
9.7 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65185 |
15 |
SS.BN-(D13Rat127-D13Rat46)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86 days-89 days |
12 |
|
|
154.0 |
mmHg |
3.1 |
10.74 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65188 |
15 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., Hum Mol Genet. 2009 Aug 1;18(15):2825-38. Epub 2009 May 7. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
serial mean |
207.0 |
mmHg |
4.7 |
21.02 |
tail cuff plethysmography |
|
345600 |
|
0 |
|
Rats warmed to 28 degrees C for measurement. |
|
|
65305 |
565 |
SS-Klf4m3Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
9 |
|
|
0.16 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63248 |
529 |
SS-Cpt2m1Mcwi |
body length, nose to tail |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
2 |
|
|
38.5 |
cm |
0.5 |
0.71 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63260 |
529 |
FHH-Adipoqm2Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
15 |
|
|
0.18 |
g |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63266 |
529 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
7 |
|
|
0.17 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63271 |
529 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
8 |
|
|
0.15 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63274 |
529 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
2 |
|
|
0.12 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63275 |
529 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
5 |
|
|
0.11 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63283 |
529 |
FHH-Procm1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
9 |
|
|
0.18 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63288 |
529 |
F344/NHsd |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
10 |
|
|
0.11 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63290 |
529 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
6 |
|
|
0.1 |
g |
0.0 |
0.0 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63303 |
529 |
FHH/EurMcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
28 |
|
|
0.16 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63308 |
529 |
FHH-Adra1am1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
9 |
|
|
0.14 |
g |
0.0 |
0.0 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63322 |
529 |
FHH-Tlr4m1Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
female |
70 days-84 days |
11 |
|
|
0.14 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63327 |
529 |
FHH-Lcatm1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
13 |
|
|
1.13 |
g |
0.03 |
0.1 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63341 |
529 |
FHH-Adipoqm1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
8 |
|
|
1.19 |
g |
0.03 |
0.07 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63354 |
529 |
FHH-Ccr2m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
7 |
|
|
0.88 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63357 |
529 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
5 |
|
|
0.62 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63355 |
529 |
FHH-Procm1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
9 |
|
|
0.95 |
g |
0.06 |
0.17 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63360 |
529 |
FHH-F10m2Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
17 |
|
|
1.23 |
g |
0.03 |
0.12 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63363 |
529 |
FHH-Htr1am1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
22 |
|
|
1.14 |
g |
0.02 |
0.1 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63369 |
529 |
FHH/EurMcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
28 |
|
|
0.91 |
g |
0.02 |
0.13 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63380 |
529 |
BN-Lcatm3Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
1 |
|
|
0.88 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63384 |
529 |
FHH-Egln3m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
6 |
|
|
1.14 |
g |
0.05 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63387 |
529 |
FHH-Tlr4m1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
13 |
|
|
1.12 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63395 |
529 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
4 |
|
|
0.98 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63407 |
529 |
FHH-Ghsrm1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
10 |
|
|
0.84 |
g |
0.03 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63450 |
529 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
1 |
|
|
0.87 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63448 |
529 |
BN-Lcatm3Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
1 |
|
|
0.76 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63456 |
529 |
FHH-Adra1am1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
9 |
|
|
0.79 |
g |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63466 |
529 |
FHH-Tlr4m1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
female |
70 days-84 days |
11 |
|
|
0.8 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63471 |
529 |
BN/NHsdMcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
45 |
|
|
0.74 |
g |
0.01 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63476 |
529 |
SS-Cpt2m1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
2 |
|
|
0.76 |
g |
0.0 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63486 |
529 |
SS-Sod3m1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
13 |
|
|
0.63 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63489 |
529 |
SS-Ghsrm3Mcwi |
body length, nose to rump |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
2 |
|
|
23.5 |
cm |
0.5 |
0.71 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63490 |
529 |
SS/JrHsdMcwi |
body length, nose to rump |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
17 |
|
|
21.38 |
cm |
0.34 |
1.42 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63498 |
529 |
SS-Sod3m1Mcwi |
body length, nose to rump |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
13 |
|
|
21.08 |
cm |
0.26 |
0.93 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63499 |
529 |
FHH-Agtr1bm1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
12 |
|
|
23.38 |
cm |
0.27 |
0.93 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63508 |
529 |
FHH-Tgfbr2m2Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
14 |
|
|
21.96 |
cm |
0.12 |
0.46 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63509 |
529 |
BN-Tgfbr2m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
7 |
|
|
23.21 |
cm |
0.15 |
0.39 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63517 |
529 |
F344/NHsd |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
10 |
|
|
29.95 |
cm |
2.66 |
8.42 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63526 |
529 |
FHH-F10m2Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
11 |
|
|
21.27 |
cm |
0.41 |
1.35 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63536 |
529 |
FHH-Nr4a1m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
13 |
|
|
21.65 |
cm |
0.2 |
0.72 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63538 |
529 |
FHH-Ghsrm1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
10 |
|
|
22.5 |
cm |
0.11 |
0.33 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63542 |
529 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
5 |
|
|
20.2 |
cm |
0.2 |
0.45 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63557 |
529 |
BN/NHsdMcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
45 |
|
|
22.29 |
cm |
0.16 |
1.11 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63568 |
529 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
4 |
|
|
23.0 |
cm |
0.0 |
0.0 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63571 |
529 |
SS-Cpt2m1Mcwi |
left kidney wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
7 |
|
|
1.45 |
g |
0.04 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63573 |
529 |
SS/JrHsdMcwi |
left kidney wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
kidney mass |
male |
70 days-84 days |
47 |
|
|
1.43 |
g |
0.03 |
0.21 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63574 |
529 |
BN-Tgfbr2m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
3 |
|
|
148.33 |
g |
2.33 |
4.04 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63588 |
529 |
FHH-Tgfbr2m2Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
14 |
|
|
182.57 |
g |
2.81 |
10.52 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63591 |
529 |
FHH-Htr1am1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
22 |
|
|
256.86 |
g |
3.44 |
16.15 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63615 |
529 |
FHH-Egln3m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
6 |
|
|
264.0 |
g |
6.39 |
15.66 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63633 |
529 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
7 |
|
|
275.14 |
g |
10.05 |
26.59 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63634 |
529 |
FHH/EurMcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
173 |
|
|
275.19 |
g |
2.26 |
29.78 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63637 |
529 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
3 |
|
|
-8.07 |
null |
0.04 |
0.08 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63068 |
528 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
3 |
|
|
-8.06 |
null |
0.2 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63077 |
528 |
FHH-Htr1am1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
12 |
|
|
-8.03 |
null |
0.07 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63079 |
528 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
1 |
|
|
-8.24 |
null |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63082 |
528 |
FHH-Htr1am1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
18 |
|
|
-8.26 |
null |
0.06 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63087 |
528 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
4 |
|
|
-8.21 |
null |
0.15 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63088 |
528 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
3 |
|
|
-8.05 |
null |
0.1 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63095 |
528 |
FHH/EurMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
119 |
|
|
-8.15 |
null |
0.03 |
0.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63108 |
528 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
1 |
|
|
-8.89 |
null |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63110 |
528 |
FHH-Egln3m1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
13 |
|
|
-8.21 |
null |
0.11 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63118 |
528 |
FHH-Agtr1bm1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
4 |
|
|
1.23 |
g/mg |
0.07 |
0.15 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63132 |
528 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
3 |
|
|
-7.81 |
null |
0.14 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63124 |
528 |
BN/NHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
-7.96 |
null |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63121 |
528 |
FHH-Adipoqm2Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
1.3 |
g/mg |
0.08 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63144 |
528 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
8 |
|
|
1.15 |
g/mg |
0.15 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63155 |
528 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
4 |
|
|
0.83 |
g/mg |
0.22 |
0.44 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63157 |
528 |
FHH-F10m2Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
12 |
|
|
1.6 |
g/mg |
0.08 |
0.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63159 |
528 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
3 |
|
|
1.27 |
g/mg |
0.32 |
0.55 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63162 |
528 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
5 |
|
|
1.3 |
g/mg |
0.07 |
0.15 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63173 |
528 |
BN/NHsdMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
2.07 |
g/mg |
0.12 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63190 |
528 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
5 |
|
|
1.17 |
g/mg |
0.09 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63191 |
528 |
SS/JrHsdMcwi |
body weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
11 |
|
|
299.18 |
g |
5.3 |
17.59 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63196 |
528 |
SS-Cpt2m1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
1 |
|
|
1.81 |
E-7mole |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63220 |
528 |
SS-Sod3m1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
12 |
|
|
2.57 |
E-7mole |
0.98 |
3.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63223 |
528 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (1 %) (for 60 days) then controlled sodium content diet (0.2 %) (between 41 and 44 days) |
Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41 |
arterial blood pressure trait |
both |
131 days-134 days |
21 |
data obtained at three consistent sessions per day |
serial mean |
244.0 |
mmHg |
|
|
tail cuff plethysmography |
|
345600 |
|
0 |
|
|
|
|
65963 |
650 |
SS.SR-(D13N1-D13Mit1)/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 24 days) then controlled sodium content diet (4 %) (for 24 days) |
Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41 |
arterial blood pressure trait |
not specified |
65 days-68 days |
26 |
data obtained at three consistent sessions per day |
serial mean |
217.0 |
mmHg |
|
|
tail cuff plethysmography |
|
345600 |
|
0 |
|
|
|
|
66029 |
650 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 10 days) then controlled sodium content diet (2 %) (for 24 days) |
Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41 |
heart mass |
not specified |
68 days
| 27 |
|
|
4.05 |
g/kg |
|
|
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
66031 |
650 |
SS/JrRkb |
body weight |
controlled sodium content diet (0.2 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
body mass |
male |
98 days
| 14 |
|
|
371.0 |
g |
5.0 |
18.71 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
66082 |
669 |
SS-Chr 19SHR/Rkb |
body weight |
controlled sodium content diet (0.2 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
body mass |
male |
98 days
| 20 |
|
|
355.0 |
g |
8.0 |
35.78 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
66084 |
669 |
SS-Ube2q2em3Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.92 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66209 |
717 |
SS-Gpr183em1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
6 |
|
|
1.57 |
g |
0.07 |
0.18 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66207 |
717 |
SS-Gpr183em2Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.66 |
g |
0.03 |
0.04 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66220 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.26 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66225 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.46 |
g |
0.06 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66223 |
717 |
SS-Cybaem1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
6 |
|
|
1.44 |
g |
0.06 |
0.15 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66227 |
717 |
SS-Mmp2em1Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.45 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66229 |
717 |
SS-Gpr183em1Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.45 |
g |
0.07 |
0.13 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66228 |
717 |
SS-Gpr183em3Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.55 |
g |
0.05 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66233 |
717 |
SS-Apoeem7Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.42 |
g |
0.04 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66231 |
717 |
SS-Nox4em2Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.28 |
g |
0.08 |
0.13 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66235 |
717 |
SS-Nckap5em2Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.63 |
g |
0.04 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66237 |
717 |
SS-Mmp2em2Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
6 |
|
|
1.36 |
g |
0.06 |
0.14 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66238 |
717 |
SS-Renem1Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.52 |
g |
0.06 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66246 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.43 |
g |
0.06 |
0.13 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66245 |
717 |
SS-Mthfrem1Mcwi-/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.67 |
g |
0.09 |
0.25 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66259 |
717 |
SS-Ube2q2em3Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.4 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66263 |
717 |
SS-Ube2q2em3Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
1 |
|
|
376.0 |
g |
|
|
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66271 |
717 |
SS-Gpr183em2Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
2 |
|
|
336.5 |
g |
10.5 |
14.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66282 |
717 |
SS-Itga9em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
4 |
|
|
317.0 |
g |
9.4 |
18.9 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66315 |
717 |
SS-Mas1em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
2 |
|
|
307.0 |
g |
15.0 |
21.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66322 |
717 |
SS-Ube2q2em3Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
358.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66333 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
338.0 |
beats/min |
38.0 |
53.74 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66336 |
717 |
SS-Tfdp2em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
373.5 |
beats/min |
7.5 |
10.61 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66339 |
717 |
SS-Bcas3em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
365.0 |
beats/min |
3.51 |
6.08 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66341 |
717 |
SS-Mthfrem1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
338.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66335 |
717 |
SS-Mmp2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
359.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66352 |
717 |
SS-Nckap5em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
328.5 |
beats/min |
6.5 |
9.19 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66359 |
717 |
SS-Apoeem8Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
354.0 |
beats/min |
23.0 |
32.53 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66361 |
717 |
SS-Alms1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
360.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66364 |
717 |
SS-Tfdp2em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
337.33 |
beats/min |
21.76 |
37.69 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66372 |
717 |
SS-Rag1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.5 |
mmHg |
10.59 |
21.17 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66390 |
717 |
SS-Alms1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
150.4 |
mmHg |
8.63 |
19.3 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66389 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.5 |
mmHg |
12.5 |
17.68 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66396 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66407 |
717 |
SS-Apoeem7Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
122.33 |
mmHg |
4.91 |
8.5 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66409 |
717 |
SS-Apoeem7Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.8 |
mmHg |
8.52 |
19.06 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66414 |
717 |
SS-Mas1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
141.0 |
mmHg |
14.46 |
28.93 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66422 |
717 |
SS-Ets1em1Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
123.71 |
mmHg |
5.02 |
13.28 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66429 |
717 |
SS-Itga9em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.0 |
mmHg |
4.92 |
9.83 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66435 |
717 |
SS-Mmp2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
/3 systolic pressure + 2/3 diastolic pressure |
|
136.4 |
mmHg |
5.59 |
12.5 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66448 |
717 |
SS-Acad10em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
13 |
/3 systolic pressure + 2/3 diastolic pressure |
|
141.62 |
mmHg |
6.7 |
24.17 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66454 |
717 |
SS-Ube2q2em3Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
/3 systolic pressure + 2/3 diastolic pressure |
|
169.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66453 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
/3 systolic pressure + 2/3 diastolic pressure |
|
125.0 |
mmHg |
6.0 |
8.49 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66456 |
717 |
SS-Gpr183em3Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
/3 systolic pressure + 2/3 diastolic pressure |
|
221.67 |
mmHg |
92.67 |
160.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66476 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
/3 systolic pressure + 2/3 diastolic pressure |
|
127.5 |
mmHg |
2.5 |
3.54 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66485 |
717 |
SS-Cybaem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
/3 systolic pressure + 2/3 diastolic pressure |
|
116.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66493 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
/3 systolic pressure + 2/3 diastolic pressure |
|
125.17 |
mmHg |
6.23 |
15.26 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66498 |
717 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
2 |
|
|
120.8 |
mg/d |
25.54 |
36.11 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66527 |
717 |
SS-Gpr183em3Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
4 |
|
|
124.52 |
mg/d |
31.69 |
63.39 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66537 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
7 |
|
|
132.1 |
mg/d |
10.01 |
26.5 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66559 |
717 |
SS-Nox4em2Mcwi-/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
2 |
|
|
97.16 |
mg/d |
7.03 |
9.94 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66565 |
717 |
SS-Acad10em2Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
5 |
|
|
96.08 |
mg/d |
22.3 |
49.86 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66564 |
717 |
SS-Ube2q2em3Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
2 |
|
|
68.98 |
mg/d |
3.36 |
4.75 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66566 |
717 |
SS-Mas1em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
2 |
|
|
159.63 |
mg/d |
7.7 |
10.88 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66563 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
318.5 |
beats/min |
35.5 |
50.2 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66577 |
717 |
SS-Nckap5em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
344.67 |
beats/min |
7.6 |
18.62 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66579 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
334.33 |
beats/min |
4.33 |
7.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66589 |
717 |
SS-Tfdp2em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
356.0 |
beats/min |
3.0 |
4.24 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66580 |
717 |
SS-Cybaem1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
330.4 |
beats/min |
12.76 |
28.54 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66591 |
717 |
SS-Rag1em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
326.0 |
beats/min |
17.43 |
42.7 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66600 |
717 |
SS-Ube2q2em3Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
320.5 |
beats/min |
28.5 |
40.31 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66626 |
717 |
SS-Adra2aem1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
358.13 |
beats/min |
7.03 |
19.89 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43443 |
421 |
SS-Sh2b3em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
14 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
120.79 |
mmHg |
2.3 |
8.62 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43456 |
421 |
SS-Rasgrp3em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.0 |
mmHg |
4.24 |
9.49 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43459 |
421 |
SS-Ulk3em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
147.0 |
mmHg |
23.0 |
32.53 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43464 |
421 |
SS-Ulk3em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
15 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
141.67 |
mmHg |
6.73 |
26.05 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43466 |
421 |
SS-Rasgrp3em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.75 |
mmHg |
4.94 |
9.88 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43475 |
421 |
SS-Wdr72em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.57 |
mmHg |
3.27 |
8.66 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43477 |
421 |
SS-Hexim2em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
10 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
129.0 |
mmHg |
3.21 |
10.14 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43486 |
421 |
SS-Sh2b3em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
1 |
|
|
318.0 |
g |
|
|
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43492 |
421 |
SS-Sh2b3em1Mcwi-/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
3 |
|
|
300.7 |
g |
1.8 |
3.1 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43494 |
421 |
SS-Ulk3em4Mcwi-/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
4 |
|
|
301.2 |
g |
7.7 |
15.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43498 |
421 |
SS-Sh2b3em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
16 |
|
|
81.78 |
mg/d |
5.64 |
22.56 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43503 |
421 |
SS-Adra2aem1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
8 |
|
|
70.43 |
mg/d |
7.87 |
22.25 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43505 |
421 |
SS-Sh2b3em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
364.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43524 |
421 |
SS-Ulk3em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
357.5 |
beats/min |
10.5 |
14.85 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43527 |
421 |
SS-Agtrapem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
340.67 |
beats/min |
6.17 |
16.33 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43532 |
421 |
SS-Sh2b3em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
12 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
124.25 |
mmHg |
2.86 |
9.9 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43535 |
421 |
SS-Sh2b3em1Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
121.0 |
mmHg |
4.0 |
5.66 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43542 |
421 |
SS-Hexim2em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
10 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.7 |
mmHg |
3.58 |
11.32 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43550 |
421 |
SS-Ulk3em4Mcwi-/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
4 |
|
|
10.01 |
mg/d |
0.67 |
1.35 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43562 |
421 |
SS-Sh2b3em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
16 |
|
|
10.41 |
mEq/d |
0.37 |
1.48 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43567 |
421 |
SS-Agtrapem4Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
6 |
|
|
10.07 |
mEq/d |
0.86 |
2.12 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43580 |
421 |
SS-Sh2b3em1Mcwi-/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
3 |
|
|
16.02 |
mg/d |
3.39 |
5.88 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43590 |
421 |
SS-Hexim2em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
154.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43622 |
421 |
SS-Wdr72em2Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.33 |
g |
0.04 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43630 |
421 |
SS-Ulk3em4Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
18 |
|
|
1.4 |
g |
0.03 |
0.12 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43637 |
421 |
SS-Adra2aem1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
363.75 |
beats/min |
7.66 |
21.66 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43659 |
421 |
SS-Sh2b3em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
10 |
|
|
371.9 |
beats/min |
5.06 |
16.01 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43657 |
421 |
SS-Rasgrp3em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
10 |
|
|
337.7 |
beats/min |
15.82 |
50.04 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43661 |
421 |
SS-Hexim2em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
344.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43666 |
421 |
SS-Agtrapem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
351.49 |
beats/min |
6.29 |
16.65 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43670 |
421 |
SS-Sh2b3em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
12 |
|
|
373.58 |
beats/min |
7.33 |
25.41 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43673 |
421 |
SS-Wdr72em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
371.57 |
beats/min |
10.47 |
27.7 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43679 |
421 |
SS-Agtrapem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
354.24 |
beats/min |
6.81 |
16.69 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43686 |
421 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left ventricle posterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle posterior wall thickness |
male |
77 days
| 11 |
|
|
0.18 |
mm |
0.01 |
0.02 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65116 |
542 |
SS/Jr |
heart left ventricle posterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle posterior wall thickness |
male |
77 days
| 40 |
|
|
0.19 |
mm |
0.0 |
0.02 |
transthoracic echocardiography |
|
0 |
|
0 |
|
|
|
|
65115 |
542 |
WKY/Bbb |
diastolic blood pressure |
controlled sodium content diet |
Kreutz R, et al., Proc Natl Acad Sci U S A 1995 Sep 12;92(19):8778-82 |
arterial blood pressure trait |
not specified |
0 days
| 8 |
|
|
83.5 |
mmHg |
0.92 |
2.6 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67198 |
116 |
FHH-Procm1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
10 |
|
|
107.5 |
mg/dl |
12.74 |
40.29 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62478 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
7 |
|
|
181.0 |
mg/dl |
8.21 |
21.71 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62479 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
4 |
|
|
159.75 |
mg/dl |
15.93 |
31.86 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62488 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
1 |
|
|
156.0 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62493 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
6 |
|
|
197.0 |
mg/dl |
12.94 |
31.7 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62499 |
527 |
FHH-Adra1am1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
9 |
|
|
140.11 |
mg/dl |
4.8 |
14.39 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62505 |
527 |
FHH-Tgfbr2m2Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
69.89 |
% |
4.2 |
12.59 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62596 |
528 |
FHH-Ccr2m1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
6 |
|
|
70.0 |
% |
7.73 |
18.94 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62608 |
528 |
FHH-Htr1am1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
55.72 |
% |
4.55 |
19.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62619 |
528 |
FHH-F10m1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
59.29 |
% |
6.33 |
16.76 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62623 |
528 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
1 |
|
|
18.0 |
% |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62626 |
528 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
2 |
|
|
95.5 |
% |
4.5 |
6.36 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62628 |
528 |
FHH/EurMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
6 |
|
|
80.33 |
% |
8.26 |
20.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62629 |
528 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
2 |
|
|
26.5 |
% |
13.5 |
19.09 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62632 |
528 |
BN-Lcatm3Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
3 |
|
|
43.0 |
% |
17.62 |
30.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62631 |
528 |
FHH-Egln3m1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
6 |
|
|
48.0 |
% |
4.27 |
10.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62635 |
528 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
61.71 |
% |
6.29 |
16.65 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62634 |
528 |
FHH-Adipoqm3Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
5 |
|
|
52.8 |
% |
11.24 |
25.14 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62637 |
528 |
FHH-Adra1am1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
80.13 |
% |
4.26 |
12.05 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62639 |
528 |
FHH-Adra1am1Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
73.75 |
% |
5.49 |
15.53 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62641 |
528 |
FHH-Adipoqm1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62733 |
528 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
3 |
|
|
57.67 |
% |
5.04 |
8.74 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62654 |
528 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62741 |
528 |
FHH-Slc8a2m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
13 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62744 |
528 |
FHH-Adipoqm1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62749 |
528 |
FHH-Procm1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
8 |
|
|
0.06 |
umol/l |
0.02 |
0.06 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62755 |
528 |
FHH-F10m2Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
17 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62758 |
528 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
3 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62772 |
528 |
FHH/EurMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
6 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62774 |
528 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
1 |
|
|
0.0 |
umol/l |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62787 |
528 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
2 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62791 |
528 |
FHH/EurMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
119 |
|
|
0.01 |
umol/l |
0.0 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62785 |
528 |
FHH-Slc8a2m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
15 |
|
|
0.02 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62792 |
528 |
FHH-Tlr4m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
11 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62793 |
528 |
FHH-Egln3m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
13 |
|
|
0.03 |
umol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62795 |
528 |
SS-Ghsrm3Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (1 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
2 |
|
|
1.01 |
g/mg |
0.2 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62808 |
528 |
SS-Klf4m3Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (1 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
1.57 |
g/mg |
0.1 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62806 |
528 |
SS/JrHsdMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (1 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
1.29 |
g/mg |
0.11 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62809 |
528 |
SS-Sod3m1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (1 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
12 |
|
|
1.33 |
g/mg |
0.07 |
0.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62810 |
528 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
1 |
|
|
-6.97 |
null |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62815 |
528 |
FHH-Adipoqm1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
-6.94 |
null |
0.16 |
0.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62828 |
528 |
FHH-Procm1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
7 |
|
|
-6.98 |
null |
0.12 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62833 |
528 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
4 |
|
|
-6.88 |
null |
0.05 |
0.1 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62843 |
528 |
FHH-F10m1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
-6.8 |
null |
0.08 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62846 |
528 |
FHH-Egln3m1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
13 |
|
|
-6.85 |
null |
0.03 |
0.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62871 |
528 |
BN/NHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
-6.98 |
null |
0.1 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62874 |
528 |
BN/NHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
-6.71 |
null |
0.05 |
0.1 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62876 |
528 |
SS-Klf4m3Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
-6.67 |
null |
0.08 |
0.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62882 |
528 |
SS-Cpt2m1Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
1 |
|
|
-5.74 |
null |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62884 |
528 |
SS-Sod3m1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
-8.11 |
null |
0.07 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
62891 |
528 |
SS/JrHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
-7.82 |
null |
0.1 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
62896 |
528 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
1 |
|
|
277.0 |
g |
|
|
whole body digital scale |
|
|
|
0 |
|
|
|
|
62902 |
528 |
FHH-Tgfbr2m2Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
274.4 |
g |
6.51 |
20.58 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62901 |
528 |
FHH-Nr0b2m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
4 |
|
|
269.0 |
g |
5.74 |
11.49 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62913 |
528 |
FHH-Ccr2m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
7 |
|
|
183.71 |
g |
2.49 |
6.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62918 |
528 |
FHH-Procm1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
8 |
|
|
215.38 |
g |
11.16 |
31.57 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62921 |
528 |
FHH-Nr4a1m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
6 |
|
|
250.67 |
g |
8.61 |
21.09 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62927 |
528 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
8 |
|
|
172.88 |
g |
4.25 |
12.02 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62929 |
528 |
FHH-Nr4a1m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
6 |
|
|
182.67 |
g |
3.18 |
7.79 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62935 |
528 |
FHH-Ghsrm1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
5 |
|
|
267.0 |
g |
19.31 |
43.19 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62946 |
528 |
FHH-Adipoqm3Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
5 |
|
|
267.4 |
g |
14.57 |
32.59 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62950 |
528 |
BN/NHsdMcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
5 |
|
|
148.8 |
g |
1.85 |
4.15 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62966 |
528 |
SS-Ghsrm3Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
2 |
|
|
46.0 |
% |
1.0 |
1.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62985 |
528 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
6 |
|
|
1.61 |
E-7mole |
0.29 |
0.72 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62994 |
528 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
2 |
|
|
0.96 |
E-7mole |
0.22 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63001 |
528 |
FHH-Adipoqm2Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
0.81 |
E-7mole |
0.15 |
0.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63007 |
528 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
1 |
|
|
1.2 |
E-7mole |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63014 |
528 |
FHH-F10m2Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
11 |
|
|
2.37 |
E-7mole |
0.46 |
1.54 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63022 |
528 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
1 |
|
|
2.84 |
E-7mole |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63030 |
528 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
5 |
|
|
1.6 |
E-7mole |
0.37 |
0.82 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63052 |
528 |
FHH-Chr 2BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
1.37 |
g/mg |
0.26 |
0.78 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57312 |
522 |
SS-Chr 9BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.53 |
g/mg |
0.18 |
0.56 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57317 |
522 |
FHH-Chr 6BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
1.37 |
g/mg |
0.19 |
0.57 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57319 |
522 |
FHH-Chr 2BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
0.73 |
g/mg |
0.09 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57328 |
522 |
FHH-Chr XBN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
1.0 |
g/mg |
0.16 |
0.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57343 |
522 |
SS-Chr 4BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
0.71 |
g/mg |
0.09 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57379 |
522 |
SS/JrHsdMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
90 |
|
|
1.09 |
g/mg |
0.06 |
0.56 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57374 |
522 |
FHH/EurMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
-7.09 |
null |
0.15 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
57409 |
522 |
WKY/NCrl |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
14 |
|
|
0.05 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57425 |
522 |
LEW/Crl |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
24 |
|
|
0.05 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57431 |
522 |
F344/DuCrl |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
20 |
|
|
0.04 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57428 |
522 |
SS-Chr 15BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
|
215.0 |
g |
4.2 |
13.3 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55199 |
522 |
SS-Chr 13BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
16 |
|
|
215.8 |
g |
4.0 |
15.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55205 |
522 |
FHH-Chr 20BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
270.3 |
g |
3.4 |
10.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55207 |
522 |
FHH-Chr 8BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
267.6 |
g |
7.8 |
24.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55203 |
522 |
FHH-Chr YBN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
11 |
|
|
217.6 |
g |
13.3 |
44.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55215 |
522 |
FHH/EurMcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
51 |
|
|
234.9 |
g |
4.6 |
33.1 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55212 |
522 |
SS-Chr 18BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
21 |
|
|
329.5 |
g |
4.6 |
21.0 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55218 |
522 |
SS-Chr YBN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
20 |
|
|
300.3 |
g |
5.9 |
26.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55216 |
522 |
FHH-Chr 4BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
227.4 |
g |
3.1 |
9.7 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55223 |
522 |
SS-Chr 19BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
305.6 |
g |
9.2 |
29.1 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55229 |
522 |
FHH-Chr 7BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
9 |
|
|
252.3 |
g |
5.3 |
16.0 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55242 |
522 |
Hsd:SD |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
16 |
|
|
-7.49 |
null |
0.05 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
55247 |
522 |
LEW/Crl |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
24 |
|
|
73.54 |
% |
3.22 |
15.75 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55383 |
522 |
LE/BluGill |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
62.79 |
% |
2.82 |
10.56 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55387 |
522 |
BN/NHsdMcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
27 |
|
|
8.12 |
x 10E6 cells/ul |
0.07 |
0.36 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60610 |
527 |
SS-Sod3m1Mcwi |
serum glucose level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
11 |
|
|
140.36 |
mg/dl |
16.35 |
54.22 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60622 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
1 |
|
|
42.8 |
% |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60651 |
527 |
F344/NHsd |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
4 |
|
|
46.38 |
% |
2.8 |
5.61 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60658 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
7 |
|
|
45.83 |
% |
0.95 |
2.51 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60689 |
527 |
FHH-Nr0b2m1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
10 |
|
|
52.07 |
fl |
0.22 |
0.7 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60751 |
527 |
FHH-F10m1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
11 |
|
|
53.67 |
fl |
0.49 |
1.64 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60757 |
527 |
FHH-F10m1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
10 |
|
|
51.48 |
fl |
0.31 |
0.97 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60772 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
2 |
|
|
53.85 |
fl |
0.35 |
0.5 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60769 |
527 |
BN-Lcatm3Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
1 |
|
|
53.0 |
fl |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60783 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
2 |
|
|
55.8 |
fl |
0.0 |
0.0 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60782 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
4 |
|
|
55.7 |
fl |
0.27 |
0.54 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60792 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
70 days-84 days |
3 |
|
|
53.27 |
fl |
0.23 |
0.4 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60795 |
527 |
SS-Klf4m3Mcwi |
serum bicarbonate level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
8 |
|
|
18.5 |
mmol/l |
0.5 |
1.41 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60812 |
527 |
SS-Chr 18BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
-8.31 |
null |
0.08 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
55483 |
522 |
SS-Chr 16BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
-8.43 |
null |
0.1 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
55486 |
522 |
SS-Chr 16BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
-8.36 |
null |
0.11 |
0.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
55490 |
522 |
Hsd:SD |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
16 |
|
|
0.33 |
10E-7mol/l |
0.05 |
0.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
55502 |
522 |
BN-Tgfbr2m1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
3 |
|
|
1.26 |
x 1000 cells/ul |
0.26 |
0.46 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60833 |
527 |
FHH-Tgfbr2m2Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
14 |
|
|
0.88 |
x 1000 cells/ul |
0.08 |
0.29 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60836 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
70 days-84 days |
6 |
|
|
1.23 |
x 1000 cells/ul |
0.26 |
0.64 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60837 |
527 |
FHH-Lcatm1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
15 |
|
|
0.73 |
x 1000 cells/ul |
0.12 |
0.46 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60839 |
527 |
FHH-Ccr2m1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
5 |
|
|
0.58 |
x 1000 cells/ul |
0.23 |
0.51 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60848 |
527 |
FHH-Procm1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
8 |
|
|
0.73 |
x 1000 cells/ul |
0.2 |
0.56 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60851 |
527 |
FHH-Procm1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
70 days-84 days |
9 |
|
|
1.07 |
x 1000 cells/ul |
0.39 |
1.18 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60858 |
527 |
FHH-F10m1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
70 days-84 days |
10 |
|
|
0.76 |
x 1000 cells/ul |
0.1 |
0.32 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60864 |
527 |
FHH-Adipoqm3Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
6 |
|
|
0.54 |
x 1000 cells/ul |
0.16 |
0.4 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60880 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
4 |
|
|
0.9 |
x 1000 cells/ul |
0.04 |
0.07 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60884 |
527 |
SS-Sod3m1Mcwi |
serum sodium level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
10 |
|
|
141.2 |
mmol/l |
1.18 |
3.74 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
60902 |
527 |
SS-Cpt2m1Mcwi |
serum sodium level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
1 |
|
|
146.0 |
mmol/l |
|
|
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
60905 |
527 |
FHH-Adipoqm2Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
12 |
|
|
1.51 |
g/dl |
0.06 |
0.19 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60911 |
527 |
FHH-Agtr1bm1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
14 |
|
|
1.51 |
g/dl |
0.04 |
0.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60924 |
527 |
FHH-Nr4a1m1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
11 |
|
|
1.77 |
g/dl |
0.05 |
0.17 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60939 |
527 |
FHH-Htr1am1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
20 |
|
|
1.75 |
g/dl |
0.03 |
0.14 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60942 |
527 |
FHH-Nr4a1m1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
11 |
|
|
1.58 |
g/dl |
0.06 |
0.21 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60947 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
4 |
|
|
1.9 |
g/dl |
0.04 |
0.08 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60948 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
1 |
|
|
2.4 |
g/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60949 |
527 |
BN-Lcatm3Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
2 |
|
|
1.75 |
g/dl |
0.05 |
0.07 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60954 |
527 |
FHH-Egln3m1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
6 |
|
|
1.78 |
g/dl |
0.06 |
0.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60960 |
527 |
FHH-Tlr4m1Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
9 |
|
|
1.54 |
g/dl |
0.07 |
0.2 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60972 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
5 |
|
|
1.9 |
g/dl |
0.07 |
0.16 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60976 |
527 |
SS-Ghsrm3Mcwi |
hematocrit |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
2 |
|
|
50.3 |
% |
1.4 |
1.98 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60981 |
527 |
SS-Sod3m1Mcwi |
hematocrit |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
10 |
|
|
48.01 |
% |
1.22 |
3.85 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60984 |
527 |
SS-Klf4m3Mcwi |
hematocrit |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
7 |
|
|
46.94 |
% |
1.27 |
3.35 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60985 |
527 |
SS-Ghsrm3Mcwi |
hematocrit |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
1 |
|
|
48.8 |
% |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60988 |
527 |
SS/JrHsdMcwi |
hematocrit |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
17 |
|
|
46.26 |
% |
0.61 |
2.53 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60989 |
527 |
FHH-Adipoqm2Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
12 |
|
|
0.28 |
mg/dl |
0.04 |
0.15 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
60993 |
527 |
FHH-Lcatm1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
13 |
|
|
0.31 |
mg/dl |
0.05 |
0.17 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
60996 |
527 |
FHH-Slc8a2m1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
12 |
|
|
0.23 |
mg/dl |
0.03 |
0.09 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61004 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
2 |
|
|
0.3 |
mg/dl |
0.1 |
0.14 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61002 |
527 |
BN-Tgfbr2m1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
7 |
|
|
0.3 |
mg/dl |
0.03 |
0.08 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61008 |
527 |
SS/JrHsdMcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
blood vessel smooth muscle dilation trait |
male |
70 days-84 days |
12 |
|
|
99.42 |
% |
0.26 |
0.9 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
55715 |
522 |
Hsd:SD |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
69.0 |
% |
6.69 |
21.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
55730 |
522 |
Hsd:SD |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
85.5 |
% |
4.86 |
18.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
55731 |
522 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
7 |
|
|
0.34 |
mg/dl |
0.04 |
0.1 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61023 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
4 |
|
|
0.43 |
mg/dl |
0.05 |
0.1 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61032 |
527 |
FHH-Egln3m1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
6 |
|
|
0.2 |
mg/dl |
0.0 |
0.0 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61042 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
6 |
|
|
0.33 |
mg/dl |
0.03 |
0.08 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61043 |
527 |
FHH-Adipoqm1Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
70 days-84 days |
9 |
|
|
25.22 |
mmol/l |
1.35 |
4.06 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61064 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
1 |
|
|
29.0 |
mmol/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61067 |
527 |
FHH-Tgfbr2m2Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
70 days-84 days |
10 |
|
|
24.4 |
mmol/l |
1.19 |
3.78 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61072 |
527 |
F344/NHsd |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
7 |
|
|
24.29 |
mmol/l |
1.19 |
3.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61089 |
527 |
FHH-Nr4a1m1Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
11 |
|
|
26.27 |
mmol/l |
1.06 |
3.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61093 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
7 |
|
|
25.14 |
mmol/l |
0.91 |
2.41 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61106 |
527 |
FHH-Egln3m1Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
6 |
|
|
22.33 |
mmol/l |
0.49 |
1.21 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61114 |
527 |
FHH-Adipoqm3Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
5 |
|
|
24.2 |
mmol/l |
1.69 |
3.77 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61117 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
70 days-84 days |
2 |
|
|
26.0 |
mmol/l |
1.0 |
1.41 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61120 |
527 |
FHH-Adipoqm3Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
70 days-84 days |
6 |
|
|
21.33 |
mmol/l |
0.95 |
2.34 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61116 |
527 |
FHH-Tgfbr2m2Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
14 |
|
|
33.29 |
g/dl |
0.24 |
0.88 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61144 |
527 |
FHH-Agtr1bm1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
15 |
|
|
33.93 |
g/dl |
0.12 |
0.45 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61143 |
527 |
FHH-Lcatm1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
15 |
|
|
33.6 |
g/dl |
0.14 |
0.54 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61147 |
527 |
FHH-Agtr1bm1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
14 |
|
|
33.34 |
g/dl |
0.11 |
0.41 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61150 |
527 |
FHH-Nr0b2m1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
10 |
|
|
33.64 |
g/dl |
0.21 |
0.67 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61151 |
527 |
BN-Tgfbr2m1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
7 |
|
|
33.5 |
g/dl |
0.14 |
0.37 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61152 |
527 |
FHH-F10m1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
10 |
|
|
33.45 |
g/dl |
0.14 |
0.45 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61172 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
4 |
|
|
32.73 |
g/dl |
0.62 |
1.24 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61174 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
7 |
|
|
32.34 |
g/dl |
0.17 |
0.45 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61178 |
527 |
FHH-Adra1am1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
8 |
|
|
33.48 |
g/dl |
0.17 |
0.48 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61191 |
527 |
FHH-Egln3m1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
14 |
|
|
32.45 |
g/dl |
0.14 |
0.53 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61200 |
527 |
SS/JrHsdMcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
16 |
|
|
174.31 |
U/l |
12.33 |
49.32 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61215 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
5 |
|
|
6.12 |
g/dl |
0.04 |
0.08 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61224 |
527 |
WKY/NCrl |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
12 |
|
|
0.55 |
E-7mole |
0.13 |
0.44 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55978 |
522 |
F344/DuCrl |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
13 |
|
|
1.8 |
E-7mole |
0.32 |
1.14 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55981 |
522 |
LEW/Crl |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
24 |
|
|
1.43 |
E-7mole |
0.27 |
1.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55984 |
522 |
SS-Chr 16BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
-8.5 |
null |
0.17 |
0.39 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
56011 |
522 |
FHH-Nr0b2m1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
10 |
|
|
5.18 |
g/dl |
0.06 |
0.19 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61233 |
527 |
FHH-Procm1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
8 |
|
|
5.24 |
g/dl |
0.15 |
0.42 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61241 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
5 |
|
|
5.84 |
g/dl |
0.17 |
0.37 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61236 |
527 |
FHH-Ccr2m1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
8 |
|
|
5.44 |
g/dl |
0.05 |
0.13 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61246 |
527 |
F344/NHsd |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
4 |
|
|
5.0 |
g/dl |
0.25 |
0.5 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61252 |
527 |
FHH-Nr4a1m1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
11 |
|
|
5.36 |
g/dl |
0.09 |
0.31 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61255 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
1 |
|
|
5.1 |
g/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61263 |
527 |
FHH/EurMcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
159 |
|
|
5.56 |
g/dl |
0.02 |
0.28 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61272 |
527 |
FHH-Adipoqm1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
9 |
|
|
4.97 |
mmol/l |
0.14 |
0.43 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61290 |
527 |
FHH-Lcatm1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
12 |
|
|
5.74 |
mmol/l |
0.55 |
1.9 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61294 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
1 |
|
|
3.4 |
mmol/l |
|
|
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61293 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
6 |
|
|
4.23 |
mmol/l |
0.4 |
0.97 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61299 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
3 |
|
|
4.67 |
mmol/l |
0.19 |
0.32 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61303 |
527 |
FHH-Agtr1bm1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
14 |
|
|
4.05 |
mmol/l |
0.13 |
0.47 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61304 |
527 |
FHH-Nr0b2m1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
10 |
|
|
4.76 |
mmol/l |
0.24 |
0.75 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61305 |
527 |
FHH-Adipoqm1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
8 |
|
|
5.99 |
mmol/l |
0.53 |
1.51 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61307 |
527 |
FHH-Htr1am1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
19 |
|
|
5.08 |
mmol/l |
0.16 |
0.71 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61322 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
4 |
|
|
4.2 |
mmol/l |
0.32 |
0.65 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61330 |
527 |
FHH-Ghsrm1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
9 |
|
|
4.28 |
mmol/l |
0.11 |
0.33 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61331 |
527 |
FHH-Ghsrm1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
15 |
|
|
5.35 |
mmol/l |
0.29 |
1.11 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61339 |
527 |
FHH-Adra1am1Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
9 |
|
|
4.91 |
mmol/l |
0.34 |
1.02 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61347 |
527 |
BN/NHsdMcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
27 |
|
|
4.18 |
mmol/l |
0.09 |
0.45 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61358 |
527 |
FHH-Adipoqm1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
9 |
|
|
3.88 |
x 1000 cells/ul |
0.41 |
1.23 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61362 |
527 |
FHH-Lcatm1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
13 |
|
|
4.78 |
x 1000 cells/ul |
0.38 |
1.39 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61366 |
527 |
FHH-Slc8a2m1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
11 |
|
|
3.53 |
x 1000 cells/ul |
0.34 |
1.12 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61374 |
527 |
BN-Tgfbr2m1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
7 |
|
|
7.44 |
x 1000 cells/ul |
0.5 |
1.33 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61378 |
527 |
FHH-Adipoqm2Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
5 |
|
|
4.64 |
x 1000 cells/ul |
0.61 |
1.36 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61381 |
527 |
FHH-F10m1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
11 |
|
|
4.25 |
x 1000 cells/ul |
0.66 |
2.18 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61383 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
1 |
|
|
4.7 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61389 |
527 |
F344/NHsd |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
4 |
|
|
4.18 |
x 1000 cells/ul |
0.6 |
1.2 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61396 |
527 |
FHH/EurMcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
25 |
|
|
5.01 |
x 1000 cells/ul |
0.3 |
1.48 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61405 |
527 |
FHH/EurMcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
157 |
|
|
5.08 |
x 1000 cells/ul |
0.19 |
2.33 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61416 |
527 |
FHH-Slc8a2m1Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
8 |
|
|
3.96 |
x 1000 cells/ul |
0.53 |
1.5 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61423 |
527 |
SS/JrHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
13 |
|
|
1.27 |
E-7mole |
0.38 |
1.36 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54596 |
522 |
SHR/NCrl |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
0.71 |
E-7mole |
0.1 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54597 |
522 |
Hsd:SD |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
13 |
|
|
40.71 |
% |
5.21 |
18.79 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
54636 |
522 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
-8.48 |
null |
0.05 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56018 |
522 |
SS-Chr 18BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
-8.05 |
null |
0.09 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56034 |
522 |
LEW/Crl |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
25 |
|
|
210.8 |
g |
1.7 |
8.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56069 |
522 |
Crl:CD(SD) |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
|
264.9 |
g |
7.0 |
22.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56072 |
522 |
F344/DuCrl |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
20 |
|
|
155.9 |
g |
3.1 |
13.7 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56076 |
522 |
FHH-Chr 12BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
12 |
|
|
-8.28 |
null |
0.21 |
0.74 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56079 |
522 |
SS-Chr 10BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
-7.78 |
null |
0.08 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56080 |
522 |
SS-Chr 6BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
21 |
|
|
-7.68 |
null |
0.11 |
0.48 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56094 |
522 |
SS-Chr 10BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
-8.06 |
null |
0.05 |
0.14 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56096 |
522 |
FHH-Chr XBN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
-7.8 |
null |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56111 |
522 |
FHH-Chr 3BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-8.16 |
null |
0.06 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56121 |
522 |
FHH-Chr 19BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-8.23 |
null |
0.06 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56125 |
522 |
SS-Chr 18BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
21 |
|
|
-8.22 |
null |
0.14 |
0.64 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56144 |
522 |
SS-Chr XBN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-8.24 |
null |
0.11 |
0.35 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56146 |
522 |
SS-Chr 12BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
-7.27 |
null |
0.06 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56156 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
-8.04 |
null |
0.09 |
0.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56163 |
522 |
FHH-Chr 7BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
-8.26 |
null |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56160 |
522 |
BN/NHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
20 |
|
|
-6.8 |
null |
0.1 |
0.44 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56165 |
522 |
SS/JrHsdMcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
20 |
|
|
99.85 |
% |
0.11 |
0.49 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56201 |
522 |
BN/NHsdMcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
43 |
|
|
0.12 |
x 1000 cells/ul |
0.02 |
0.13 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62269 |
527 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
2 |
|
|
0.03 |
x 1000 cells/ul |
0.03 |
0.04 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62265 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
7 |
|
|
0.08 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62267 |
527 |
FHH-Nr0b2m1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
6 |
|
|
103.17 |
mmol/l |
1.51 |
3.71 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62283 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
1 |
|
|
99.0 |
mmol/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62287 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
6 |
|
|
99.17 |
mmol/l |
0.6 |
1.47 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62293 |
527 |
FHH-Agtr1bm1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
14 |
|
|
104.71 |
mmol/l |
0.46 |
1.73 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62298 |
527 |
FHH-Htr1am1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
13 |
|
|
105.15 |
mmol/l |
0.78 |
2.82 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62308 |
527 |
FHH-F10m2Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
16 |
|
|
104.44 |
mmol/l |
0.63 |
2.53 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62310 |
527 |
FHH-F10m1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
10 |
|
|
103.7 |
mmol/l |
0.78 |
2.45 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62320 |
527 |
FHH-Ghsrm1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
15 |
|
|
104.73 |
mmol/l |
0.74 |
2.87 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62333 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
4 |
|
|
101.75 |
mmol/l |
1.18 |
2.36 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62340 |
527 |
FHH-Tlr4m1Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
female |
70 days-84 days |
9 |
|
|
102.89 |
mmol/l |
0.26 |
0.78 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62346 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
7 |
|
|
99.86 |
mmol/l |
1.42 |
3.76 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62349 |
527 |
BN/NHsdMcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
44 |
|
|
103.82 |
mmol/l |
0.5 |
3.34 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62351 |
527 |
FHH-F10m2Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
16 |
|
|
60.19 |
mg/dl |
1.95 |
7.78 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62382 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
7 |
|
|
67.0 |
mg/dl |
2.28 |
6.03 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62398 |
527 |
FHH/EurMcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
25 |
|
|
63.04 |
mg/dl |
1.84 |
9.19 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62399 |
527 |
SS-Ghsrm3Mcwi |
serum total protein level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
2 |
|
|
6.1 |
g/dl |
0.3 |
0.42 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62437 |
527 |
FHH-Nr0b2m1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
6 |
|
|
178.5 |
mg/dl |
6.69 |
16.39 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62447 |
527 |
FHH-Tgfbr2m2Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
13 |
|
|
131.46 |
mg/dl |
11.6 |
41.83 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62450 |
527 |
FHH-Lcatm1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
15 |
|
|
146.13 |
mg/dl |
4.61 |
17.86 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62459 |
527 |
FHH-Tgfbr2m2Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
14 |
|
|
137.43 |
mg/dl |
7.74 |
28.95 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62456 |
527 |
FHH-Adipoqm2Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
7 |
|
|
109.0 |
mg/dl |
12.47 |
32.99 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62467 |
527 |
FHH-Chr 10BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
73.5 |
% |
4.84 |
15.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54776 |
522 |
GH/OmrMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
3 |
|
|
54.33 |
% |
4.33 |
7.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54784 |
522 |
FHH-Chr XBN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
92.3 |
% |
3.45 |
10.92 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54789 |
522 |
FHH-Chr 16BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
66.1 |
% |
4.51 |
14.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54790 |
522 |
SS-Chr 15BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
73.63 |
% |
6.48 |
18.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54797 |
522 |
SS-Chr 13BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
89.5 |
% |
2.32 |
8.7 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54805 |
522 |
FHH-Chr 20BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
85.9 |
% |
4.5 |
14.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54807 |
522 |
SS-Chr 18BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
20 |
|
|
63.05 |
% |
4.72 |
21.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54819 |
522 |
SS-Chr 18BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
18 |
|
|
67.11 |
% |
4.57 |
19.37 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54823 |
522 |
FHH-Chr 4BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
78.0 |
% |
4.57 |
13.7 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54828 |
522 |
SS-Chr 19BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
81.89 |
% |
7.49 |
22.47 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54834 |
522 |
SS/JrHsdMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
12 |
|
|
50.42 |
% |
4.9 |
16.97 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54856 |
522 |
FHH-Chr 7BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
82.44 |
% |
6.48 |
19.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54843 |
522 |
SS-Chr 16BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
3 |
|
|
39.67 |
% |
2.19 |
3.79 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54854 |
522 |
FHH-Chr 6BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54887 |
522 |
FHH-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
0.02 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54884 |
522 |
SS-Chr 5BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54908 |
522 |
SS-Chr 16BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
0.03 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54921 |
522 |
FHH-Chr 13BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
12 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54932 |
522 |
SS-Chr 20BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.04 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54936 |
522 |
SS-Chr 18BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
19 |
|
|
0.02 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54949 |
522 |
SS-Chr 4BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.06 |
umol/l |
0.03 |
0.08 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54951 |
522 |
SS-Chr 4BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
0.04 |
umol/l |
0.02 |
0.05 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54959 |
522 |
SS-Chr XBN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54968 |
522 |
SS-Chr 2BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.04 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54971 |
522 |
SS-Chr YBN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
20 |
|
|
0.03 |
10E-7mol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56241 |
522 |
GH/OmrMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
0.08 |
10E-7mol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56245 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
6 |
|
|
0.05 |
10E-7mol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56249 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
0.09 |
10E-7mol/l |
0.02 |
0.05 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56251 |
522 |
SS-Chr 6BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
36.25 |
% |
5.54 |
15.66 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56275 |
522 |
FHH/EurMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
26.11 |
% |
3.86 |
11.59 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56283 |
522 |
SS-Chr 18BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
40.0 |
% |
4.73 |
10.58 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56289 |
522 |
BN/NHsdMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
59.0 |
% |
3.48 |
9.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56295 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
23.14 |
% |
3.27 |
8.65 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56294 |
522 |
SS-Chr 16BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
100.0 |
% |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56309 |
522 |
FHH-Ghsrm1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
15 |
|
|
16.4 |
mmol/l |
0.48 |
1.84 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61647 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
3 |
|
|
19.67 |
mmol/l |
0.67 |
1.15 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61657 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
5 |
|
|
19.6 |
mmol/l |
0.68 |
1.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61667 |
527 |
FHH-Lcatm1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
15 |
|
|
0.19 |
x 1000 cells/ul |
0.04 |
0.15 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61681 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
3 |
|
|
0.23 |
x 1000 cells/ul |
0.11 |
0.19 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61692 |
527 |
FHH-Htr1am1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
13 |
|
|
0.14 |
x 1000 cells/ul |
0.03 |
0.13 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61694 |
527 |
FHH-Procm1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
9 |
|
|
0.14 |
x 1000 cells/ul |
0.06 |
0.19 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61700 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
1 |
|
|
0.0 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61697 |
527 |
FHH-Ghsrm1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
9 |
|
|
0.11 |
x 1000 cells/ul |
0.05 |
0.15 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61711 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
2 |
|
|
0.18 |
x 1000 cells/ul |
0.08 |
0.11 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61716 |
527 |
FHH-Adipoqm3Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
6 |
|
|
0.18 |
x 1000 cells/ul |
0.06 |
0.13 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61722 |
527 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
2 |
|
|
0.04 |
x 1000 cells/ul |
0.04 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61733 |
527 |
SS-Cpt2m1Mcwi |
serum calcium level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
6 |
|
|
9.32 |
mg/dl |
0.15 |
0.38 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61742 |
527 |
SS-Cpt2m1Mcwi |
serum potassium level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
female |
70 days-84 days |
1 |
|
|
4.1 |
mmol/l |
|
|
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61757 |
527 |
FHH-Tgfbr2m2Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
12 |
|
|
140.0 |
mmol/l |
0.44 |
1.54 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61774 |
527 |
BN-Tgfbr2m1Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
7 |
|
|
139.86 |
mmol/l |
1.03 |
2.73 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61788 |
527 |
FHH-F10m2Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
16 |
|
|
139.38 |
mmol/l |
0.49 |
1.96 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61798 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
4 |
|
|
143.5 |
mmol/l |
1.55 |
3.11 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61812 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
1 |
|
|
142.0 |
mmol/l |
|
|
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61811 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
4 |
|
|
139.75 |
mmol/l |
3.3 |
6.6 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61810 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
2 |
|
|
140.0 |
mmol/l |
1.0 |
1.41 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61818 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
3 |
|
|
140.67 |
mmol/l |
1.2 |
2.08 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61820 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
4 |
|
|
142.25 |
mmol/l |
0.75 |
1.5 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61828 |
527 |
FHH-Adra1am1Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
8 |
|
|
141.25 |
mmol/l |
0.77 |
2.19 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61827 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
3 |
|
|
140.0 |
mmol/l |
0.0 |
0.0 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61831 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
2 |
|
|
142.5 |
mmol/l |
1.5 |
2.12 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61832 |
527 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
2 |
|
|
138.0 |
mmol/l |
1.0 |
1.41 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61835 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
5 |
|
|
140.6 |
mmol/l |
1.47 |
3.29 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61838 |
527 |
BN/NHsdMcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
44 |
|
|
141.27 |
mmol/l |
0.43 |
2.86 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61839 |
527 |
Crl:CD(SD) |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
42.78 |
% |
4.97 |
14.92 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55001 |
522 |
LE/BluGill |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
33.71 |
% |
3.38 |
12.65 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55002 |
522 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
13 |
|
|
40.23 |
% |
4.6 |
16.59 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55078 |
522 |
SS-Chr 6BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
28.25 |
% |
5.29 |
14.95 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55075 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
13.07 |
% |
3.87 |
14.47 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55097 |
522 |
SS/JrHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
84.07 |
% |
4.74 |
17.72 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
55100 |
522 |
LE/BluGill |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
-8.48 |
null |
0.06 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55116 |
522 |
SS-Chr 10BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70 days-84 days |
10 |
|
|
324.9 |
g |
6.0 |
19.0 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55160 |
522 |
SS-Chr 10BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
10 |
|
|
203.4 |
g |
6.2 |
19.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55174 |
522 |
SS-Chr 7BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
12 |
|
|
187.6 |
g |
2.3 |
7.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55186 |
522 |
SHR/NCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
45.63 |
% |
1.58 |
4.47 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56441 |
522 |
GH/OmrMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
6 |
|
|
47.33 |
% |
5.9 |
14.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56443 |
522 |
SS-Chr 10BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
2.89 |
E-7mole |
0.69 |
1.82 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56495 |
522 |
Hsd:SD |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
14 |
|
|
-7.49 |
null |
0.09 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
56492 |
522 |
SS-Chr 6BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
17 |
|
|
6.71 |
E-7mole |
2.23 |
9.19 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56509 |
522 |
FHH-Chr 17BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
1.48 |
E-7mole |
0.19 |
0.61 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56523 |
522 |
FHH-Chr XBN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
1.02 |
E-7mole |
0.09 |
0.29 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56526 |
522 |
FHH-Chr 10BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
1.76 |
E-7mole |
0.28 |
0.83 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56528 |
522 |
SS-Chr 15BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
1.23 |
E-7mole |
0.16 |
0.49 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56539 |
522 |
SS-Chr 15BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
2.23 |
E-7mole |
0.45 |
1.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56537 |
522 |
FHH/EurMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
1.58 |
E-7mole |
0.24 |
0.77 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56534 |
522 |
SS/JrHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
13 |
|
|
1.46 |
E-7mole |
0.26 |
0.95 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56566 |
522 |
SS-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
0.92 |
E-7mole |
0.33 |
1.25 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56577 |
522 |
BN/NHsdMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
3.1 |
E-7mole |
0.51 |
2.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56580 |
522 |
FHH-Chr 1BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
17 |
|
|
1.61 |
E-7mole |
0.35 |
1.44 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56586 |
522 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
3 |
|
|
4.29 |
x 1000 cells/ul |
0.87 |
1.51 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62061 |
527 |
FHH-Adipoqm2Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
5 |
|
|
3.68 |
x 1000 cells/ul |
0.45 |
1.01 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62067 |
527 |
F344/NHsd |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
7 |
|
|
3.77 |
x 1000 cells/ul |
0.62 |
1.65 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62073 |
527 |
FHH-Htr1am1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
13 |
|
|
4.28 |
x 1000 cells/ul |
0.23 |
0.81 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62072 |
527 |
FHH-Nr4a1m1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
11 |
|
|
5.65 |
x 1000 cells/ul |
0.63 |
2.09 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62077 |
527 |
FHH-Htr1am1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
21 |
|
|
4.04 |
x 1000 cells/ul |
0.18 |
0.83 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62080 |
527 |
FHH-F10m2Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
12 |
|
|
3.78 |
x 1000 cells/ul |
0.35 |
1.2 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62083 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
2 |
|
|
3.86 |
x 1000 cells/ul |
0.11 |
0.16 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62094 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
3 |
|
|
3.7 |
x 1000 cells/ul |
0.42 |
0.72 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62096 |
527 |
FHH-Ghsrm1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
15 |
|
|
4.3 |
x 1000 cells/ul |
0.3 |
1.16 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62097 |
527 |
FHH-Adipoqm3Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
6 |
|
|
3.79 |
x 1000 cells/ul |
0.68 |
1.66 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62100 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
2 |
|
|
4.09 |
x 1000 cells/ul |
1.13 |
1.59 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62108 |
527 |
BN/NHsdMcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
27 |
|
|
5.94 |
x 1000 cells/ul |
0.39 |
2.0 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62116 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
4 |
|
|
4.38 |
x 1000 cells/ul |
0.23 |
0.45 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62118 |
527 |
FHH-Nr0b2m1Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
6 |
|
|
0.13 |
mg/dl |
0.02 |
0.05 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62119 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
6 |
|
|
0.11 |
mg/dl |
0.02 |
0.05 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62129 |
527 |
FHH-Nr0b2m1Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
10 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62135 |
527 |
F344/NHsd |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
7 |
|
|
0.07 |
mg/dl |
0.01 |
0.03 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62145 |
527 |
FHH-Adra1am1Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
8 |
|
|
0.09 |
mg/dl |
0.01 |
0.02 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62175 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
4 |
|
|
0.13 |
mg/dl |
0.03 |
0.05 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62176 |
527 |
FHH-Egln3m1Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
14 |
|
|
0.19 |
mg/dl |
0.01 |
0.05 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62184 |
527 |
SS-Sod3m1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
10 |
|
|
90.3 |
U/l |
29.22 |
92.42 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62194 |
527 |
SS/JrHsdMcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
17 |
|
|
40.94 |
U/l |
3.17 |
13.06 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62199 |
527 |
FHH-Tgfbr2m2Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
13 |
|
|
0.06 |
x 1000 cells/ul |
0.02 |
0.05 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62204 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
1 |
|
|
0.0 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62205 |
527 |
FHH-Adipoqm2Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
12 |
|
|
0.05 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62203 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
5 |
|
|
0.07 |
x 1000 cells/ul |
0.03 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62208 |
527 |
FHH-Tgfbr2m2Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
14 |
|
|
0.05 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62210 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
2 |
|
|
0.0 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62212 |
527 |
FHH-Slc8a2m1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
11 |
|
|
0.04 |
x 1000 cells/ul |
0.01 |
0.05 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62214 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
1 |
|
|
0.0 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62229 |
527 |
FHH-F10m2Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
16 |
|
|
0.07 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62228 |
527 |
FHH-Nr4a1m1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
11 |
|
|
0.07 |
x 1000 cells/ul |
0.03 |
0.08 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62231 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
4 |
|
|
0.0 |
x 1000 cells/ul |
0.0 |
0.0 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62258 |
527 |
SS-Kcnq1em14Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
340.57 |
beats/min |
13.34 |
35.3 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43706 |
441 |
SS-Cyp1a1em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
341.0 |
beats/min |
18.0 |
25.46 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43724 |
441 |
SS-Plcd3em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
9 |
|
|
322.67 |
beats/min |
10.58 |
31.74 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43727 |
441 |
SS-Plekha7em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
12 |
|
|
372.0 |
beats/min |
6.02 |
20.86 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43728 |
441 |
SS-Cyp1a1em5Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
364.0 |
beats/min |
3.0 |
4.24 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43735 |
441 |
SS-Ulk3em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
366.67 |
beats/min |
7.31 |
12.66 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43738 |
441 |
SS-Aldh2em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
364.17 |
beats/min |
7.78 |
19.06 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43736 |
441 |
SS-Cyp1a1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
356.14 |
beats/min |
7.11 |
18.81 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43744 |
441 |
SS-Agtr1aem1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
10 |
|
|
339.7 |
beats/min |
11.64 |
36.82 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43754 |
441 |
SS-Plcd3em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
338.0 |
beats/min |
15.0 |
21.21 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43762 |
441 |
SS-Nppbem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
8 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.38 |
mmHg |
4.44 |
12.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43773 |
441 |
SS-Cdh13em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.0 |
mmHg |
4.38 |
8.76 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43775 |
441 |
SS-Slc30a8em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.0 |
mmHg |
2.04 |
4.08 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43776 |
441 |
SS-Plod1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
8 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.85 |
mmHg |
6.05 |
17.1 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43791 |
441 |
SS-Plekha7em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
151.5 |
mmHg |
9.5 |
13.44 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43788 |
441 |
SS-Plcd3em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
135.33 |
mmHg |
5.61 |
16.82 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43789 |
441 |
SS-Mstnem3Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
125.29 |
mmHg |
4.64 |
12.28 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43799 |
441 |
SS-Msraem3Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
147.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43804 |
441 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
131.0 |
mmHg |
6.09 |
14.93 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43807 |
441 |
SS-Mstnem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
124.67 |
mmHg |
6.06 |
10.5 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43818 |
441 |
SS-Slc30a8em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
11 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.73 |
mmHg |
4.81 |
15.97 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43820 |
441 |
SS-Plcd3em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
143.5 |
mmHg |
17.5 |
24.75 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43824 |
441 |
SS-Stk39em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.33 |
mmHg |
16.13 |
27.93 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43828 |
441 |
SS-Msraem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
138.5 |
mmHg |
10.46 |
20.92 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43834 |
441 |
SS-Cdh13em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.0 |
mmHg |
2.94 |
5.89 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43837 |
441 |
SS-Mstnem3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
144.0 |
mmHg |
6.0 |
8.49 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43844 |
441 |
SS-Ulk3em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
11 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.45 |
mmHg |
4.9 |
16.25 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43846 |
441 |
SS-Mstnem3Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
124.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43849 |
441 |
SS-Aldh2em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
151.67 |
mmHg |
10.92 |
26.76 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43864 |
441 |
SS-Ulk3em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
136.33 |
mmHg |
5.55 |
9.61 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43862 |
441 |
SS-Plod1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.25 |
mmHg |
2.78 |
5.56 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43870 |
441 |
SS-Agtr1aem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.67 |
mmHg |
4.37 |
13.11 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43878 |
441 |
SS-Stk39em2Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
6 |
|
|
324.5 |
g |
7.3 |
17.9 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43891 |
441 |
SS-Kcnq1em14Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
7 |
|
|
251.0 |
g |
3.7 |
9.7 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43893 |
441 |
SS-Agtrapem8Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
10 |
|
|
327.4 |
g |
3.9 |
12.3 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43899 |
441 |
SS-Cyp1a1em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
3 |
|
|
307.3 |
g |
16.5 |
28.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43910 |
441 |
WKY/NCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
71.9 |
% |
3.29 |
10.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56710 |
522 |
SS-Chr 16BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
3 |
|
|
58.67 |
% |
8.35 |
14.47 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56716 |
522 |
SS/JrHsdMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
12 |
|
|
1.38 |
g/mg |
0.11 |
0.39 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
56757 |
522 |
SS/JrHsdMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
1.84 |
g/mg |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
56759 |
522 |
LEW/Crl |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
23 |
|
|
0.01 |
10E-7mol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56763 |
522 |
F344/DuCrl |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
0.05 |
10E-7mol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56765 |
522 |
WKY/NCrl |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
0.05 |
10E-7mol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56769 |
522 |
Hsd:SD |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
15 |
|
|
65.48 |
% |
5.85 |
22.64 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
56782 |
522 |
WKY/NCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
13 |
|
|
29.0 |
% |
2.97 |
10.69 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56825 |
522 |
F344/DuCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
18 |
|
|
32.94 |
% |
5.29 |
22.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56833 |
522 |
FHH-Tgfbr2m2Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
12 |
|
|
19.58 |
mg/dl |
0.47 |
1.62 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60144 |
527 |
FHH-Lcatm1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
13 |
|
|
20.08 |
mg/dl |
1.13 |
4.07 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60146 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
3 |
|
|
24.33 |
mg/dl |
1.45 |
2.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60155 |
527 |
FHH-Nr0b2m1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
10 |
|
|
18.8 |
mg/dl |
0.49 |
1.55 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60157 |
527 |
FHH-Ccr2m1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
5 |
|
|
17.8 |
mg/dl |
0.86 |
1.92 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60162 |
527 |
FHH-Agtr1bm1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
15 |
|
|
53.67 |
U/l |
3.54 |
13.72 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61441 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
1 |
|
|
22.0 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60187 |
527 |
FHH-Slc8a2m1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
12 |
|
|
44.0 |
U/l |
4.04 |
14.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61446 |
527 |
FHH-F10m1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
11 |
|
|
44.0 |
U/l |
4.36 |
14.46 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61455 |
527 |
FHH-F10m2Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
16 |
|
|
51.5 |
U/l |
3.92 |
15.69 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61460 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
1 |
|
|
36.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61461 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
6 |
|
|
58.67 |
U/l |
11.18 |
27.38 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61485 |
527 |
FHH-Adra1am1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
9 |
|
|
46.11 |
U/l |
4.92 |
14.76 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61491 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
7 |
|
|
63.0 |
U/l |
7.12 |
18.83 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61499 |
527 |
SS/JrHsdMcwi |
red blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
41 |
|
|
8.42 |
x 10E6 cells/ul |
0.09 |
0.6 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61507 |
527 |
SS-Klf4m3Mcwi |
red blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
8 |
|
|
8.06 |
x 10E6 cells/ul |
0.14 |
0.39 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61510 |
527 |
SS-Ghsrm3Mcwi |
red blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
1 |
|
|
8.08 |
x 10E6 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61512 |
527 |
SS-Sod3m1Mcwi |
red blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
10 |
|
|
8.02 |
x 10E6 cells/ul |
0.11 |
0.36 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61514 |
527 |
SS-Cpt2m1Mcwi |
plasma creatinine level |
controlled sodium content diet (1 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
6 |
|
|
0.62 |
mg/dl |
0.11 |
0.26 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61516 |
527 |
SS-Cpt2m1Mcwi |
plasma creatinine level |
controlled sodium content diet (1 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
1 |
|
|
0.8 |
mg/dl |
|
|
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61521 |
527 |
SS/JrHsdMcwi |
plasma creatinine level |
controlled sodium content diet (1 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
17 |
|
|
0.33 |
mg/dl |
0.02 |
0.08 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61523 |
527 |
FHH-Adipoqm1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
9 |
|
|
6.43 |
mg/dl |
0.61 |
1.82 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61526 |
527 |
FHH-Lcatm1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
13 |
|
|
9.55 |
mg/dl |
0.83 |
3.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61530 |
527 |
FHH-Agtr1bm1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
15 |
|
|
7.99 |
mg/dl |
0.12 |
0.46 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61533 |
527 |
FHH-Tgfbr2m2Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
11 |
|
|
7.92 |
mg/dl |
0.64 |
2.11 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61534 |
527 |
FHH-Agtr1bm1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
14 |
|
|
7.24 |
mg/dl |
0.15 |
0.56 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61540 |
527 |
F344/NHsd |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
7 |
|
|
8.44 |
mg/dl |
0.32 |
0.84 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61551 |
527 |
FHH-Nr4a1m1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
11 |
|
|
8.12 |
mg/dl |
0.69 |
2.29 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61563 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
2 |
|
|
4.2 |
mg/dl |
3.9 |
5.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61572 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
3 |
|
|
6.87 |
mg/dl |
0.78 |
1.34 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61574 |
527 |
FHH-Adipoqm3Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
5 |
|
|
8.46 |
mg/dl |
1.21 |
2.7 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61579 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
3 |
|
|
8.33 |
mg/dl |
0.55 |
0.95 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61585 |
527 |
FHH-Agtr1bm1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
14 |
|
|
17.79 |
mmol/l |
0.67 |
2.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61612 |
527 |
FHH-Slc8a2m1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
12 |
|
|
13.92 |
mmol/l |
1.16 |
4.03 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61610 |
527 |
FHH-F10m2Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
16 |
|
|
16.44 |
mmol/l |
1.26 |
5.06 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61624 |
527 |
SS-Plcd3em4Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
13 |
|
|
310.8 |
g |
5.1 |
18.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43914 |
441 |
SS-Plod1em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
5 |
|
|
307.2 |
g |
14.7 |
32.9 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43933 |
441 |
SS-Nppaem4Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
13 |
|
|
72.53 |
mg/d |
8.27 |
29.81 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43950 |
441 |
SS-Prokr1em2Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
6 |
|
|
70.44 |
mg/d |
12.79 |
31.32 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43952 |
441 |
SS-Slc30a8em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
4 |
|
|
127.37 |
mg/d |
5.84 |
11.69 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43963 |
441 |
SS-Mstnem1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
13 |
|
|
79.34 |
mg/d |
9.3 |
33.54 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43966 |
441 |
SS-Mstnem3Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
3 |
|
|
56.3 |
mg/d |
2.31 |
4.0 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43968 |
441 |
SS-Plekha7em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
9 |
|
|
79.69 |
mg/d |
6.5 |
19.5 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43979 |
441 |
SS-Cyp1a1em5Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
2 |
|
|
77.71 |
mg/d |
6.98 |
9.88 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43983 |
441 |
SS-Plcd3em7Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
9 |
|
|
108.74 |
mg/d |
9.87 |
29.6 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43987 |
441 |
SS-Cyp1a1em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
7 |
|
|
72.43 |
mg/d |
9.46 |
25.04 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43992 |
441 |
SS-Wdr72em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
2 |
|
|
77.22 |
mg/d |
11.0 |
15.56 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43995 |
441 |
SS-Slc30a8em2Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
1 |
|
|
46.59 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43997 |
441 |
SS-Stk39em2Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
10 |
|
|
50.85 |
mg/d |
6.03 |
19.06 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43999 |
441 |
SS-Slc30a8em2Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
10 |
|
|
105.78 |
mg/d |
9.72 |
30.74 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44006 |
441 |
SS-Msraem4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
353.5 |
beats/min |
8.22 |
16.44 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44020 |
441 |
SS-Tcf7l2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
342.0 |
beats/min |
13.82 |
27.64 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44028 |
441 |
SS-Plekha7em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
352.13 |
beats/min |
6.55 |
18.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44041 |
441 |
SS-Aldh2em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
365.33 |
beats/min |
8.22 |
20.14 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44050 |
441 |
SS-Wdr72em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
350.0 |
beats/min |
9.0 |
12.73 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44057 |
441 |
SS-Agtrapem8Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
345.5 |
beats/min |
7.5 |
10.61 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44058 |
441 |
SS-Plekha7em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.17 |
mmHg |
4.8 |
11.75 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44079 |
441 |
SS-Tcf7l2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
144.6 |
mmHg |
4.3 |
9.61 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44090 |
441 |
SS-Wdr72em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
108.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44093 |
441 |
SS-Mstnem3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
116.0 |
mmHg |
9.0 |
12.73 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44092 |
441 |
SS-Plcd3em7Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
120.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44113 |
441 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.57 |
mmHg |
4.7 |
12.45 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44116 |
441 |
SS-Plod1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
145.75 |
mmHg |
6.05 |
12.09 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44117 |
441 |
SS-Agtr1aem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.67 |
mmHg |
4.68 |
14.03 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44125 |
441 |
Crl:CD(SD) |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
71.9 |
% |
8.91 |
28.16 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56853 |
522 |
F344/DuCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
99.71 |
% |
0.29 |
1.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56854 |
522 |
WKY/NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
99.29 |
% |
0.27 |
0.99 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56851 |
522 |
F344/DuCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
11 |
|
|
99.91 |
% |
0.09 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56859 |
522 |
LEW/Crl |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
24 |
|
|
1.3 |
g/mg |
0.06 |
0.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56867 |
522 |
SS-Chr 18BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
0.11 |
umol/l |
0.02 |
0.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56879 |
522 |
SS/JrHsdMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
0.19 |
umol/l |
0.07 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56883 |
522 |
GH/OmrMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.11 |
umol/l |
0.03 |
0.09 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56885 |
522 |
FHH-Chr 15BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
-6.99 |
null |
0.09 |
0.23 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56888 |
522 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
11 |
|
|
-7.15 |
null |
0.1 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56899 |
522 |
SS-Chr 6BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
17 |
|
|
-6.61 |
null |
0.13 |
0.54 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56904 |
522 |
GH/OmrMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
3 |
|
|
-6.66 |
null |
0.11 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56919 |
522 |
FHH-Chr 8BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
-6.81 |
null |
0.12 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56926 |
522 |
FHH-Chr 19BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
7 |
|
|
-6.85 |
null |
0.03 |
0.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56935 |
522 |
FHH-Chr 11BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
-6.84 |
null |
0.11 |
0.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56967 |
522 |
FHH-Chr 7BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
-6.96 |
null |
0.07 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56970 |
522 |
FHH/EurMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
1.23 |
g/mg |
0.11 |
0.35 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56984 |
522 |
FHH/EurMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.36 |
g/mg |
0.14 |
0.43 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56990 |
522 |
GH/OmrMcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.0 |
g/mg |
0.08 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56993 |
522 |
FHH-Adipoqm1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
9 |
|
|
9.96 |
mg/dl |
0.13 |
0.39 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60214 |
527 |
FHH-Agtr1bm1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
14 |
|
|
9.94 |
mg/dl |
0.11 |
0.41 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60228 |
527 |
BN-Tgfbr2m1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
7 |
|
|
10.03 |
mg/dl |
0.18 |
0.47 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60230 |
527 |
FHH-Ccr2m1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
5 |
|
|
9.32 |
mg/dl |
0.25 |
0.57 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60234 |
527 |
FHH-F10m2Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
16 |
|
|
10.06 |
mg/dl |
0.09 |
0.36 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60240 |
527 |
FHH-Htr1am1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
male |
70 days-84 days |
21 |
|
|
9.74 |
mg/dl |
0.08 |
0.35 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60246 |
527 |
F344/NHsd |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
4 |
|
|
8.55 |
mg/dl |
0.1 |
0.21 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60248 |
527 |
FHH-Ghsrm1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
9 |
|
|
9.93 |
mg/dl |
0.15 |
0.45 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60255 |
527 |
BN-Lcatm3Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
2 |
|
|
9.1 |
mg/dl |
0.2 |
0.28 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60258 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
4 |
|
|
9.82 |
mg/dl |
0.64 |
1.29 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60270 |
527 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
2 |
|
|
9.0 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60277 |
527 |
BN/NHsdMcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
27 |
|
|
9.97 |
mg/dl |
0.09 |
0.47 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60282 |
527 |
SS-Klf4m3Mcwi |
total white blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
8 |
|
|
8.49 |
x 1000 cells/ul |
1.04 |
2.94 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60290 |
527 |
BN-Tgfbr2m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
3 |
|
|
14.67 |
g/dl |
0.19 |
0.32 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60301 |
527 |
FHH-Adipoqm2Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
12 |
|
|
13.82 |
g/dl |
0.69 |
2.38 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60297 |
527 |
BN-Tgfbr2m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
7 |
|
|
14.91 |
g/dl |
0.11 |
0.3 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60312 |
527 |
FHH-Adipoqm1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
8 |
|
|
15.06 |
g/dl |
0.38 |
1.07 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60313 |
527 |
FHH-Htr1am1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
13 |
|
|
13.52 |
g/dl |
0.18 |
0.64 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60320 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
2 |
|
|
15.6 |
g/dl |
0.1 |
0.14 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60329 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
4 |
|
|
14.78 |
g/dl |
0.24 |
0.48 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60334 |
527 |
FHH-F10m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
10 |
|
|
14.94 |
g/dl |
0.27 |
0.84 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60332 |
527 |
FHH-Slc8a2m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
8 |
|
|
16.48 |
g/dl |
0.76 |
2.16 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60357 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
2 |
|
|
14.85 |
g/dl |
0.95 |
1.34 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60356 |
527 |
BN/NHsdMcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
27 |
|
|
14.4 |
g/dl |
0.09 |
0.45 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60364 |
527 |
SS-Cpt2m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
6 |
|
|
18.7 |
pg |
0.14 |
0.33 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60368 |
527 |
SS-Sod3m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
10 |
|
|
19.0 |
pg |
0.08 |
0.27 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60376 |
527 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
3 |
|
|
110.67 |
U/l |
11.29 |
19.55 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60401 |
527 |
SS-Sod3m1Mcwi |
serum globulin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
11 |
|
|
1.91 |
g/dl |
0.06 |
0.2 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
61872 |
527 |
SS-Klf4m3Mcwi |
serum globulin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
8 |
|
|
2.26 |
g/dl |
0.07 |
0.18 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
61868 |
527 |
SS-Cpt2m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
1 |
|
|
12.9 |
g/dl |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61879 |
527 |
FHH-Nr0b2m1Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
6 |
|
|
3.78 |
g/dl |
0.11 |
0.27 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61893 |
527 |
BN-Tgfbr2m1Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
3 |
|
|
3.57 |
g/dl |
0.2 |
0.35 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61899 |
527 |
FHH-Ghsrm1Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
7 |
|
|
3.79 |
g/dl |
0.06 |
0.17 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61935 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
4 |
|
|
3.83 |
g/dl |
0.21 |
0.41 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61932 |
527 |
FHH-Adipoqm3Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
6 |
|
|
3.9 |
g/dl |
0.07 |
0.18 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61946 |
527 |
BN/NHsdMcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
female |
70 days-84 days |
27 |
|
|
3.6 |
g/dl |
0.03 |
0.18 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61962 |
527 |
FHH-Adipoqm1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
9 |
|
|
224.44 |
U/l |
23.7 |
71.09 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61966 |
527 |
FHH-Htr1am1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
13 |
|
|
184.54 |
U/l |
17.67 |
63.71 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61990 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
1 |
|
|
129.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61993 |
527 |
FHH-F10m2Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
12 |
|
|
211.83 |
U/l |
23.14 |
80.17 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62001 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
6 |
|
|
239.33 |
U/l |
41.61 |
101.92 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62017 |
527 |
FHH/EurMcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
158 |
|
|
230.06 |
U/l |
18.8 |
236.33 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62020 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
7 |
|
|
216.29 |
U/l |
44.54 |
117.85 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62031 |
527 |
SS-Cyp1a1em2Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
10 |
|
|
10.17 |
mg/d |
0.45 |
1.41 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44138 |
441 |
SS-Plekha7em1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
6 |
|
|
10.61 |
mg/d |
0.71 |
1.74 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44140 |
441 |
SS-Cdh13em1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
4 |
|
|
9.69 |
mg/d |
1.0 |
2.0 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44146 |
441 |
SS-Ulk3em1Mcwi-/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
10.63 |
mg/d |
1.01 |
1.75 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44149 |
441 |
SS-Mstnem3Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
16.43 |
mg/d |
0.6 |
1.03 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44153 |
441 |
SS-Agtr1aem5Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
8.33 |
mg/d |
0.3 |
0.42 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44165 |
441 |
SS-Plcd3em4Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
13 |
|
|
10.39 |
mg/d |
0.35 |
1.25 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44160 |
441 |
SS-Cyp1a1em5Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
9.62 |
mg/d |
0.34 |
0.47 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44168 |
441 |
SS/JrHsdMcwi |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
7 |
|
|
9.31 |
mg/d |
0.42 |
1.11 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44178 |
441 |
SS-Wdr72em1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
10.26 |
mg/d |
0.06 |
0.08 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44180 |
441 |
SS-Mstnem1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
10.53 |
mg/d |
0.73 |
1.26 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44189 |
441 |
SS-Plcd3em4Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
11.62 |
mg/d |
0.32 |
0.55 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44195 |
441 |
SS-Cyp1a1em5Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
10.88 |
mEq/d |
0.47 |
0.66 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44203 |
441 |
SS-Msraem4Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
5 |
|
|
8.58 |
mEq/d |
0.79 |
1.76 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44205 |
441 |
SS-Ulk3em1Mcwi-/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
6.61 |
mEq/d |
3.13 |
5.43 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44211 |
441 |
SS-Cyp1a1em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
9.2 |
mEq/d |
0.51 |
0.88 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44218 |
441 |
SS-Tcf7l2em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
10 |
|
|
9.71 |
mEq/d |
0.94 |
2.98 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44250 |
441 |
SS-Nppaem4Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
12 |
|
|
25.37 |
mg/d |
2.78 |
9.62 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44258 |
441 |
SS-Agtr1aem1Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
6 |
|
|
50.27 |
mg/d |
20.21 |
49.51 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44259 |
441 |
SS-Msraem3Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
11.49 |
mEq/d |
0.18 |
0.32 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44254 |
441 |
SS-Plekha7em4Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
12 |
|
|
32.25 |
mg/d |
5.86 |
20.29 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44285 |
441 |
SS-Plekha7em1Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
9 |
|
|
31.02 |
mg/d |
3.97 |
11.9 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44288 |
441 |
SS-Slc30a8em2Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
1 |
|
|
11.57 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44306 |
441 |
SS-Slc30a8em2Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
10 |
|
|
54.88 |
mg/d |
6.22 |
19.68 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44315 |
441 |
SS-Kcnq1em14Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
7 |
|
|
1.19 |
g |
0.04 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44325 |
441 |
SS-Nppaem4Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
13 |
|
|
1.36 |
g |
0.02 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44320 |
441 |
SS/JrHsdMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
40 |
|
|
54.13 |
% |
2.52 |
15.94 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57149 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
42.71 |
% |
6.79 |
17.96 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57157 |
522 |
FHH-Chr 1BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
44.14 |
% |
5.69 |
21.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57160 |
522 |
FHH-Agtr1bm1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
14 |
|
|
148.86 |
U/l |
10.38 |
38.84 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60402 |
527 |
FHH-Ccr2m1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
5 |
|
|
169.2 |
U/l |
16.47 |
36.83 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60408 |
527 |
FHH-F10m1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
11 |
|
|
193.27 |
U/l |
14.4 |
47.77 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60409 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
3 |
|
|
169.67 |
U/l |
19.1 |
33.08 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60410 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
1 |
|
|
110.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60415 |
527 |
FHH-Htr1am1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
21 |
|
|
205.86 |
U/l |
5.28 |
24.19 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60420 |
527 |
FHH/EurMcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
25 |
|
|
143.96 |
U/l |
8.55 |
42.73 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60431 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
2 |
|
|
110.5 |
U/l |
2.5 |
3.54 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60434 |
527 |
FHH-Adipoqm3Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
5 |
|
|
182.4 |
U/l |
38.74 |
86.62 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60441 |
527 |
FHH-Egln3m1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
6 |
|
|
217.67 |
U/l |
11.74 |
28.74 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60438 |
527 |
FHH-Adra1am1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
8 |
|
|
194.0 |
U/l |
4.75 |
13.44 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60443 |
527 |
FHH-Adipoqm3Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
6 |
|
|
163.67 |
U/l |
18.96 |
46.45 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60440 |
527 |
FHH-Adra1am1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
9 |
|
|
145.89 |
U/l |
11.53 |
34.58 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60445 |
527 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
2 |
|
|
103.0 |
U/l |
4.0 |
5.66 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60451 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
70 days-84 days |
5 |
|
|
167.2 |
U/l |
3.67 |
8.2 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60457 |
527 |
FHH-Nr0b2m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
6 |
|
|
18.08 |
pg |
0.1 |
0.24 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60459 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
2 |
|
|
18.0 |
pg |
0.0 |
0.0 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60470 |
527 |
FHH-Nr0b2m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
10 |
|
|
17.51 |
pg |
0.14 |
0.44 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60475 |
527 |
FHH-Adipoqm2Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
7 |
|
|
17.17 |
pg |
0.17 |
0.44 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60479 |
527 |
FHH-Htr1am1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
13 |
|
|
18.19 |
pg |
0.15 |
0.55 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60484 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
1 |
|
|
17.8 |
pg |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60487 |
527 |
FHH-Nr4a1m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
11 |
|
|
17.76 |
pg |
0.12 |
0.41 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60497 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
1 |
|
|
17.6 |
pg |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60499 |
527 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
4 |
|
|
18.05 |
pg |
0.1 |
0.19 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60500 |
527 |
FHH-Adipoqm3Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
5 |
|
|
17.32 |
pg |
0.17 |
0.38 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60513 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
6 |
|
|
17.47 |
pg |
0.15 |
0.36 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60511 |
527 |
FHH-Adra1am1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
9 |
|
|
17.63 |
pg |
0.04 |
0.11 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60517 |
527 |
FHH-Tlr4m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
9 |
|
|
18.04 |
pg |
0.14 |
0.42 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60522 |
527 |
SS-Klf4m3Mcwi |
serum total cholesterol level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
7 |
|
|
86.29 |
mg/dl |
18.04 |
47.74 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60535 |
527 |
FHH-Adipoqm2Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
12 |
|
|
7.49 |
x 10E6 cells/ul |
0.54 |
1.88 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60543 |
527 |
FHH-Ccr2m1Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
8 |
|
|
8.97 |
x 10E6 cells/ul |
0.34 |
0.96 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60570 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
7 |
|
|
8.01 |
x 10E6 cells/ul |
0.19 |
0.5 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60573 |
527 |
FHH-F10m2Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
12 |
|
|
7.6 |
x 10E6 cells/ul |
0.15 |
0.51 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60577 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
2 |
|
|
8.1 |
x 10E6 cells/ul |
0.24 |
0.34 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60588 |
527 |
BN-Lcatm3Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
2 |
|
|
8.45 |
x 10E6 cells/ul |
0.14 |
0.2 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60586 |
527 |
BN-Lcatm3Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
1 |
|
|
8.01 |
x 10E6 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60589 |
527 |
FHH-Adra1am1Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
9 |
|
|
7.84 |
x 10E6 cells/ul |
0.18 |
0.53 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60599 |
527 |
F344-AbatTn(sb-T2/Bart3)2.163Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
3 |
|
|
8.86 |
x 10E6 cells/ul |
0.4 |
0.69 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60601 |
527 |
SS-Wdr72em1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.41 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44340 |
441 |
SS-Plekha7em4Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
12 |
|
|
1.33 |
g |
0.05 |
0.16 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44347 |
441 |
SS-Prokr1em2Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.5 |
g |
0.04 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44349 |
441 |
SS-Plekha7em1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
9 |
|
|
1.41 |
g |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44350 |
441 |
SS-Nppbem4Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.44 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44352 |
441 |
SS-Prokr1em1Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.46 |
g |
0.04 |
0.08 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44353 |
441 |
SS/JrHsdMcwi |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
7 |
|
|
1.61 |
g |
0.05 |
0.13 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44364 |
441 |
SS-Stk39em2Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
10 |
|
|
1.33 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44370 |
441 |
SS-Msraem3Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.6 |
g |
0.07 |
0.12 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44378 |
441 |
SS-Nppbem2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
133.25 |
mmHg |
3.68 |
7.37 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44390 |
441 |
SS-Msraem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.0 |
mmHg |
8.75 |
19.57 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44391 |
441 |
SS-Plekha7em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
155.5 |
mmHg |
10.5 |
14.85 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44407 |
441 |
SS-Plekha7em4Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
11 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
135.64 |
mmHg |
6.09 |
20.19 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44409 |
441 |
SS-Sh2b3em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
147.14 |
mmHg |
7.95 |
21.03 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44423 |
441 |
SS-Tcf7l2em1Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
150.0 |
mmHg |
2.0 |
2.83 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44430 |
441 |
SS-Agtrapem8Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
122.0 |
mmHg |
4.0 |
5.66 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44428 |
441 |
SS-Stk39em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
10 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.2 |
mmHg |
4.07 |
12.87 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44431 |
441 |
SS-Agtr1aem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
131.89 |
mmHg |
4.34 |
13.02 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44434 |
441 |
SS-Plekha7em4Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.53 |
g |
0.04 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44468 |
441 |
SS-Plod1em1Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
11 |
|
|
1.49 |
g |
0.06 |
0.18 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44471 |
441 |
SS-Plcd3em7Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
10 |
|
|
1.41 |
g |
0.05 |
0.17 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44481 |
441 |
SS/JrHsdMcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
7 |
|
|
1.58 |
g |
0.06 |
0.15 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44487 |
441 |
SS-Tcf7l2em1Mcwi-/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.57 |
g |
0.04 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44492 |
441 |
SS-Wdr72em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.56 |
g |
0.08 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44489 |
441 |
SS-Agtrapem8Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.46 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44490 |
441 |
SS-Mstnem1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.67 |
g |
0.06 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44498 |
441 |
SS-Nppaem4Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.37 |
g |
0.02 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44502 |
441 |
SS-Nppbem4Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
9 |
|
|
1.13 |
g |
0.04 |
0.12 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44515 |
441 |
SS-Ulk3em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
11 |
|
|
1.09 |
g |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44526 |
441 |
SS-Cyp1a1em1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.09 |
g |
0.06 |
0.1 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44527 |
441 |
SS-Plcd3em4Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
13 |
|
|
1.1 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44531 |
441 |
SS-Plekha7em4Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
13 |
|
|
1.04 |
g |
0.03 |
0.12 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44532 |
441 |
SS-Prokr1em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
5 |
|
|
1.12 |
g |
0.04 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44538 |
441 |
SS-Plod1em1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
12 |
|
|
1.14 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44533 |
441 |
SS-Aldh2em2Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
6 |
|
|
1.19 |
g |
0.05 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44544 |
441 |
SS-Stk39em2Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
10 |
|
|
0.96 |
g |
0.03 |
0.11 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44555 |
441 |
SS-Slc30a8em2Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
9 |
|
|
1.2 |
g |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44562 |
441 |
SS-Kcnq1em14Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
350.29 |
beats/min |
11.7 |
30.96 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44572 |
441 |
SS-Agtrapem8Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
361.97 |
beats/min |
9.06 |
23.96 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44578 |
441 |
SS-Msraem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
358.83 |
beats/min |
17.96 |
43.99 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44581 |
441 |
SS-Stk39em2Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
373.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44585 |
441 |
SS-Mstnem3Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
341.0 |
beats/min |
13.0 |
18.38 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44586 |
441 |
SS-Ulk3em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
10 |
|
|
362.9 |
beats/min |
6.43 |
20.34 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44588 |
441 |
SS-Plcd3em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
338.73 |
beats/min |
9.57 |
31.74 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44593 |
441 |
SS-Plekha7em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
12 |
|
|
378.33 |
beats/min |
7.67 |
26.58 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44594 |
441 |
SS-Prokr1em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
364.0 |
beats/min |
4.74 |
12.54 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44596 |
441 |
SS-Plcd3em7Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
354.5 |
beats/min |
6.26 |
17.7 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44605 |
441 |
SS-Tcf7l2em1Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
378.5 |
beats/min |
5.5 |
7.78 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44615 |
441 |
SS-Nppbem2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
14 |
|
|
354.71 |
beats/min |
6.54 |
24.45 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44617 |
441 |
SS-Kcnq1em14Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
380.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44626 |
441 |
SS-Tcf7l2em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
9 |
|
|
364.33 |
beats/min |
7.03 |
21.08 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44620 |
441 |
SS-Mstnem3Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
321.5 |
beats/min |
22.5 |
31.82 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44647 |
441 |
SS-Msraem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
379.5 |
beats/min |
16.45 |
40.3 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44642 |
441 |
SS-Tcf7l2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
369.6 |
beats/min |
15.17 |
33.93 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44645 |
441 |
SS-Cyp1a1em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
402.33 |
beats/min |
8.41 |
14.57 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44650 |
441 |
SS-Plekha7em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
385.73 |
beats/min |
6.12 |
20.31 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44655 |
441 |
SS-Aldh2em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
370.0 |
beats/min |
6.38 |
16.87 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44663 |
441 |
SS-Plcd3em7Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
9 |
|
|
363.89 |
beats/min |
9.64 |
28.93 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44666 |
441 |
SS-Agtrapem8Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
365.5 |
beats/min |
0.5 |
0.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44674 |
441 |
SS-Slc30a8em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
363.13 |
beats/min |
7.1 |
20.07 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44679 |
441 |
SS-Msraem3Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
375.33 |
beats/min |
30.07 |
52.08 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44685 |
441 |
SS.LEW-(D10Wox51-D10Rat27)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hypertension. 2005 Dec;46(6):1300-8. Epub 2005 Nov 14. |
arterial blood pressure trait |
male |
56 days-59 days |
5 |
|
|
140.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
67878 |
830 |
SS.LEW-(D5Mco39-D5Mco57)(D5Mco42-D5Mco47)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11. |
arterial blood pressure trait |
male |
62 days-66 days |
0 |
|
|
226.0 |
mmHg |
5.5 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
|
|
70586 |
1482 |
SS.LEW-(D5Mco41-D5Mco47)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11. |
arterial blood pressure trait |
male |
62 days-66 days |
0 |
|
|
204.0 |
mmHg |
5.4 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
|
|
70591 |
1482 |
SS/JrHsd |
systolic blood pressure |
controlled sodium content diet (8 %) (between 83 and 84 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
arterial blood pressure trait |
female |
167 days-168 days |
8 |
|
|
199.5 |
mmHg |
6.93 |
19.6 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67857 |
810 |
SR/JrHsd |
heart weight to body weight ratio |
controlled sodium content diet (8 %) (for 84 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
heart mass |
female |
168 days
| 5 |
|
|
2.37 |
g/kg |
0.04 |
0.09 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67867 |
810 |
SS/JrHsd |
heart weight to body weight ratio |
controlled sodium content diet (8 %) (for 56 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
heart mass |
male |
140 days
| 6 |
|
|
3.31 |
g/kg |
0.13 |
0.32 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67866 |
810 |
SS.LEW-(D8Chm14-D8Rat16)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
7 |
|
|
138.0 |
mmHg |
5.0 |
13.23 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70441 |
1438 |
SS.LEW-(D2Rat199-D2Mco17)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
8 |
|
|
199.0 |
mmHg |
4.0 |
11.31 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70446 |
1438 |
SS.LEW-(D10Rat194-D10Chm243)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
11 |
|
|
144.0 |
mmHg |
2.0 |
6.63 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70450 |
1438 |
SS.MNS-(D2Mit6-D2Rat166)/Ayd |
heart right ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart right ventricle DNA amount |
male |
98 days
| 4 |
|
|
0.5 |
ug/g |
0.09 |
0.18 |
spectrophotometry |
|
0.0 |
|
0 |
|
|
|
|
69041 |
1096 |
SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb |
percentage of study population developing cerebrovascular lesions during a period of time |
controlled sodium content diet (3.7 mg/g) (between 28 and 49 days) and controlled sodium content drinking water (1 %) (between 28 and 49 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 49 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
cerebrovascular system integrity trait |
not specified |
70 days-91 days |
20 |
|
|
61.0 |
% |
|
|
ex vivo light microscopy |
|
0.0 |
|
0 |
|
|
|
|
69121 |
1126 |
SS/JrSeac |
heart left ventricle relative wall thickness |
controlled sodium content diet (8 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
77 days
| 5 |
RWT = 2 × PWT/EDD |
|
86.0 |
% |
16.55 |
37.0 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68588 |
733 |
SS/JrSeac |
heart left ventricle relative wall thickness |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
77 days
| 5 |
RWT = 2 × PWT/EDD |
|
44.0 |
% |
7.16 |
16.0 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68587 |
733 |
SS/JrSeac |
heart left ventricle relative wall thickness |
controlled sodium content diet (8 %) (for 84 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart left ventricle wall thickness |
not specified |
126 days
| 5 |
RWT = 2 × PWT/EDD |
|
29.0 |
% |
5.81 |
13.0 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68590 |
733 |
SS/JrSeac |
heart rate |
controlled sodium content diet (8 %) (for 84 days) then controlled oxygen content Kreb's solution perfusate |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart pumping trait |
not specified |
126 days
| 5 |
|
|
284.0 |
beats/min |
58.58 |
131.0 |
isolated perfused heart method |
|
0.0 |
|
0 |
|
|
|
|
68594 |
733 |
SS/JrSeac |
heart rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart pumping trait |
not specified |
77 days
| 5 |
|
|
264.0 |
beats/min |
37.12 |
83.0 |
isolated perfused heart method |
|
0.0 |
|
0 |
|
|
|
|
68591 |
733 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
147.2 |
mmHg |
3.9 |
14.06 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69532 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
120.4 |
mmHg |
5.3 |
24.29 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69535 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
131.3 |
mmHg |
4.2 |
15.14 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69530 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
|
serial mean |
111.3 |
mmHg |
4.6 |
21.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69541 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
9 |
|
serial mean |
159.0 |
mmHg |
7.1 |
21.3 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
0 |
|
|
|
|
69546 |
151 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
heart left ventricle anterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle anterior wall thickness |
male |
77 days
| 14 |
|
|
0.17 |
mm |
0.0 |
0.01 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68254 |
542 |
SS.LEW-(D3Rat52-D3Chm57)/Ayd |
heart left ventricle anterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle anterior wall thickness |
male |
77 days
| 8 |
|
|
0.17 |
mm |
0.0 |
0.01 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68256 |
542 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 11 |
|
|
2.75 |
mg/g |
0.11 |
0.37 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
68259 |
542 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 14 |
|
|
2.67 |
mg/g |
0.08 |
0.31 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
68262 |
542 |
SS/Jr |
heart left ventricle end-systolic area |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart left ventricle size trait |
not specified |
0 days
| 6 |
|
|
0.25 |
cm2 |
0.07 |
0.17 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
69602 |
749 |
SS/Jr |
heart left ventricle posterior wall thickness |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart left ventricle posterior wall thickness |
not specified |
0 days
| 6 |
|
|
2.9 |
mm |
0.3 |
0.73 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
69604 |
749 |
SS/Jr |
age at time of death |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 66 and 68 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
total life span |
not specified |
0 days
| 8 |
|
median |
108.0 |
d |
|
|
necropsy |
|
0.0 |
|
0 |
|
visual observation |
|
|
69608 |
749 |
SS/JrHsd |
pulse pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013. |
arterial blood pressure trait |
male |
108 days-112 days |
8 |
|
|
57.1 |
mmHg |
0.4 |
1.13 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70504 |
1458 |
SS/JrHsd |
diastolic blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2012;7(7):e42214. doi: 10.1371/journal.pone.0042214. Epub 2012 Jul 30. |
arterial blood pressure trait |
female |
108 days-112 days |
9 |
|
|
139.7 |
mmHg |
5.8 |
17.4 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70354 |
1358 |
SS.SR-(rs65785750-rs13452155)/Opaz |
diastolic blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2012;7(7):e42214. doi: 10.1371/journal.pone.0042214. Epub 2012 Jul 30. |
arterial blood pressure trait |
female |
108 days-112 days |
10 |
|
|
131.9 |
mmHg |
3.6 |
11.38 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70355 |
1358 |
SS.SR-(rs65785750-rs13452155)/Opaz |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2012;7(7):e42214. doi: 10.1371/journal.pone.0042214. Epub 2012 Jul 30. |
arterial blood pressure trait |
female |
108 days-112 days |
10 |
|
|
157.7 |
mmHg |
3.7 |
11.7 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70358 |
1358 |
SHRSP/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
56 days
| 31 |
|
|
35.0 |
mg/d |
0.61 |
3.4 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
69216 |
1126 |
SHRSP/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
70 days
| 26 |
|
|
215.0 |
mg/d |
18.43 |
94.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
69217 |
1126 |
SS/JrHsdMcwi |
urine sodium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92 days-94 days |
14 |
|
|
149.5 |
mmol/l |
5.2 |
19.46 |
unspecified method |
|
0.0 |
|
0 |
|
urine sodium analysis |
|
|
69467 |
151 |
SS/JrHsdMcwi |
hematocrit |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
erythrocyte quantity |
female |
89 days-92 days |
15 |
|
|
38.8 |
% |
1.4 |
5.42 |
hematocrit analysis |
|
0.0 |
|
0 |
|
|
|
|
69482 |
151 |
SS.SR-(rs106870553-rs63922710)/Opaz |
systolic blood pressure |
controlled sodium content diet (8 %) (between 24 and 28 days) |
Herrera VL, et al., PLoS One. 2013 Jul 4;8(7):e67673. doi: 10.1371/journal.pone.0067673. Print 2013. |
arterial blood pressure trait |
female |
108 days-112 days |
10 |
|
|
187.0 |
mmHg |
3.0 |
9.49 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
70566 |
1458 |
LEW |
heart left ventricle end-systolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-systolic diameter |
male |
77 days
| 14 |
|
|
3.69 |
mm |
0.16 |
0.6 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
heart left ventricle anterior wall thickness |
|
68273 |
542 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
heart left ventricle end-systolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-systolic diameter |
male |
77 days
| 14 |
|
|
3.77 |
mm |
0.15 |
0.57 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68278 |
542 |
SS.LEW-(D16Chm36-D16Mit2)/Ayd |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 18 |
(LVDdLVDs)/LVDd x 100 |
|
44.1 |
% |
1.38 |
5.87 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68285 |
542 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
heart left ventricle fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 14 |
(LVDdLVDs)/LVDd x 100 |
|
50.0 |
% |
1.51 |
5.66 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68286 |
542 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
ejection fraction |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
cardiac output trait |
male |
77 days
| 14 |
|
|
85.3 |
% |
1.39 |
5.21 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
peak aortic velocity |
|
68294 |
542 |
SS/NEisSlc |
systolic blood pressure |
controlled sodium content diet (8 %) (for 28 days) then adrenalectomy then controlled sodium content diet (0.3 %) (for 28 days) and dexamethasone (20 ug/d) |
Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24. |
arterial blood pressure trait |
male |
98 days
| 4 |
|
|
141.0 |
mmHg |
8.0 |
16.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69688 |
736 |
SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
70 days
| 31 |
|
|
74.0 |
mg/d |
2.69 |
15.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
70244 |
1126 |
SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
126 days
| 31 |
|
|
58.0 |
mg/d |
1.33 |
7.4 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
70248 |
1126 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
7 |
|
|
150.0 |
mmHg |
3.0 |
7.94 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70436 |
1438 |
SS/JrSeac |
myocardial flow rate |
controlled sodium content diet (8 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then controlled oxygen content Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
coronary blood flow trait |
not specified |
77 days
| 5 |
|
|
2.36 |
ml/min |
0.48 |
1.07 |
isolated perfused heart method |
|
0.0 |
|
0 |
|
|
K1, myocardial flow rate |
|
68596 |
733 |
SS/JrSeac |
myocardial clearance rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
heart muscle physiology trait |
not specified |
77 days
| 5 |
|
|
0.0 |
/min |
0.0 |
0.0 |
isolated perfused heart method |
|
0.0 |
|
0 |
|
|
K2, myocardial clearance rate |
|
68599 |
733 |
SS/JrSeac |
myocardial flow rate |
controlled sodium content diet (0.3 %) (for 35 days) then controlled oxygen content Kreb's solution perfusate (for 0.2 hours) then 99mTc-sestamibi (37 MBq/l) (for 0.3 hours) then controlled oxygen content Kreb's solution perfusate (for 0.4 hours) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
coronary blood flow trait |
not specified |
126 days
| 5 |
|
|
2.84 |
ml/min |
0.25 |
0.57 |
isolated perfused heart method |
|
0.0 |
|
0 |
|
|
K1, myocardial flow rate |
|
68597 |
733 |
SS.MNS-(Mme-D2Rat131)/Ayd |
heart left ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart left ventricle DNA amount |
male |
98 days
| 5 |
|
|
3.7 |
ug/g |
0.3 |
0.67 |
spectrophotometry |
|
0.0 |
|
0 |
|
|
|
|
69038 |
1096 |
BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days
| 20 |
|
serial mean |
140.6 |
mmHg |
4.4 |
19.68 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69509 |
151 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
94 days
| 16 |
|
serial mean |
370.1 |
beats/min |
6.3 |
25.2 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69525 |
151 |
LEW/Crlc |
cerebrospinal fluid chloride level |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
cerebrospinal fluid mineral amount |
male |
43 days-52 days |
0 |
|
|
121.0 |
mmol/l |
1.0 |
|
chloride ion-selective electrode method |
|
0.0 |
|
0 |
|
|
|
|
69694 |
344 |
SS/JrHsd |
diastolic blood pressure |
controlled sodium content diet (8 %) (between 83 and 84 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
arterial blood pressure trait |
female |
167 days-168 days |
8 |
|
|
143.0 |
mmHg |
4.88 |
13.8 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67871 |
810 |
SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
56 days
| 33 |
|
|
148.0 |
mmHg |
3.13 |
18.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69166 |
1126 |
SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
56 days
| 31 |
|
|
146.0 |
mmHg |
1.26 |
7.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69173 |
1126 |
SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
70 days
| 31 |
|
|
176.0 |
mmHg |
1.89 |
10.5 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69174 |
1126 |
SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
84 days
| 31 |
|
|
181.0 |
mmHg |
1.65 |
9.2 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69175 |
1126 |
SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
126 days
| 31 |
|
|
208.0 |
mmHg |
1.44 |
8.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69178 |
1126 |
SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
84 days
| 31 |
|
|
191.0 |
mmHg |
0.72 |
4.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69182 |
1126 |
SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
98 days
| 3 |
|
|
195.0 |
mmHg |
2.89 |
5.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69190 |
1126 |
SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb |
systolic blood pressure |
controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
arterial blood pressure trait |
not specified |
112 days
| 5 |
|
|
198.0 |
mmHg |
1.34 |
3.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
69200 |
1126 |
SS/JrHsdMcwi |
thymus wet weight |
controlled sodium content diet (4 %) (for 21 days) |
Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30. |
thymus mass |
not specified |
84 days
| 4 |
|
|
500.0 |
mg |
100.0 |
200.0 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
69289 |
1057 |
SS |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
12 |
|
|
183.0 |
mmHg |
4.0 |
13.86 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70469 |
1438 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-91 days |
15 |
|
serial mean |
184.0 |
mmHg |
7.7 |
29.82 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69444 |
151 |
BN/NHsdMcwi |
urine creatinine level |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
89 days-92 days |
24 |
|
|
30.2 |
mg/dl |
3.87 |
18.96 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
69455 |
151 |
BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
89 days-92 days |
24 |
|
|
6.35 |
mEq/d |
0.35 |
1.74 |
unspecified method |
|
0.0 |
|
0 |
|
urine sodium analysis |
umol/min |
|
69459 |
151 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
89 days-92 days |
17 |
|
|
5.06 |
mEq/d |
0.6 |
2.49 |
unspecified method |
|
0.0 |
|
0 |
|
urine sodium analysis |
umol/min |
|
69460 |
151 |
SS/JrTol |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11. |
arterial blood pressure trait |
male |
62 days-66 days |
0 |
|
|
196.0 |
mmHg |
6.8 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
|
|
70583 |
1482 |
SS.LEW-(D18Chm90-D18Chm4)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 12 days) |
Chauvet C, et al., J Hypertens. 2011 Jul;29(7):1320-6. doi: 10.1097/HJH.0b013e32834705e4. |
arterial blood pressure trait |
male |
68 days
| 5 |
|
serial mean |
170.0 |
mmHg |
8.0 |
17.89 |
radiotelemetry |
abdominal aorta |
1036800.0 |
|
0 |
|
telemetry probe |
averaged over 12 days |
has records that will be duplicated if entered need to add multiple refs once the functionality is in |
96572 |
1663 |
SS-Chr 12BN/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (40 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
7 |
|
|
17.2 |
% |
0.6 |
1.59 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96874 |
1719 |
SS-Chr 12BN/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (100 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
7 |
|
|
9.4 |
% |
0.5 |
1.32 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96877 |
1719 |
SS-Chr 12BN/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (80 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
7 |
|
|
10.8 |
% |
0.6 |
1.59 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96876 |
1719 |
SS.LEW-(D10Chm10-D10Rat11)(D16Chm48-D16Chm60)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
8 |
|
|
137.0 |
mmHg |
3.0 |
8.49 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84488 |
1438 |
SS.LEW-(D16Chm48-D16Chm60)(D18Rat101-D18Rat92)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
141.0 |
mmHg |
4.0 |
8.94 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84498 |
1438 |
SS.MNS-(D2Chm33-Tm2sf1),LEW-(D3Rat2-D3Chm79)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
9 |
|
|
117.0 |
mmHg |
2.0 |
6.0 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84511 |
1438 |
SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
56 days
| 35 |
|
|
24.0 |
mg/d |
1.86 |
11.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
84582 |
1126 |
SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
98 days
| 14 |
|
|
343.0 |
mg/d |
16.04 |
60.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
84585 |
1126 |
ACI.FHH-(D1Mit18-D1Rat90)(D3Rat6-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi |
urine albumin excretion rate |
right nephrectomy (for 28 days) then controlled sodium content diet (0.4 %) (for 28 days) |
O'Meara CC, et al., J Am Soc Nephrol. 2011 Mar;22(3):518-25. Epub 2010 Dec 2. |
urine albumin amount |
male |
63 days-70 days |
13 |
|
|
15.4 |
mg/d |
2.4 |
8.65 |
fluorometry |
|
0.0 |
right nephrectomy |
28 |
days |
|
|
|
84747 |
1600 |
ACI.FHH-(D1Mit18-D1Rat90)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Eur |
urine albumin excretion rate |
right nephrectomy (for 28 days) then controlled sodium content diet (0.4 %) (for 28 days) |
O'Meara CC, et al., J Am Soc Nephrol. 2011 Mar;22(3):518-25. Epub 2010 Dec 2. |
urine albumin amount |
male |
63 days-70 days |
9 |
|
|
11.18 |
mg/d |
3.18 |
9.54 |
fluorometry |
|
0.0 |
right nephrectomy |
28 |
days |
|
|
|
84748 |
1600 |
ACI.FHH-(D1Mit18-D1Rat90)(D3Rat6-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi |
ratio of the area occupied by protein casts to the total area of the kidney outer medulla outer stripe and cortex |
right nephrectomy (for 42 days) then controlled sodium content diet (0.4 %) (for 42 days) |
O'Meara CC, et al., J Am Soc Nephrol. 2011 Mar;22(3):518-25. Epub 2010 Dec 2. |
kidney integrity trait |
male |
84 days
| 3 |
|
|
1.18 |
% |
0.26 |
0.45 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
42 |
days |
|
area of cast to kidney area ratio |
|
84750 |
1600 |
SS.MNS-(D2Chm153-D2Chm410)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 12 days) |
Chauvet C, et al., Hypertens Res. 2009 Jul;32(7):631-7. doi: 10.1038/hr.2009.70. Epub 2009 May 22. |
arterial blood pressure trait |
male |
68 days
| 6 |
|
serial mean |
141.0 |
mmHg |
6.0 |
14.7 |
radiotelemetry |
|
1036800.0 |
|
0 |
|
telemetry probe |
averaged over 12 days |
has records that will be duplicated if entered need to add multiple refs once the functionality is in |
96576 |
1664 |
SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (1 %) (between 42 and 49 days) |
Prisco SZ, et al., Hypertension. 2014 Jul 7. pii: HYPERTENSIONAHA.114.03550. |
arterial blood pressure trait |
male |
71 days-77 days |
14 |
|
|
110.0 |
mmHg |
2.0 |
7.48 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
96801 |
1698 |
SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (160 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
5 |
|
|
6.3 |
% |
0.3 |
0.67 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96888 |
1719 |
SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (140 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
5 |
|
|
6.5 |
% |
0.3 |
0.67 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96887 |
1719 |
SS.BN-(D12Hmgc3-AU047911)/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (60 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
12 |
|
|
12.2 |
% |
0.5 |
1.73 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96891 |
1719 |
SS.BN-(D12Hmgc3-AU047911)/Mcwi |
artery wall thickness to artery inner diameter ratio |
controlled sodium content diet (0.3 %) then controlled ex vivo artery perfusion pressure (140 mmHg) |
Prisco SZ, et al., Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22. |
mesenteric artery morphology trait |
male |
63 days-70 days |
12 |
|
|
7.5 |
% |
0.3 |
1.04 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
mesenteric artery morphology trait |
96895 |
1719 |
SHR-Ndufc2em2Mcwi+/+ |
body weight |
controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
70 days
| 12 |
|
|
239.0 |
g |
3.75 |
13.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97900 |
1938 |
SHR-Ndufc2em2Mcwi+/+ |
body weight |
controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
98 days
| 12 |
|
|
299.0 |
g |
4.62 |
16.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97901 |
1938 |
SHR-Ndufc2em2Mcwi-/+ |
body weight |
controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
70 days
| 26 |
|
|
237.0 |
g |
5.3 |
27.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97903 |
1938 |
SHR/Bbb |
body weight |
controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
126 days
| 18 |
|
|
289.0 |
g |
1.89 |
8.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97908 |
1938 |
SHRSP/Bbb |
body weight |
controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
70 days
| 18 |
|
|
177.0 |
g |
1.41 |
6.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97909 |
1938 |
SHR-Ndufc2em1Mcwi+/+ |
body weight |
controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
body mass |
not specified |
98 days
| 10 |
|
|
287.0 |
g |
3.79 |
12.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
97878 |
1938 |
SS.LEW-(D1Mco55-D1Wox6)/Bj |
mean arterial blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 28 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
73 days-75 days |
10 |
|
|
128.0 |
mmHg |
6.0 |
18.97 |
radiotelemetry |
|
345600.0 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 24 hour |
|
96960 |
1778 |
SS/JrTol |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
body mass |
male |
73 days-75 days |
10 |
|
|
338.0 |
g |
4.0 |
12.65 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
96966 |
1778 |
SS/JrTol |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
64 days-66 days |
30 |
|
continuous mean |
198.0 |
mmHg |
8.0 |
43.82 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
average of 2-3 readings/day over 4 days |
|
96980 |
1778 |
SS/JrTol |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) and housing in pairs (between 26 and 66 days) then controlled sodium content diet (2 %) (for 24 days) |
Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. |
arterial blood pressure trait |
male |
64 days-66 days |
30 |
|
continuous mean |
208.0 |
mmHg |
6.0 |
32.86 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
average of 2-3 readings/day over 4 days |
|
96982 |
1778 |
SHRSP/Bbb |
systolic blood pressure |
controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
arterial blood pressure trait |
not specified |
70 days
| 18 |
undefined |
|
181.0 |
mmHg |
3.3 |
14.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
97914 |
1938 |
SHR-Ndufc2em2Mcwi+/+ |
systolic blood pressure |
controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
arterial blood pressure trait |
not specified |
70 days
| 12 |
undefined |
|
181.0 |
mmHg |
0.87 |
3.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
97922 |
1938 |
SHR-Ndufc2em2Mcwi+/+ |
systolic blood pressure |
controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
arterial blood pressure trait |
not specified |
98 days
| 12 |
undefined |
|
181.0 |
mmHg |
2.6 |
9.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
97923 |
1938 |
SHR-Ndufc2em1Mcwi-/+ |
urine total protein excretion rate |
controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
total urine protein amount |
not specified |
126 days
| 17 |
|
|
71.0 |
mg/d |
4.61 |
19.0 |
urine analysis |
|
0.0 |
|
0 |
|
|
|
|
97938 |
1938 |
SS/JrHsd |
plasma estradiol level |
controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) and 17 beta-estradiol (5 mg) (between 56 and 63 days) |
Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. |
blood estradiol amount |
female |
112 days
| 6 |
|
|
21.2 |
pg/ml |
3.2 |
7.84 |
radioimmunoassay |
|
0.0 |
ovx |
63 |
days |
|
|
|
102360 |
2686 |
SS/NEisSlc |
mean arterial blood pressure |
controlled sodium content diet (8 %) (for 28 days) |
Fujita M, et al., Hypertension. 2007 Aug;50(2):360-7. Epub 2007 Jun 18. |
arterial blood pressure trait |
male |
63 days-70 days |
8 |
|
|
146.0 |
mmHg |
6.0 |
16.97 |
vascular fluid filled catheter |
|
0.0 |
|
0 |
|
|
|
|
102365 |
2687 |
SR/JrHsd |
plasma estradiol level |
controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) and 17 beta-estradiol (5 mg) (between 56 and 63 days) |
Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. |
blood estradiol amount |
female |
112 days
| 6 |
|
|
42.9 |
pg/ml |
12.6 |
30.86 |
radioimmunoassay |
|
0.0 |
ovx |
63 |
days |
|
|
|
102363 |
2686 |
SR/NEisSlc |
mean arterial blood pressure |
controlled sodium content diet (0.3 %) (for 28 days) |
Fujita M, et al., Hypertension. 2007 Aug;50(2):360-7. Epub 2007 Jun 18. |
arterial blood pressure trait |
male |
63 days-70 days |
7 |
|
|
103.0 |
mmHg |
3.0 |
7.94 |
vascular fluid filled catheter |
|
0.0 |
|
0 |
|
|
|
|
102366 |
2687 |
SS/NEisSlc |
ratio of change in renal sympathetic nerve activity |
controlled sodium content diet (8 %) (for 28 days) then tempol (4 mol/l) (between 0 and 0 hours) |
Fujita M, et al., Hypertension. 2007 Aug;50(2):360-7. Epub 2007 Jun 18. |
kidney sympathetic nerve activity |
male |
63 days-70 days |
8 |
|
|
-18.7 |
% |
2.0 |
5.66 |
implanted wire electrode recording method |
|
0.0 |
|
0 |
|
|
|
|
102373 |
2687 |
SR/NEisSlc |
heart rate |
controlled sodium content diet (8 %) (for 28 days) |
Fujita M, et al., Hypertension. 2007 Aug;50(2):360-7. Epub 2007 Jun 18. |
heart pumping trait |
male |
63 days-70 days |
6 |
|
|
342.0 |
beats/min |
11.0 |
26.94 |
vascular fluid filled catheter |
|
0.0 |
|
0 |
|
|
|
|
102371 |
2687 |
SS/NEisSlc |
serum urea nitrogen level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
blood urea nitrogen amount |
male |
126 days
| 8 |
|
|
33.6 |
mg/dl |
4.1 |
11.6 |
serum urea nitrogen analysis |
|
0.0 |
|
0 |
|
|
|
|
102329 |
2684 |
SS/NEisSlc |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
kidney mass |
male |
126 days
| 8 |
|
|
4.55 |
g/kg |
0.06 |
0.17 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
102324 |
2684 |
SS/NEisSlc |
creatinine clearance |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
glomerular filtration trait |
male |
126 days
| 8 |
|
|
1.9 |
ml/min |
0.5 |
1.41 |
serum creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
102332 |
2684 |
SR/Jr |
respiration rate |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) then atropine (1 mg/kg) then ambient air (between 0 and 0.4 hours) |
Sobajima M, et al., Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2214-20. doi: 10.1152/ajpheart.00615.2010. Epub 2011 Mar 18. |
respiratory function trait |
not specified |
86 days
| 5 |
sampling once per minute |
|
100.0 |
breaths/min |
8.94 |
20.0 |
spirometry |
|
0.0 |
|
0 |
|
|
|
|
103209 |
2787 |
SS/Jr |
respiration rate |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) then atropine (1 mg/kg) then 10% CO2, 20% O2, 70% N2 (10 %) (for 0.4 hours) then ambient air (for 0.1 hours) |
Sobajima M, et al., Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2214-20. doi: 10.1152/ajpheart.00615.2010. Epub 2011 Mar 18. |
respiratory function trait |
not specified |
86 days
| 4 |
sampling once per minute |
|
96.0 |
breaths/min |
4.0 |
8.0 |
spirometry |
|
0.0 |
|
0 |
|
|
|
|
103212 |
2787 |
SR |
heart rate |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart pumping trait |
male |
126 days
| 6 |
|
|
375.0 |
beats/min |
11.02 |
27.0 |
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
103283 |
2803 |
SS-Agtrapem4Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
total urine protein amount |
male |
60 days-69 days |
0 |
|
|
54.0 |
mg/d |
9.0 |
|
urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
98435 |
2059 |
SS-Agtrapem4Mcwi-/- |
heart wet weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
heart mass |
male |
60 days-69 days |
0 |
|
|
1.08 |
g |
0.03 |
|
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98463 |
2059 |
SS-Plod1em1Mcwi-/- |
body weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
body mass |
male |
60 days-69 days |
0 |
|
|
298.0 |
g |
6.0 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
98465 |
2059 |
SS-Agtrapem4Mcwi-/- |
body weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
body mass |
male |
60 days-69 days |
0 |
|
|
327.0 |
g |
4.0 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
98470 |
2059 |
SS/Hsd |
body weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
body mass |
male |
60 days-69 days |
0 |
|
|
321.0 |
g |
5.0 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
98471 |
2059 |
SS.BN-(D13Hmgc354-D13Rat32)/Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
15 |
|
serial mean |
116.0 |
mmHg |
5.0 |
19.36 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-J |
|
98592 |
2098 |
SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
46 days-53 days |
3 |
|
serial mean |
104.0 |
mmHg |
1.73 |
3.0 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-I |
|
98606 |
2098 |
SS.BN-(D13Got45-D13Hmgc664)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
46 days-53 days |
3 |
|
serial mean |
103.0 |
mmHg |
2.89 |
5.0 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-M |
|
98608 |
2098 |
SS/JrHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
heart pumping trait |
male |
60 days-67 days |
12 |
|
serial mean |
388.0 |
beats/min |
6.0 |
20.78 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
intra-carotid radiotelemetry |
|
98609 |
2098 |
SS.BN-(D13Got42-D13Hmgc664)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
heart pumping trait |
male |
60 days-67 days |
5 |
|
serial mean |
385.0 |
beats/min |
6.0 |
13.42 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
intra-carotid radiotelemetry |
|
98617 |
2098 |
SS/NEisSlc |
serum total protein level |
controlled sodium content diet (0.3 %) (for 91 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood total protein amount |
male |
91 days
| 6 |
|
|
5.33 |
g/dl |
2.35 |
5.76 |
serum total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
100668 |
2519 |
SS-Agtrapem4Mcwi-/- |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
|
serial mean |
139.0 |
mmHg |
2.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98416 |
2059 |
SS-Agtrapem4Mcwi-/- |
heart rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
heart pumping trait |
male |
58 days-67 days |
0 |
|
serial mean |
350.0 |
beats/min |
6.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98423 |
2059 |
SR |
heart weight |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart mass |
male |
84 days
| 6 |
|
|
1.0 |
g |
0.04 |
0.11 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
103293 |
2803 |
SS |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart mass |
male |
126 days
| 6 |
|
|
4.25 |
g/kg |
0.16 |
0.39 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
103306 |
2803 |
SS |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 6 |
|
|
8.7 |
mm |
0.12 |
0.3 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
103310 |
2803 |
SS |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-diastolic diameter |
male |
84 days
| 7 |
|
|
32.0 |
% |
1.89 |
5.0 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
103316 |
2803 |
SS |
plasma insulin level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood insulin amount |
male |
84 days
| 13 |
|
|
5.0 |
mU/l |
0.55 |
2.0 |
plasma insulin analysis |
|
0.0 |
|
0 |
|
|
|
|
103328 |
2803 |
SR |
plasma free fatty acids level |
controlled sodium content diet (0.3 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood free fatty acid amount |
male |
42 days
| 13 |
|
|
1.3 |
mmol/l |
0.08 |
0.3 |
thin layer chromatography |
|
0.0 |
|
0 |
|
|
|
|
103333 |
2803 |
SS |
plasma free fatty acids level |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
blood free fatty acid amount |
male |
84 days
| 13 |
|
|
0.9 |
mmol/l |
0.14 |
0.5 |
thin layer chromatography |
|
0.0 |
|
0 |
|
|
|
|
103334 |
2803 |
SR |
body weight |
controlled sodium content diet (6 %) (between 35 and 49 days) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
body mass |
male |
77 days-91 days |
7 |
|
|
360.0 |
g |
9.83 |
26.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
103345 |
2804 |
SS |
body weight |
controlled sodium content diet (6 %) (between 21 and 28 days) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
body mass |
male |
63 days-70 days |
7 |
|
|
312.0 |
g |
11.72 |
31.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
103347 |
2804 |
SS |
systolic blood pressure |
controlled sodium content diet (6 %) (between 21 and 28 days) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
arterial blood pressure trait |
male |
63 days-70 days |
7 |
|
|
208.0 |
mmHg |
15.5 |
41.0 |
oscillometric sphygmomanometer |
|
0.0 |
|
0 |
|
|
|
|
103353 |
2804 |
SS |
systolic blood pressure |
controlled sodium content diet (6 %) (between 35 and 49 days) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
arterial blood pressure trait |
male |
77 days-91 days |
7 |
|
|
226.0 |
mmHg |
10.21 |
27.0 |
oscillometric sphygmomanometer |
|
0.0 |
|
0 |
|
|
|
|
103354 |
2804 |
SS |
systolic blood pressure |
controlled sodium content diet (6 %) (between 56 and 70 days) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
arterial blood pressure trait |
male |
98 days-132 days |
7 |
|
|
234.0 |
mmHg |
15.87 |
42.0 |
oscillometric sphygmomanometer |
|
0.0 |
|
0 |
|
|
|
|
103355 |
2804 |
SS |
heart ventricle septal wall thickness |
controlled sodium content diet (6 %) (between 35 and 49 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle wall thickness |
male |
77 days-91 days |
7 |
|
|
0.16 |
cm |
0.01 |
0.03 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
103366 |
2804 |
SS |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (6 %) (between 35 and 49 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle end-diastolic diameter |
male |
77 days-91 days |
7 |
|
|
5.7 |
mm |
0.42 |
1.1 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
103372 |
2804 |
SS |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (6 %) (between 21 and 28 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart left ventricle end-diastolic diameter |
male |
63 days-70 days |
7 |
|
|
6.1 |
mm |
0.42 |
1.1 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
103371 |
2804 |
SR |
monophasic action potential |
controlled sodium content diet (6 %) (between 21 and 28 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart electrical impulse conduction trait |
male |
63 days-70 days |
7 |
|
|
66.0 |
ms |
1.51 |
4.0 |
electrocardiography |
|
0.0 |
|
0 |
|
|
ecg map |
|
103380 |
2804 |
SS |
monophasic action potential |
controlled sodium content diet (6 %) (between 35 and 49 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart electrical impulse conduction trait |
male |
77 days-91 days |
7 |
|
|
98.0 |
ms |
5.29 |
14.0 |
electrocardiography |
|
0.0 |
|
0 |
|
|
ecg map |
|
103384 |
2804 |
SS |
conduction velocity |
controlled sodium content diet (6 %) (between 35 and 49 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart electrical impulse conduction trait |
male |
77 days-91 days |
7 |
|
|
56.0 |
cm/min |
2.65 |
7.0 |
electrocardiography |
|
0.0 |
|
0 |
|
|
conduction velocity |
|
103390 |
2804 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
|
300.3 |
umol/g |
4.7 |
11.51 |
osmometry |
|
0.0 |
|
0 |
|
|
p osmolality mosm/kg |
|
102245 |
2682 |
SS/Hsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
|
139.6 |
mmol/l |
1.9 |
4.65 |
flame atomic emission spectrometry |
|
0.0 |
|
0 |
|
|
|
|
102243 |
2682 |
SR/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
|
298.6 |
umol/g |
3.8 |
9.31 |
osmometry |
|
0.0 |
|
0 |
|
|
p osmolality mosm/kg |
|
102257 |
2682 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
|
301.8 |
umol/g |
3.6 |
8.82 |
osmometry |
|
0.0 |
|
0 |
|
|
p osmolality mosm/kg |
|
102262 |
2682 |
SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
15 |
|
serial mean |
153.0 |
mmHg |
4.0 |
15.49 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-N |
|
98501 |
2079 |
SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
heart pumping trait |
male |
44 days-53 days |
15 |
|
serial mean |
401.0 |
beats/min |
4.0 |
15.49 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-N |
|
98515 |
2079 |
SS.BN-(D13Hmgc1041-D13Hmgc885)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
15 |
|
serial mean |
181.0 |
mmHg |
5.0 |
19.36 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-S |
|
98506 |
2079 |
SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
heart pumping trait |
male |
58 days-67 days |
13 |
|
serial mean |
385.0 |
beats/min |
4.0 |
14.42 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-Q |
|
98525 |
2079 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 50 and 52 days) then controlled sodium content diet (4 %) (for 21 days) |
Cowley AW Jr, et al., Hypertension. 2016 Feb;67(2):440-50. doi: 10.1161/HYPERTENSIONAHA.115.06280. Epub 2015 Dec 7. |
arterial blood pressure trait |
male |
71 days-73 days |
8 |
|
serial mean |
151.0 |
mmHg |
3.0 |
8.49 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
86400.0 |
|
0 |
|
|
|
|
98643 |
2118 |
SS.SHR-(D9Mco113-D9Mco124)/Bj |
tibia midshaft endosteal cross-sectional area |
controlled sodium content diet (2 %) (between 38 and 42 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
tibia morphology trait |
male |
66 days-70 days |
0 |
|
|
2.08 |
mm2 |
0.21 |
|
micro-computed tomography |
|
0.0 |
|
0 |
|
|
|
|
98014 |
1958 |
SS.BN-(D13Got42-D13Rat130)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
urine albumin amount |
male |
60 days-67 days |
14 |
|
|
239.0 |
mg/d |
29.0 |
108.51 |
urine microalbumin analysis |
|
0.0 |
|
0 |
|
|
strain 26-C |
|
98628 |
2098 |
SS.BN-(D13Got42-D13Hmgc885)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
urine albumin amount |
male |
60 days-67 days |
15 |
|
|
172.0 |
mg/d |
25.0 |
96.82 |
urine microalbumin analysis |
|
0.0 |
|
0 |
|
|
strain 26-F |
|
98631 |
2098 |
SS.SHR-(D9Mco115-D9Mco124)/Bj |
heart rate |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
heart pumping trait |
male |
68 days-70 days |
6 |
|
serial mean |
400.0 |
beats/min |
4.24 |
10.39 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97977 |
1958 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
6 |
|
serial mean |
203.0 |
mmHg |
4.17 |
10.21 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97984 |
1958 |
SS.BN-(D13Rat111-D13Rat20)/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89 days
| 12 |
|
|
265.0 |
mg/d |
34.0 |
117.78 |
Bradford protein assay |
|
1.0 |
|
0 |
|
|
strain 5-10 |
|
98698 |
2138 |
LH/MavRrrcAek |
serum low density lipoprotein cholesterol level |
controlled sodium content diet (0.3 %) (for 105 days) then controlled sodium content diet (4 %) (for 21 days) |
Ma MCJ, et al., PLoS One. 2017 Aug 8;12(8):e0182650. doi: 10.1371/journal.pone.0182650. eCollection 2017. |
blood LDL cholesterol amount |
male |
126 days
| 7 |
|
|
33.5 |
mg/dl |
4.4 |
11.64 |
serum low-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
0 |
|
|
|
|
102784 |
2722 |
SS/Jr |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
6 |
|
serial mean |
149.0 |
mmHg |
3.55 |
8.7 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97988 |
1958 |
SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Flister MJ, et al., Hypertension. 2013 Apr;61(4):850-6. doi: 10.1161/HYPERTENSIONAHA.111.01008. Epub 2013 Mar 4. |
arterial blood pressure trait |
male |
91 days
| 13 |
|
serial mean |
147.0 |
mmHg |
11.0 |
39.66 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
0 |
|
|
strain 9A |
|
98721 |
2142 |
SS.BN-(2340-RN34_13048990782)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Flister MJ, et al., Hypertension. 2013 Apr;61(4):850-6. doi: 10.1161/HYPERTENSIONAHA.111.01008. Epub 2013 Mar 4. |
arterial blood pressure trait |
male |
91 days
| 10 |
|
serial mean |
190.0 |
mmHg |
4.0 |
12.65 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
0 |
|
|
strain 9D |
|
98724 |
2142 |
SS.BN-(2340-RN34_13048990782)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Flister MJ, et al., Hypertension. 2013 Apr;61(4):850-6. doi: 10.1161/HYPERTENSIONAHA.111.01008. Epub 2013 Mar 4. |
urine albumin amount |
male |
91 days
| 10 |
|
|
320.0 |
mg/d |
29.0 |
91.71 |
urine microalbumin analysis |
|
10800.0 |
|
0 |
|
|
strain 9D |
|
98730 |
2142 |
SS.SHR-(D9Mco113-D9Mco124)/Bj |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
6 |
|
serial mean |
126.0 |
mmHg |
2.7 |
6.61 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97959 |
1958 |
SS/JrHsd |
body weight |
controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) |
Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. |
body mass |
female |
112 days
| 6 |
|
|
350.5 |
g |
11.3 |
27.68 |
body weighing method |
|
0.0 |
ovx |
63 |
days |
|
|
|
102341 |
2686 |
SR/JrHsd |
uterus weight |
controlled sodium content diet (0.1 %) (for 112 days) then sham surgical control condition (between 56 and 63 days) |
Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. |
uterus mass |
female |
112 days
| 6 |
|
|
0.41 |
g |
0.02 |
0.05 |
post excision weight measurement |
|
0.0 |
sham ovx |
63 |
days |
|
|
|
102355 |
2686 |
SS-Renem1Mcwi+/- |
body weight |
controlled sodium content diet (0.4 %) (for 49 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
body mass |
female |
70 days
| 8 |
|
|
203.13 |
g |
3.02 |
8.54 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
98293 |
2038 |
SS-Renem1Mcwi+/- |
single kidney wet weight to body weight ratio |
controlled sodium content diet (0.4 %) (for 49 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
kidney mass |
male |
70 days
| 9 |
|
|
4.6 |
g/kg |
0.2 |
0.6 |
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98302 |
2038 |
SS-Clcn6em2Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
|
serial mean |
123.0 |
mmHg |
1.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98400 |
2059 |
SS/Hsd |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
|
serial mean |
136.0 |
mmHg |
2.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98403 |
2059 |
SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
44 days-53 days |
10 |
|
serial mean |
86.0 |
mmHg |
2.0 |
6.32 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-R |
|
98491 |
2079 |
SS.BN-(D13Hmgc1041-D13Hmgc885)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
15 |
|
serial mean |
168.0 |
mmHg |
4.0 |
15.49 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-S |
|
98499 |
2079 |
SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
13 |
|
serial mean |
141.0 |
mmHg |
4.0 |
14.42 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-Q |
|
98511 |
2079 |
SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
heart pumping trait |
male |
44 days-53 days |
11 |
|
serial mean |
397.0 |
beats/min |
4.0 |
13.27 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-P |
|
98517 |
2079 |
SS/Jr |
bone section mineralized tissue surface area |
controlled sodium content diet (2 %) (between 38 and 42 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
tibia morphology trait |
male |
66 days-70 days |
0 |
|
|
5.3 |
mm2 |
0.17 |
|
micro-computed tomography |
|
0.0 |
|
0 |
|
|
|
|
98121 |
1958 |
SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
15 |
|
serial mean |
117.0 |
mmHg |
4.0 |
15.49 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-N |
|
98508 |
2079 |
SS.BN-(D13Got45-D13Hmgc664)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
14 |
|
serial mean |
137.0 |
mmHg |
3.0 |
11.22 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-M |
|
98565 |
2098 |
SS.BN-(D13Got42-D13Hmgc354)/Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
16 |
|
serial mean |
138.0 |
mmHg |
5.0 |
20.0 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-D |
|
98585 |
2098 |
SS.BN-(D13Rat111-D13Hmgc86)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
arterial blood pressure trait |
male |
89 days
| 14 |
|
serial mean |
175.0 |
mmHg |
6.0 |
22.45 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
0 |
|
|
strain 5-9 |
|
98683 |
2138 |
SS-Chr 13BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89 days
| 9 |
|
|
162.0 |
mg/d |
24.0 |
72.0 |
Bradford protein assay |
|
1.0 |
|
0 |
|
|
|
|
98686 |
2138 |
SS.BN-(D13Rat111-D13Hmgc85)/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89 days
| 21 |
|
|
159.0 |
mg/d |
27.0 |
123.73 |
Bradford protein assay |
|
1.0 |
|
0 |
|
|
strain 5-11 |
|
98692 |
2138 |
SS.BN-(D13Rat25-rs106935835)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Hoffman MJ, et al., Hypertension. 2013 Sep;62(3):557-63. doi: 10.1161/HYPERTENSIONAHA.113.01708. Epub 2013 Jul 1. |
arterial blood pressure trait |
male |
91 days
| 11 |
|
serial mean |
187.0 |
mmHg |
6.0 |
19.9 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
0 |
|
|
strain 9E |
|
98705 |
2141 |
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Hoffman MJ, et al., Hypertension. 2013 Sep;62(3):557-63. doi: 10.1161/HYPERTENSIONAHA.113.01708. Epub 2013 Jul 1. |
urine albumin amount |
female |
91 days
| 11 |
|
|
45.0 |
mg/d |
12.0 |
39.8 |
urine microalbumin analysis |
|
1.0 |
|
0 |
|
|
|
|
98712 |
2141 |
SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Hoffman MJ, et al., Hypertension. 2013 Sep;62(3):557-63. doi: 10.1161/HYPERTENSIONAHA.113.01708. Epub 2013 Jul 1. |
urine albumin amount |
female |
91 days
| 28 |
|
|
70.0 |
mg/d |
8.0 |
42.33 |
urine microalbumin analysis |
|
1.0 |
|
0 |
|
|
strain 9C |
|
98714 |
2141 |
SS.BN-(D13Rat25-rs198199323)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Hoffman MJ, et al., Hypertension. 2013 Sep;62(3):557-63. doi: 10.1161/HYPERTENSIONAHA.113.01708. Epub 2013 Jul 1. |
urine albumin amount |
female |
91 days
| 9 |
|
|
60.0 |
mg/d |
11.0 |
33.0 |
urine microalbumin analysis |
|
1.0 |
|
0 |
|
|
strain 9F |
|
98718 |
2141 |
SS/NEisSlc |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
|
|
44.3 |
% |
1.0 |
2.83 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
102318 |
2684 |
SS/JrHsdMcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 20 and 29 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
41 days-50 days |
14 |
|
|
2.8 |
mg/d |
0.5 |
1.87 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
|
|
98528 |
2079 |
SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 20 and 29 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
41 days-50 days |
11 |
|
|
1.2 |
mg/d |
0.3 |
0.99 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-N |
|
98530 |
2079 |
SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 20 and 29 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
41 days-50 days |
13 |
|
|
2.9 |
mg/d |
0.5 |
1.8 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-Q |
|
98532 |
2079 |
SS.BN-(D13Hmgc1041-D13Hmgc885)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
59 days-68 days |
15 |
|
|
300.0 |
mg/d |
35.0 |
135.55 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-S |
|
98541 |
2079 |
SS-Renem1Mcwi+/- |
serum chloride level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood chloride amount |
female |
63 days
| 9 |
|
|
99.0 |
mmol/l |
0.54 |
1.62 |
automated serum electrolyte analysis |
|
0.0 |
|
0 |
|
|
|
|
98365 |
2038 |
SS-Renem1Mcwi+/- |
serum alanine aminotransferase activity level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood alanine transaminase amount |
female |
63 days
| 9 |
|
|
31.0 |
U/l |
2.36 |
7.08 |
automated serum analysis |
|
0.0 |
|
0 |
|
|
|
|
98359 |
2038 |
SS-Renem1Mcwi-/- |
serum bicarbonate level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood bicarbonate amount |
male |
63 days
| 8 |
|
|
20.88 |
mmol/l |
0.72 |
2.04 |
automated serum bicarbonate test |
|
0.0 |
|
0 |
|
|
|
|
98369 |
2038 |
SS-Renem1Mcwi-/- |
serum bicarbonate level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood bicarbonate amount |
female |
63 days
| 4 |
|
|
16.75 |
mmol/l |
1.2 |
2.4 |
automated serum bicarbonate test |
|
0.0 |
|
0 |
|
|
|
|
98372 |
2038 |
SS-Renem1Mcwi-/- |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 66 and 69 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
arterial blood pressure trait |
male |
66 days-69 days |
8 |
|
serial mean |
46.44 |
mmHg |
2.34 |
6.62 |
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98381 |
2038 |
SS.BN-(D13Got42-D13Hmgc885)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
15 |
|
serial mean |
171.0 |
mmHg |
5.0 |
19.36 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-F |
|
98573 |
2098 |
SS.BN-(D13Got42-D13Hmgc885)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
15 |
|
serial mean |
151.0 |
mmHg |
5.0 |
19.36 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-F |
|
98558 |
2098 |
SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
14 |
|
serial mean |
170.0 |
mmHg |
5.0 |
18.71 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-I |
|
98561 |
2098 |
SS-Nppbem2Mcwi-/- |
heart left ventricle end-diastolic posterior wall thickness |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
98 days
| 4 |
|
|
1.87 |
mm |
0.2 |
0.4 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
99715 |
2319 |
SS-Nppbem2Mcwi+/+ |
heart left ventricle end-systolic posterior wall thickness |
controlled sodium content diet (for 21 days) |
Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. |
heart left ventricle posterior wall thickness |
male |
98 days
| 4 |
|
|
2.51 |
mm |
0.23 |
0.46 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
99720 |
2319 |
SS.BN-(D13Rat130-D13Rat32)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
12 |
|
serial mean |
141.0 |
mmHg |
3.0 |
10.39 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-K |
|
98563 |
2098 |
SS.BN-(D13Rat151-D13Rat197)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
14 |
|
serial mean |
156.0 |
mmHg |
5.0 |
18.71 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
|
|
98567 |
2098 |
SS/Jr |
bone section mineralized tissue volume |
controlled sodium content diet (2 %) (between 38 and 42 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
tibia morphology trait |
male |
66 days-70 days |
0 |
|
|
4.92 |
mm3 |
0.88 |
|
micro-computed tomography |
|
0.0 |
|
0 |
|
|
bone volume |
|
98019 |
1958 |
SR/JrIpcv |
systolic blood pressure |
controlled sodium content diet (0.3 %) |
Hojn¿ S, et al., Physiol Res. 2005;54(2):201-6. |
arterial blood pressure trait |
male |
0 days
| 0 |
undefined |
|
137.0 |
mmHg |
3.0 |
|
vascular indwelling catheter method |
|
0.0 |
|
0 |
|
|
|
|
102395 |
2688 |
SS/JrIpcv |
plasma triglyceride level |
controlled sodium content diet (0.3 %) |
Hojn¿ S, et al., Physiol Res. 2005;54(2):201-6. |
blood triglyceride amount |
male |
0 days
| 0 |
|
|
1.2 |
mmol/l |
0.16 |
|
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
|
102402 |
2688 |
SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
59 days-68 days |
11 |
|
|
117.0 |
mg/d |
36.0 |
119.4 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-O |
|
98537 |
2079 |
SS-Nppbem2Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
urine creatinine amount |
male |
60 days-69 days |
0 |
|
|
11.5 |
mg/d |
0.5 |
|
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
98438 |
2059 |
SS-Plod1em1Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
urine creatinine amount |
male |
60 days-69 days |
0 |
|
|
9.0 |
mg/d |
0.4 |
|
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
98437 |
2059 |
SS-Mthfrem1Mcwi-/+ |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
urine creatinine amount |
male |
60 days-69 days |
0 |
|
|
12.1 |
mg/d |
0.4 |
|
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
98441 |
2059 |
SS.SHR-(D9Mco115-D9Mco124)/Bj |
mean arterial blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
6 |
|
serial mean |
172.0 |
mmHg |
11.48 |
28.12 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97966 |
1958 |
WKY/NHsd |
skin chloride level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
0 days
| 7 |
|
|
0.07 |
mmol/g |
0.01 |
0.02 |
ex vivo analysis of atomic composition following dry ashing |
|
0.0 |
|
0 |
|
ashed skin |
skin cl mmol/g |
|
99137 |
2238 |
WKY/NHsd |
plasma cystatin C level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood cystatin C amount |
male |
0 days
| 7 |
|
|
3.5 |
mg/l |
0.2 |
0.53 |
automated plasma protein analysis |
|
0.0 |
|
0 |
|
|
|
|
99177 |
2238 |
SS.SHR-(D9Mco110-D9Mco124)/Bj |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
7 |
|
serial mean |
157.0 |
mmHg |
0.82 |
2.17 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97951 |
1958 |
SS.BN-(D13Rat130-D13Rat32)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
12 |
|
serial mean |
159.0 |
mmHg |
4.0 |
13.86 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-K |
|
98578 |
2098 |
WKY/NHsd |
urine sodium excretion rate |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
urine sodium amount |
male |
0 days
| 7 |
|
|
41.9 |
mEq/d |
5.2 |
13.76 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
99185 |
2238 |
SR/NEisSlc |
urine aldosterone excretion rate |
controlled sodium content diet (0.3 %) (for 84 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
urine aldosterone amount |
male |
84 days
| 6 |
|
|
39.87 |
ng/d |
11.4 |
27.92 |
radioimmunoassay |
|
0.0 |
|
0 |
|
|
ng/d |
|
100695 |
2519 |
SR/NEisSlc |
kidney weight |
controlled sodium content diet (0.3 %) (for 91 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
kidney mass |
male |
91 days
| 6 |
|
|
1.43 |
g |
0.04 |
0.09 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
100703 |
2519 |
SS-Renem1Mcwi+/- |
retroperitoneal fat pad weight to body weight ratio |
controlled sodium content diet (0.4 %) (for 49 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
retroperitoneal fat pad mass |
male |
70 days
| 9 |
|
|
0.49 |
% |
0.05 |
0.15 |
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98308 |
2038 |
SS-Renem1Mcwi+/+ |
single kidney wet weight to body weight ratio |
controlled sodium content diet (0.4 %) (for 49 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
kidney mass |
female |
70 days
| 8 |
|
|
5.1 |
g/kg |
0.2 |
0.57 |
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98304 |
2038 |
SS-Renem1Mcwi+/+ |
retroperitoneal fat pad weight to body weight ratio |
controlled sodium content diet (0.4 %) (for 49 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
retroperitoneal fat pad mass |
male |
70 days
| 5 |
|
|
0.44 |
% |
0.07 |
0.16 |
digital scale post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
98307 |
2038 |
SS-Renem1Mcwi+/- |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
total urine protein amount |
male |
56 days
| 9 |
|
|
85.47 |
mg/d |
10.93 |
32.79 |
urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
98320 |
2038 |
SS-Renem1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
urine sodium amount |
male |
56 days
| 5 |
|
|
0.65 |
mEq/d |
0.25 |
0.56 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
98325 |
2038 |
SS-Renem1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
urine sodium amount |
female |
56 days
| 8 |
|
|
0.71 |
mEq/d |
0.08 |
0.23 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
98328 |
2038 |
SS-Renem1Mcwi+/- |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
urine creatinine amount |
male |
56 days
| 9 |
|
|
8.41 |
mg/d |
0.4 |
1.2 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
98332 |
2038 |
SS-Renem1Mcwi+/- |
serum urea nitrogen level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood urea nitrogen amount |
male |
63 days
| 8 |
|
|
112.25 |
mg/dl |
7.52 |
21.27 |
serum urea nitrogen analysis |
|
0.0 |
|
0 |
|
|
|
|
98339 |
2038 |
SS-Renem1Mcwi+/- |
serum creatinine level |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
blood creatinine amount |
female |
63 days
| 9 |
|
|
0.26 |
mg/dl |
0.02 |
0.06 |
serum creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
98347 |
2038 |
WKY/NHsd |
creatinine clearance |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
glomerular filtration trait |
male |
0 days
| 7 |
|
|
3.5 |
ml/min |
0.3 |
0.79 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
99181 |
2238 |
SS.SHR-(D9Mco113-D9Mco124)/Bj |
heart rate |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
heart pumping trait |
male |
68 days-70 days |
6 |
|
serial mean |
390.0 |
beats/min |
4.83 |
11.83 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97975 |
1958 |
F344-Hsd11b2em1Jmul+/+ |
mean arterial blood pressure |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
arterial blood pressure trait |
not specified |
182 days-210 days |
4 |
1000hz 5min/hour |
|
113.5 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
0.0 |
|
0 |
|
|
|
|
104994 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
food intake rate |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
eating behavior trait |
male |
161 days
| 4 |
|
|
15.13 |
g/d |
0.25 |
0.5 |
food intake measuring method |
|
0.0 |
|
0 |
|
|
|
|
104997 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
food intake rate |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
eating behavior trait |
male |
168 days
| 5 |
|
|
13.6 |
g/d |
0.3 |
0.67 |
food intake measuring method |
|
0.0 |
|
0 |
|
|
|
|
105001 |
3008 |
F344-Hsd11b2em1Jmul-/- |
water drink intake rate |
controlled sodium content diet (0.3 %) then controlled sodium content diet (3 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
drinking behavior trait |
male |
168 days
| 5 |
|
|
76.38 |
ml/d |
1.92 |
4.29 |
drink intake measuring method |
|
0.0 |
|
0 |
|
|
|
|
105006 |
3008 |
F344-Hsd11b2em1Jmul-/- |
water drink intake rate |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
drinking behavior trait |
male |
168 days
| 5 |
|
|
13.1 |
ml/d |
0.6 |
1.34 |
drink intake measuring method |
|
0.0 |
|
0 |
|
|
|
|
105008 |
3008 |
F344-Hsd11b2em1Jmul-/- |
timed urine volume |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
161 days
| 5 |
|
|
16.15 |
ml/d |
0.78 |
1.74 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
105010 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
timed urine volume |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
168 days
| 5 |
|
|
3.4 |
ml/d |
0.2 |
0.45 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
105013 |
3008 |
F344-Hsd11b2em1Jmul-/- |
timed urine volume |
controlled sodium content diet (0.3 %) then controlled sodium content diet (3 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine output |
male |
168 days
| 5 |
|
|
69.15 |
ml/d |
2.06 |
4.61 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
105012 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
urine sodium level |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine sodium amount |
male |
168 days
| 5 |
|
|
35.1 |
mmol/l |
9.1 |
20.35 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
105025 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
urine sodium level |
controlled sodium content diet (0.3 %) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine sodium amount |
male |
161 days
| 4 |
|
|
817.2 |
mmol/l |
39.6 |
79.2 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
105021 |
3008 |
F344-Hsd11b2em1Jmul-/- |
urine potassium level |
controlled sodium content diet (0.3 %) then controlled sodium content diet (3 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine potassium amount |
male |
168 days
| 5 |
|
|
1862.4 |
mmol/l |
334.5 |
747.96 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
|
105030 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
urine potassium level |
controlled sodium content diet (0.3 %) then controlled sodium content diet (0.03 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine potassium amount |
male |
168 days
| 5 |
|
|
1151.0 |
mmol/l |
44.5 |
99.51 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
|
105031 |
3008 |
SS-Plekha7em4Mcwi+/+ |
urine sodium level |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine sodium amount |
male |
91 days
| 10 |
|
|
284.0 |
mmol/l |
16.0 |
50.6 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
105782 |
3022 |
SS-Plekha7em4Mcwi-/- |
timed urine volume |
controlled sodium content diet (0.4 %) (for 63 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
63 days
| 10 |
|
|
5.26 |
ml/d |
0.51 |
1.61 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
105765 |
3022 |
SS-Plekha7em4Mcwi-/- |
timed urine volume |
controlled sodium content diet (8 %) (for 21 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine output |
male |
84 days
| 10 |
|
|
71.34 |
ml/d |
2.26 |
7.15 |
urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
105771 |
3022 |
SS-Plekha7em4Mcwi-/- |
urine sodium level |
controlled sodium content diet (8 %) (for 14 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine sodium amount |
male |
77 days
| 10 |
|
|
348.0 |
mmol/l |
16.0 |
50.6 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
105779 |
3022 |
SS-Plekha7em4Mcwi+/+ |
urine potassium level |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
urine potassium amount |
male |
91 days
| 10 |
|
|
15.1 |
mmol/l |
1.2 |
3.79 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
|
105792 |
3022 |
SS-Plekha7em4Mcwi+/+ |
body weight |
controlled sodium content diet (0.4 %) (for 42 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
body mass |
male |
63 days
| 10 |
|
|
250.0 |
g |
8.0 |
25.3 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
105736 |
3022 |
SS-Plekha7em4Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
total urine protein amount |
male |
91 days
| 10 |
|
|
190.0 |
mg/d |
16.0 |
50.6 |
urine protein analysis |
|
0.0 |
|
0 |
|
|
|
|
105741 |
3022 |
SHRSP/A3NCrl |
brain infarction volume |
controlled protein content diet (16 %) (between 28 and 120 days) and controlled sodium content diet (4 %) (for 28 days) and controlled potassium content diet (0.75 %) (for 28 days) and unilateral carotid artery occlusion (for 28 days) |
Yang Y, etal., Neurobiol Dis. 2018 Jun;114:95-110. doi: 10.1016/j.nbd.2018.02.012. Epub 2018 Feb 24. |
brain integrity trait |
male |
112 days
| 8 |
|
|
19.7 |
mm3 |
4.4 |
12.45 |
magnetic resonance imaging |
corpus callosum |
0.0 |
|
0 |
|
corpus callosum-right hemisphere |
corpus callosum-right hemisphere |
|
107282 |
3079 |
SS-Chr 2BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
10 |
|
|
174.3 |
mg/d |
23.06 |
72.93 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52728 |
482 |
SS-Chr 4BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
8 |
|
|
11.82 |
mEq/d |
1.51 |
4.27 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52772 |
482 |
LEW/Crl |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
9 |
|
|
-2.43 |
beats/min |
15.64 |
46.93 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50517 |
481 |
FHH-Chr 12BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80 days-99 days |
10 |
|
|
12.16 |
mEq/d |
2.29 |
7.24 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52780 |
482 |
SS-Chr 18BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
5 |
|
|
0.3 |
ng/ml/h |
0.03 |
0.07 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50535 |
481 |
WKY/NCrl |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
118.22 |
mmHg |
2.65 |
7.94 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50546 |
481 |
BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
0.28 |
beats/min |
13.27 |
39.81 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50624 |
481 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
139.27 |
mmHg |
3.66 |
10.35 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50638 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
46.25 |
mmHg |
3.11 |
7.61 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50660 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
6 |
|
|
55.32 |
mmHg |
2.61 |
6.39 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50663 |
481 |
SS-Chr 16BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
125.38 |
mmHg |
2.94 |
6.57 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50677 |
481 |
LEW/Crl |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
6 |
|
|
0.33 |
mg/dl |
0.01 |
0.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
|
50691 |
481 |
SS-Chr 9BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
14 |
|
|
6.91 |
mmHg |
2.02 |
7.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50699 |
481 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
4 |
|
|
-9.46 |
mmHg |
3.26 |
6.51 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50813 |
481 |
Crl:CD(SD) |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
-0.2 |
mmHg |
2.08 |
4.16 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50816 |
481 |
F344/DuCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
1 |
|
|
-0.7 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50819 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
-0.68 |
mmHg |
4.11 |
12.32 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
50830 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
5 |
|
|
8.29 |
beats/min |
21.22 |
47.46 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50905 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
5 |
|
|
34.4 |
mmHg |
3.93 |
8.78 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50902 |
481 |
SS-Chr 9BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
6 |
|
|
128.48 |
mmHg |
4.68 |
11.46 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50946 |
481 |
GH/OmrMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
9 |
|
|
18.73 |
mmHg |
1.8 |
5.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50963 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
4 |
|
|
29.71 |
mmHg |
9.04 |
18.07 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50966 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
14 |
|
|
13.28 |
mmHg |
2.14 |
8.01 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50958 |
481 |
SHR/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
8 |
|
|
1.24 |
mmHg |
2.67 |
7.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51028 |
481 |
SS-Chr 9BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
12 |
|
|
0.56 |
ml/min |
0.15 |
0.53 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51059 |
481 |
FHH/EurMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
4 |
|
|
1.21 |
ml/min |
0.21 |
0.42 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51062 |
481 |
SS/Jr |
plasma chloride level |
controlled sodium content diet (8 %) (between 8 and 10 days) |
Huang BS, et al., Hypertension. 2007 Apr 9;. |
blood chloride amount |
male |
43 days-52 days |
12 |
|
|
105.0 |
mmol/l |
2.0 |
6.93 |
chloride ion-selective electrode method |
|
|
|
0 |
|
chloride ion-selective electrode |
|
|
13330 |
344 |
Crl:CD(SD) |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
7 |
|
|
113.23 |
mmHg |
1.95 |
5.15 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51076 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
3 |
|
|
-11.72 |
beats/min |
10.1 |
17.5 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51090 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
3.87 |
mmHg |
2.0 |
4.48 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51102 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-27.08 |
beats/min |
15.11 |
33.78 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51217 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
9 |
|
|
-12.27 |
beats/min |
14.94 |
44.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51220 |
481 |
FHH/EurMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
2 |
|
|
4.3 |
beats/min |
93.3 |
131.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51234 |
481 |
F344/DuCrl |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87 days-120 days |
8 |
|
|
0.92 |
ml/min |
0.08 |
0.22 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51259 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
1 |
|
|
432.84 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51254 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
8 |
|
|
1.74 |
mEq/d |
0.27 |
0.76 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51265 |
481 |
SHR/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
10 |
|
|
1.46 |
mEq/d |
0.11 |
0.36 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51270 |
481 |
SS-Chr 9BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
15 |
|
|
420.94 |
beats/min |
4.88 |
18.88 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51287 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
6 |
|
|
5.93 |
mEq/d |
0.44 |
1.07 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51299 |
481 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
0 |
|
|
197.0 |
mmHg |
3.85 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67513 |
749 |
SS.SHR-(D9Mco72-D9Uia4)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
0 |
|
|
181.0 |
mmHg |
3.91 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67516 |
749 |
SS.SHR-(D9Rat7-D9Rat52)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
arterial blood pressure trait |
not specified |
65 days-70 days |
0 |
|
|
203.0 |
mmHg |
6.11 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
|
67526 |
749 |
SS.SHR-(D9Mco72-D9Rat55)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
body mass |
not specified |
0 days
| 0 |
|
|
302.0 |
g |
2.88 |
|
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67528 |
749 |
SS.SHR-(D9Mco72-D9Mco109)/Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
1.23 |
g |
0.01 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67549 |
749 |
SS.SHR-(D9Mco72-D9Mco109)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.01 |
g/kg |
0.03 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67565 |
749 |
SS.SHR-(D9Rat7-D9Rat84)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.09 |
g/kg |
0.07 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67573 |
749 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart mass |
not specified |
0 days
| 0 |
|
|
4.24 |
g/kg |
0.1 |
|
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67575 |
749 |
Hsd:SD |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
16 |
|
|
0.74 |
mEq/d |
0.11 |
0.43 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51399 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
2 |
|
|
-109.6 |
beats/min |
11.6 |
16.4 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51407 |
481 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
17 |
|
|
30.86 |
mmHg |
2.26 |
9.32 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51421 |
481 |
FHH/EurMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
8 |
|
|
38.72 |
mmHg |
3.96 |
11.19 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51430 |
481 |
SS/JrHsdMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
11 |
|
|
41.53 |
mg/d |
8.23 |
27.31 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51441 |
481 |
SS-Chr 18BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
4 |
|
|
1.66 |
ml/min |
0.1 |
0.2 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51447 |
481 |
SS-Chr 16BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
8 |
|
|
3.91 |
mg/d |
0.77 |
2.17 |
automated urine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51459 |
481 |
SHR/NCrl |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
8 |
|
|
1.08 |
mEq/d |
0.16 |
0.45 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51521 |
481 |
SS-Chr 16BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87 days-120 days |
6 |
|
|
0.3 |
mg/dl |
0.06 |
0.15 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51538 |
481 |
SS-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
7 |
|
|
1.93 |
ml/min |
0.1 |
0.27 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51546 |
481 |
SS-Chr 16BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
6 |
|
|
19.21 |
mg/d |
2.42 |
5.92 |
automated urine analysis |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51555 |
481 |
FHH/EurMcwi |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
8 |
|
|
1.96 |
mg/d |
0.27 |
0.76 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51560 |
481 |
SHR/NCrl |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
male |
87 days-120 days |
10 |
|
|
1.03 |
mg/d |
0.16 |
0.51 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51566 |
481 |
SHR/NCrl |
urine albumin excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine albumin amount |
female |
87 days-120 days |
9 |
|
|
0.29 |
mg/d |
0.05 |
0.16 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51569 |
481 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
8 |
|
|
437.8 |
beats/min |
17.4 |
49.21 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51588 |
481 |
Crl:CD(SD) |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
6 |
|
|
1.14 |
ng/ml/h |
0.3 |
0.74 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
51603 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
3 |
|
|
-12.6 |
beats/min |
13.02 |
22.55 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51608 |
481 |
SS.LEW-(D3Mco21-D3Rat17)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
4 |
|
|
166.0 |
mmHg |
9.0 |
18.0 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11941 |
226 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
18 |
|
|
157.55 |
mmHg |
5.0 |
21.21 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51628 |
481 |
SS.LEW-(D10Chm128-D10Chm169)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
arterial blood pressure trait |
male |
68 days-98 days |
8 |
|
|
184.0 |
mmHg |
8.0 |
22.63 |
radiotelemetry |
|
30 |
|
0 |
|
|
|
|
11957 |
226 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
5 |
|
|
-20.24 |
beats/min |
14.12 |
31.57 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50337 |
481 |
Crl:CD(SD) |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
109.1 |
mmHg |
3.86 |
10.21 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50351 |
481 |
Hsd:SD |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
7 |
|
|
3.42 |
mmHg |
1.85 |
4.89 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
50342 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
1 |
|
|
8.0 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
50354 |
481 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
8 |
|
|
3.34 |
ng/ml/h |
0.14 |
0.39 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50393 |
481 |
F344/DuCrl |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
7 |
|
|
15.17 |
ng/ml/h |
1.06 |
2.81 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
50414 |
481 |
SS-Chr 16BN/Mcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
2 |
|
|
455.2 |
beats/min |
31.4 |
44.41 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
50447 |
481 |
SS.LEW-(D18Chm91-D18Rat67)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 5 |
|
|
10.0 |
g/kg |
0.4 |
0.89 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64774 |
226 |
SS.LEW-(D17Chm14-D17Rat181)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 5 |
|
|
9.7 |
g/kg |
0.2 |
0.45 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64779 |
226 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
female |
87 days-120 days |
6 |
|
|
2.08 |
ng/ml/h |
0.23 |
0.56 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50458 |
481 |
SS.LEW-(D17Chm9-D17Rat97)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 10 |
|
|
10.3 |
g/kg |
0.4 |
1.26 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64777 |
226 |
SS-Chr 16BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
renin activity |
male |
87 days-120 days |
8 |
|
|
1.22 |
ng/ml/h |
0.11 |
0.31 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
50461 |
481 |
SS.LEW-(D10Rat27-Igfbp4)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 7 |
|
|
10.9 |
g/kg |
0.4 |
1.06 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64787 |
226 |
SS.LEW-(D3Rat52-D3Rat130)/Ayd |
both kidneys wet weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
kidney mass |
male |
98 days
| 7 |
|
|
9.5 |
g/kg |
0.2 |
0.53 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64793 |
226 |
SS.MNS-(D2Wox27-Adh1)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 5 |
|
|
3.1 |
mg/g |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64956 |
226 |
SS.LEW-(D10Mco84-D10Rat58)/Mco |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Hypertension. 2007 |
heart mass |
male |
64 days-66 days |
0 |
|
|
4.67 |
g/kg |
0.09 |
|
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12054 |
205 |
SS.LEW-(D3Rat52-D3Rat130)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 7 |
|
|
3.23 |
g/kg |
0.09 |
0.24 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12097 |
226 |
SS.LEW-(D16Rat38-D16Chm66)/Ayd |
heart weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart mass |
male |
98 days
| 8 |
|
|
3.9 |
g/kg |
0.1 |
0.28 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12114 |
226 |
SS/Jr |
body weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
body mass |
male |
64 days-68 days |
20 |
|
|
306.0 |
g |
3.09 |
13.82 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12144 |
232 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
1.18 |
g |
0.01 |
0.04 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12155 |
232 |
SS.MNS-(D10Mco62-D10Got99)/Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 24 days) |
Saad Y, et al., Mamm Genome. 2008 Jan 4 |
heart mass |
male |
64 days-68 days |
20 |
|
|
1.24 |
g |
0.01 |
0.04 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12204 |
232 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
heart mass |
male |
70 days-72 days |
40 |
|
|
1.13 |
g |
0.01 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12254 |
237 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
heart mass |
male |
70 days-72 days |
20 |
|
|
1.27 |
g |
0.02 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12262 |
237 |
SS.SR-(D3Mco36-D3Got159)/Jr |
heart wet weight |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
heart mass |
male |
70 days-72 days |
20 |
|
|
1.15 |
g |
0.01 |
0.05 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12259 |
237 |
SS.SHR-(D8Uia1-D8Rat90)/Mco |
both kidneys wet weight |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
kidney mass |
male |
84 days
| 12 |
|
|
2.7 |
g |
0.02 |
0.08 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12339 |
246 |
SS.SHR-(D9Wox16-D9Rat64)/Mco |
heart rate |
controlled sodium content diet (2 %) (for 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart pumping trait |
male |
75 days-79 days |
5 |
|
|
396.0 |
beats/min |
8.72 |
19.5 |
intra-aortic abdominal radiotelemetry |
|
172800 |
|
0 |
|
|
|
|
64987 |
305 |
SS.SHR-(D9Mco72-D9Mco93)/Mco |
urine total protein excretion rate |
controlled sodium content diet (2 %) (between 31 and 32 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
total urine protein amount |
male |
71 days-73 days |
20 |
|
|
61.64 |
mg/d |
4.56 |
20.39 |
pyrogallol red-molybdate complex-based urine total protein analysis |
|
86400 |
|
0 |
|
|
|
|
64990 |
305 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 23 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
arterial blood pressure trait |
male |
56 days-60 days |
5 |
|
|
151.0 |
mmHg |
2.24 |
5.0 |
radiotelemetry |
|
86400 |
|
0 |
|
|
two 24 hours widely separated periods, data represent averages of all readings over the 24-h measurements |
|
65001 |
542 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
body weight |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
body mass |
male |
77 days
| 11 |
|
|
324.5 |
g |
3.89 |
12.9 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
65006 |
542 |
SS.BN-(D13Rat127-D13Rat61)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
70.8 |
mg/d |
12.2 |
42.26 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65229 |
15 |
SS.BN-(D13Rat101-D13Rat46)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84 days-88 days |
12 |
|
|
51.5 |
mg/d |
7.9 |
27.37 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65234 |
15 |
SS.BN-(D13Rat151-D13Rat197)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84 days-88 days |
12 |
|
|
17.8 |
mg/d |
2.1 |
7.27 |
urine analysis |
|
86400 |
|
0 |
|
|
|
|
65248 |
15 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
heart left ventricle wet weight |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle mass |
male |
77 days
| 5 |
|
|
0.8 |
g |
0.05 |
0.12 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65033 |
542 |
SS.BN-(D13Rat7-D13Rat88)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86 days-89 days |
12 |
|
|
165.0 |
mmHg |
4.2 |
14.55 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65161 |
15 |
FHH-Chr 1BN-Sorcs1em1Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
12 |
|
|
7.01 |
mg/d |
0.5 |
1.73 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66709 |
717 |
SS-Tfdp2em2Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
9.51 |
mg/d |
0.73 |
1.26 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66736 |
717 |
SS-Nckap5em3Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
11.28 |
mg/d |
1.27 |
1.8 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66744 |
717 |
SS-Gpr183em3Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.57 |
g |
0.07 |
0.21 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66805 |
717 |
SS-Ube2q2em3Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.4 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66811 |
717 |
SR/Jr |
body weight |
controlled sodium content diet (0.2 %) (for 168 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
body mass |
male |
203 days
| 10 |
|
|
422.0 |
g |
5.4 |
17.08 |
body weighing method |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64709 |
222 |
SS.BN-(D13Rat20-D13Got22)/Mcwi-Nckap5em4Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
4 |
|
|
10.68 |
mEq/d |
0.94 |
1.88 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66854 |
717 |
SS-Cybaem1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
8.17 |
mEq/d |
4.75 |
6.71 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66860 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
7 |
|
|
7.84 |
mEq/d |
1.38 |
3.66 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66865 |
717 |
SS-Ncf2em1Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
6 |
|
|
37.83 |
mg/d |
10.61 |
25.99 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66873 |
717 |
SS-Acad10em2Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
5 |
|
|
8.32 |
mEq/d |
1.39 |
3.11 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66870 |
717 |
SS-Ncf2em1Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
5 |
|
|
45.7 |
mg/d |
6.07 |
13.58 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66892 |
717 |
SS-Apoeem7Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
5 |
|
|
33.37 |
mg/d |
5.71 |
12.78 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66902 |
717 |
SS-Bcas3em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
117.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66978 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
121.5 |
mmHg |
1.31 |
3.21 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66986 |
717 |
SS/JrSeac |
body weight |
controlled sodium content diet (0.3 %) (for 35 days) |
Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. |
body mass |
not specified |
126 days
| 5 |
|
|
303.0 |
g |
14.31 |
32.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67255 |
733 |
BN/NHsdMcwi |
ratio of change in renal blood flow rate to kidney weight |
controlled sodium content diet (0.4 %) (for 16 hours) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renal blood flow trait |
female |
97 days-101 days |
19 |
|
|
-1.4 |
ml/min/g |
0.2 |
0.87 |
electromagnetic flowmetry |
|
0.0 |
|
0 |
|
electromagnetic flowmetry |
|
|
67307 |
151 |
SS-Chr 5BN-Cyp4a2em1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.25 |
g |
0.06 |
0.11 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67016 |
717 |
SS-Nckap5em2Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
2 |
|
|
1.27 |
g |
0.04 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67029 |
717 |
SS-Nox4em2Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.08 |
g |
0.07 |
0.12 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67027 |
717 |
SS-Cybaem1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
2 |
|
|
1.38 |
g |
0.28 |
0.39 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67043 |
717 |
SS-Ncf2em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
361.0 |
beats/min |
11.06 |
27.09 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67056 |
717 |
SS-Acad10em2Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
5 |
|
|
1.07 |
g |
0.04 |
0.09 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67053 |
717 |
SS.LEW-(D17Chm14-D17Rat181)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 5 |
|
|
0.56 |
mg/g |
0.1 |
0.22 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64907 |
226 |
SS.LEW-(D16Rat12-D16Chm23)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 10 |
|
|
3.54 |
mg/g |
0.05 |
0.16 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64910 |
226 |
SS.LEW-(D16Rat38-D16Chm66)/Ayd |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart right ventricle mass |
male |
98 days
| 8 |
|
|
0.62 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64913 |
226 |
SS.LEW-(D8Chm14-D8Rat16)/Ayd |
heart left ventricle weight to body weight ratio |
controlled sodium content diet (2 %) (between 35 and 98 days) |
Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 |
heart left ventricle mass |
male |
98 days
| 7 |
|
|
2.57 |
mg/g |
0.05 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
64933 |
226 |
SS/Jr |
diastolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 47 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
114 days-116 days |
3 |
|
|
158.2 |
mmHg |
3.9 |
6.75 |
intra-aortic abdominal radiotelemetry |
|
86400 |
|
0 |
|
|
|
|
65066 |
283 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 17 and 18 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
85 days-87 days |
9 |
|
|
214.9 |
mmHg |
8.9 |
26.7 |
tail cuff photoplethysmography |
|
172800 |
|
0 |
|
|
|
|
65074 |
283 |
SS.SR-(D7Mco19-D7Mco7)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
body mass |
male |
114 days-118 days |
3 |
|
|
360.3 |
g |
15.3 |
26.5 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
65099 |
283 |
SS-Alms1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
353.0 |
beats/min |
13.56 |
30.32 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67119 |
717 |
SS-Gpr183em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
380.67 |
beats/min |
11.11 |
27.22 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67121 |
717 |
SS-Acad10em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
12 |
|
|
375.42 |
beats/min |
9.61 |
33.28 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
67124 |
717 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. |
arterial blood pressure trait |
male |
64 days-72 days |
20 |
|
serial mean |
206.6 |
mmHg |
2.4 |
10.73 |
tail cuff plethysmography |
|
345600 |
|
0 |
|
Rats warmed to 28 degrees C for measurement. |
|
|
65793 |
237 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-13.51 |
beats/min |
6.01 |
15.9 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51710 |
481 |
SS-Chr 20BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
15 |
|
|
-83.44 |
beats/min |
10.79 |
41.81 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51713 |
481 |
GH/OmrMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
7 |
|
|
-0.83 |
beats/min |
8.19 |
21.68 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51724 |
481 |
FHH/EurMcwi |
urine total protein excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
total urine protein amount |
female |
87 days-120 days |
7 |
|
|
19.85 |
mg/d |
4.01 |
10.61 |
automated urine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51749 |
481 |
LEW/Crl |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
4 |
|
|
352.38 |
beats/min |
10.21 |
20.42 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51782 |
481 |
SS-Chr 16BN/Mcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87 days-120 days |
10 |
|
|
2.35 |
ml/min |
0.14 |
0.44 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
51802 |
481 |
SS/Hsd |
plasma total cholesterol level |
controlled sodium content diet (0.3 %) then fasting (for 16 hours) |
Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 |
blood cholesterol amount |
male |
180 days
| 20 |
|
|
171.81 |
mg/dl |
6.95 |
31.08 |
plasma total cholesterol measurement test |
|
|
|
0 |
|
|
|
|
11884 |
204 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
3 |
|
|
23.81 |
mmHg |
5.74 |
9.95 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51813 |
481 |
SS-Chr 18BN/Mcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87 days-120 days |
5 |
|
|
14.36 |
mmHg |
3.33 |
7.45 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51816 |
481 |
Hsd:SD |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
20 |
|
|
11.22 |
beats/min |
7.91 |
35.37 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
51875 |
481 |
FHH/EurMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87 days-120 days |
6 |
|
|
13.2 |
mEq/d |
1.8 |
4.41 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
51892 |
481 |
SS-Chr 18BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87 days-120 days |
1 |
|
|
0.35 |
mg/dl |
|
|
radioimmunoassay |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51903 |
481 |
WKY/NCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
-14.79 |
mmHg |
5.52 |
16.56 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51914 |
481 |
SS/JrHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
male |
87 days-120 days |
3 |
|
|
1.67 |
beats/min |
20.69 |
35.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51978 |
481 |
SS-Chr 16BN/Mcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (for 0.2 hours) then angiotensin (50 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
heart pumping trait |
female |
87 days-120 days |
2 |
|
|
-55.0 |
beats/min |
29.4 |
41.58 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
51980 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then angiotensin (5 ng/kg/min) (for 0.2 hours) then angiotensin (10 ng/kg/min) (for 0.2 hours) then angiotensin (25 ng/kg/min) (between 0.2 and 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
1.65 |
mmHg |
2.61 |
7.83 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
51994 |
481 |
SS/JrHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87 days-120 days |
11 |
|
|
7.72 |
mEq/d |
1.23 |
4.07 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
52017 |
481 |
LEW/Crl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 24 and 31 days) then norepinephrine (0.1 ng/kg/min) (for 0.2 hours) then norepinephrine (0.2 ng/kg/min) (for 0.2 hours) then norepinephrine (0.5 ng/kg/min) (for 0.2 hours) then norepinephrine (1 ng/kg/min) (for 0.2 hours) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87 days-120 days |
9 |
|
|
-0.47 |
mmHg |
3.39 |
10.17 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
|
52025 |
481 |
FHH-Chr 18BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80 days-99 days |
9 |
|
|
64.77 |
mg/d |
14.16 |
42.49 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52114 |
482 |
FHH-Chr 10BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
6 |
|
|
556.36 |
mg/d |
51.87 |
127.06 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52133 |
482 |
SS-Chr 6BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80 days-99 days |
7 |
|
|
1.3 |
ml/min |
0.1 |
0.28 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52144 |
482 |
FHH-Chr 13BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
10 |
|
|
12.0 |
mEq/d |
2.14 |
6.77 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52796 |
482 |
FHH-Chr 2BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
5 |
|
|
17.74 |
mEq/d |
4.06 |
9.07 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52806 |
482 |
FHH-Chr 14BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
7 |
|
|
30.48 |
mEq/d |
3.7 |
9.8 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52804 |
482 |
FHH-Chr XBN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
7 |
|
|
19.66 |
mEq/d |
2.76 |
7.3 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52815 |
482 |
FHH-Chr 9BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80 days-99 days |
6 |
|
|
19.96 |
mEq/d |
1.86 |
4.56 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52823 |
482 |
SS-Chr 5BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
8 |
|
|
122.04 |
mmHg |
2.16 |
6.11 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52842 |
482 |
SS.LEW-(D10Arb9-D10Rat57)/Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.1 |
g |
0.02 |
0.08 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12682 |
282 |
SS.LEW-(D10Mco84-D10Got93)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
body mass |
male |
68 days-70 days |
30 |
|
|
305.0 |
g |
1.96 |
10.74 |
whole body digital scale |
|
0 |
|
0 |
|
|
|
|
12706 |
282 |
SS.SHR-(D9Wox16-D9Rat64)/Mco |
diastolic blood pressure |
controlled sodium content diet (2 %) (between 35 and 37 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
arterial blood pressure trait |
male |
75 days-79 days |
5 |
|
serial mean |
103.0 |
mmHg |
1.15 |
2.57 |
intra-aortic abdominal radiotelemetry |
lower abdominal aorta |
172800 |
|
0 |
|
C-40 transmitter (Data Sciences International, St. Paul, MN) |
average of 12 4-hour averages over 48 hours using 5 or 6 rats |
|
13032 |
305 |
SS/Jr |
urine albumin excretion rate |
controlled sodium content diet (0.2 %) |
Poyan Mehr A, et al., Physiol Genomics 2003 Aug 15;14(3):209-16. |
urine albumin amount |
not specified |
28 days
| 12 |
|
|
4.7 |
mg/d |
|
|
enzyme linked immunosorbent assay |
urine |
0.0 |
|
0 |
|
rat albumin ELISA |
|
|
13281 |
335 |
SS.LEW-(D1Uia2-D1Rat49)/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. |
body mass |
male |
68 days-70 days |
20 |
|
|
307.0 |
g |
5.02 |
22.45 |
body weighing method |
|
|
|
0 |
|
|
|
|
12500 |
266 |
WKY |
heart wet weight |
controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
heart mass |
female |
360 days
| 4 |
|
|
0.55 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12594 |
268 |
SS.LEW-(D18Chm41-D18Rat45)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hum Mol Genet. 2005 Dec 15;14(24):3877-84. Epub 2005 Nov 8. |
arterial blood pressure trait |
male |
56 days
| 5 |
|
|
130.0 |
mmHg |
3.0 |
6.71 |
intra-aortic abdominal radiotelemetry |
aorta |
|
|
0 |
|
|
|
|
12597 |
269 |
SS.LEW-(D18Rat29-D18Rat55)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hum Mol Genet. 2005 Dec 15;14(24):3877-84. Epub 2005 Nov 8. |
arterial blood pressure trait |
male |
56 days
| 11 |
|
|
148.0 |
mmHg |
4.0 |
13.27 |
intra-aortic abdominal radiotelemetry |
aorta |
|
|
0 |
|
|
|
|
12607 |
269 |
SS.LEW-(D5Rat130-D5Rat31)/JrMcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 21 and 25 days) |
Roman RJ, et al., Am J Physiol Renal Physiol. 2006 Jun;290(6):F1463-71. Epub 2006 Jan 5. |
arterial blood pressure trait |
male |
82 days-86 days |
32 |
|
serial mean |
159.0 |
mmHg |
|
|
vascular fluid filled catheter |
femoral artery |
345600 |
|
0 |
|
connected to solid-state transducer (Argon Medical Technologies, Athens, TX) |
5 hr recording session - 1 min. averages, averaged over 4 days |
|
12618 |
272 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
8 |
|
|
38.63 |
cm |
0.49 |
1.38 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63664 |
529 |
FHH-Procm1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
9 |
|
|
37.72 |
cm |
1.43 |
4.28 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63678 |
529 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
8 |
|
|
33.13 |
cm |
1.43 |
4.03 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63686 |
529 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
1 |
|
|
35.0 |
cm |
|
|
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63694 |
529 |
FHH-Egln3m1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
6 |
|
|
42.58 |
cm |
0.42 |
1.02 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63705 |
529 |
FHH-Tlr4m1Mcwi |
body length, nose to tail |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
12 |
|
|
40.83 |
cm |
0.38 |
1.3 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63713 |
529 |
FHH-Egln3m1Mcwi |
heart left ventricle wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart left ventricle mass |
female |
70 days-84 days |
14 |
|
|
0.52 |
g |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63791 |
529 |
SS-Chr 5BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
7 |
|
|
130.42 |
mmHg |
2.59 |
6.85 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52844 |
482 |
SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
18 |
|
|
143.27 |
mmHg |
0.95 |
4.05 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52855 |
482 |
SS-Chr XBN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
5 |
|
|
167.1 |
mmHg |
9.3 |
20.79 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52861 |
482 |
SS-Chr 18BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
8 |
|
|
134.57 |
mmHg |
2.52 |
7.13 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52858 |
482 |
SS-Chr 10BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
11 |
|
|
1.26 |
mEq/d |
0.21 |
0.69 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52927 |
482 |
SS-Chr YBN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
17 |
|
|
1.4 |
mEq/d |
0.1 |
0.4 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52955 |
482 |
SS/JrHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
64 |
|
|
1.29 |
mEq/d |
0.06 |
0.5 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52957 |
482 |
SS/JrHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
11 |
|
|
1.15 |
mEq/d |
0.05 |
0.18 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52963 |
482 |
SS-Chr 4BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
8 |
|
|
1.1 |
mEq/d |
0.1 |
0.27 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52968 |
482 |
SS-Chr 1BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
14 |
|
|
2.08 |
ml/min |
0.21 |
0.79 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52172 |
482 |
SS-Chr 17BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
5 |
|
|
0.34 |
mg/dl |
0.05 |
0.12 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52200 |
482 |
SS-Chr 15BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
7 |
|
|
0.36 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52208 |
482 |
SS-Chr 12BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
6 |
|
|
0.3 |
mg/dl |
0.02 |
0.06 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52229 |
482 |
SS-Chr 1BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
14 |
|
|
0.33 |
mg/dl |
0.02 |
0.07 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52221 |
482 |
LE/BluGill |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80 days-99 days |
6 |
|
|
0.32 |
mg/dl |
0.02 |
0.05 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
52240 |
482 |
FHH-Chr 6BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
8 |
|
|
1.1 |
mEq/d |
0.06 |
0.16 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52303 |
482 |
FHH-Chr YBN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80 days-99 days |
5 |
|
|
1.47 |
mEq/d |
0.06 |
0.14 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52317 |
482 |
FHH-Chr 11BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
6 |
|
|
0.62 |
mEq/d |
0.16 |
0.4 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52328 |
482 |
FHH-Chr 4BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80 days-99 days |
9 |
|
|
0.97 |
mEq/d |
0.1 |
0.29 |
flame atomic emission spectrometry |
|
|
|
0 |
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52325 |
482 |
FHH-Chr 6BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
9 |
|
|
1.69 |
ml/min |
0.15 |
0.46 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52348 |
482 |
FHH-Chr 4BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80 days-99 days |
5 |
|
|
0.98 |
ml/min |
0.12 |
0.26 |
urine creatinine analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52369 |
482 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
20 |
|
|
1.35 |
g |
0.01 |
0.04 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12845 |
313 |
SS.LEW-(D1Mco36-D1Rat131)/1Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
20 |
|
|
1.18 |
g |
0.01 |
0.04 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12853 |
313 |
SS/Jr |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
body mass |
male |
64 days-66 days |
20 |
|
|
309.0 |
g |
2.53 |
11.31 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12864 |
313 |
SS.LEW-(D1Mco36-D1Mco101)/Mco |
body weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
body mass |
male |
64 days-66 days |
30 |
|
|
323.0 |
g |
2.25 |
12.32 |
body weighing method |
|
0 |
|
0 |
|
|
|
|
12877 |
313 |
SS/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. |
heart mass |
male |
64 days-66 days |
20 |
|
|
4.04 |
g/kg |
0.03 |
0.13 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12883 |
313 |
SHR |
heart wet weight |
controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) |
Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. |
heart mass |
female |
360 days
| 4 |
|
|
0.68 |
g |
0.05 |
0.09 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12576 |
268 |
SS/Jr |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.31 |
g |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
12667 |
282 |
SS.SR-(D7Mco19-D7Mco7)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 26 and 27 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
arterial blood pressure trait |
male |
42 days-69 days |
14 |
|
|
170.8 |
mmHg |
3.3 |
12.35 |
tail cuff photoplethysmography |
|
172800 |
|
0 |
|
|
|
|
12678 |
283 |
SS.SHR-(D9Wox16-D9Mco77)/Mco |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
301.0 |
g |
5.65 |
25.27 |
body weighing method |
|
|
|
0 |
|
|
|
|
12951 |
305 |
SS.SHR-(D9Wox16-D9Rat64)/Mco |
heart wet weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
heart mass |
male |
68 days-70 days |
20 |
|
|
1.17 |
g |
0.02 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
|
12959 |
305 |
SS.SHR-(D9Rat7-D9Mco93)/Mco |
body weight |
controlled sodium content diet (2 %) (for 28 days) |
Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. |
body mass |
male |
68 days-70 days |
20 |
|
|
314.0 |
g |
2.76 |
12.34 |
body weighing method |
|
|
|
0 |
|
|
|
|
12957 |
305 |
SS.BN-(D13Rat127-D13Rat61)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86 days-89 days |
12 |
|
|
187.0 |
mmHg |
2.6 |
9.01 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
0 |
|
on 3 consecutive days |
|
|
65181 |
15 |
FHH-Chr 12BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
11 |
|
|
111.94 |
mg/d |
15.39 |
51.03 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52405 |
482 |
FHH-Chr 15BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
7 |
|
|
36.68 |
mg/d |
12.67 |
33.51 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52408 |
482 |
SS-Chr 14BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80 days-99 days |
8 |
|
|
0.42 |
ng/ml/h |
0.1 |
0.29 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52441 |
482 |
FHH-Chr 10BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
5 |
|
|
406.89 |
beats/min |
10.72 |
23.98 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52523 |
482 |
FHH-Chr XBN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80 days-99 days |
5 |
|
|
452.27 |
beats/min |
6.2 |
13.85 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52526 |
482 |
FHH-Chr 17BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
8 |
|
|
404.47 |
beats/min |
25.87 |
73.18 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52515 |
482 |
FHH-Chr 7BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
9 |
|
|
429.18 |
beats/min |
10.25 |
30.75 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52528 |
482 |
FHH-Chr 12BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80 days-99 days |
11 |
|
|
163.84 |
mmHg |
7.46 |
24.74 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52531 |
482 |
FHH-Chr 7BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) and controlled NG-nitroarginine methyl ester content drinking water (12.5 mg/l) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80 days-99 days |
9 |
|
|
185.36 |
mmHg |
6.33 |
18.99 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52575 |
482 |
SS-Chr 10BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
10 |
|
|
26.81 |
mg/d |
7.11 |
22.47 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52589 |
482 |
SS-Chr 7BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
11 |
|
|
15.16 |
mg/d |
2.95 |
9.78 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52594 |
482 |
SS-Chr 1BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80 days-99 days |
20 |
|
|
6.78 |
mg/d |
1.12 |
5.0 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52611 |
482 |
SS/JrHsdMcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80 days-99 days |
11 |
|
|
73.53 |
mg/d |
19.27 |
63.93 |
radioimmunoassay |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52616 |
482 |
LE/BluGill |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80 days-99 days |
7 |
|
|
382.48 |
beats/min |
3.97 |
10.5 |
vascular fluid filled catheter |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
52630 |
482 |
SS-Chr 20BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80 days-99 days |
9 |
|
|
134.48 |
mg/d |
19.15 |
57.45 |
automated urine total protein analysis |
|
|
|
0 |
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52704 |
482 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 25 and 28 days) |
Dukhanina OI, et al., Mamm Genome 1997 Apr;8(4):229-35. |
arterial blood pressure trait |
not specified |
64 days-68 days |
18 |
|
serial mean |
217.0 |
mmHg |
4.0 |
16.97 |
tail cuff plethysmography |
|
|
|
0 |
|
|
average of 12 readings from 4 daily sessions |
|
11831 |
148 |
SS.LEW-(D10Arb9-D10Got101)/Jr |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
serial mean |
217.0 |
mmHg |
4.28 |
19.14 |
tail cuff photoplethysmography |
tail |
345600 |
|
0 |
|
|
average of 4 daily averages of 3-4 measurements/day |
|
13127 |
282 |
SS.LEW-(D10Rat29-D10Mco88)/Mco |
systolic blood pressure |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) |
Saad Y, et al., Genomics. 2007 Mar;89(3):343-53. Epub 2007 Jan 10. |
arterial blood pressure trait |
male |
64 days-70 days |
20 |
|
serial mean |
191.0 |
mmHg |
4.07 |
18.2 |
tail cuff photoplethysmography |
tail |
345600 |
|
0 |
|
|
average of 4 daily averages of 3-4 measurements/day |
|
13135 |
282 |
SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
126 days
| 26 |
|
|
294.0 |
mg/d |
2.94 |
15.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
69225 |
1126 |
BN/NHsdMcwi |
urine sodium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92 days-94 days |
22 |
|
|
100.4 |
mmol/l |
6.5 |
30.49 |
unspecified method |
|
0.0 |
|
0 |
|
urine sodium analysis |
|
|
69466 |
151 |
SS/JrHsdMcwi |
creatinine clearance |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
glomerular filtration trait |
female |
92 days-94 days |
10 |
|
|
1.08 |
ml/min |
0.37 |
1.17 |
urine creatinine analysis |
|
0.0 |
|
0 |
|
|
mg/min |
|
69480 |
151 |
SS/Jr |
heart left ventricle end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle end-diastolic diameter |
male |
77 days
| 40 |
|
|
7.18 |
mm |
0.09 |
0.57 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68266 |
542 |
SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb |
urine total protein excretion rate |
controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) |
Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11. |
total urine protein amount |
not specified |
98 days
| 3 |
|
|
351.0 |
mg/d |
28.87 |
50.0 |
Bradford protein assay |
|
0.0 |
|
0 |
|
|
|
|
70260 |
1126 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
arterial blood pressure trait |
male |
68 days-98 days |
9 |
|
|
168.0 |
mmHg |
|
|
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
69028 |
1096 |
SS.MNS-(D2Mit6-Adh1)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
arterial blood pressure trait |
male |
68 days-98 days |
5 |
|
|
120.0 |
mmHg |
|
|
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
69026 |
1096 |
SS.MNS-(D2Mit6-D2Rat166)/Ayd |
heart left ventricle deoxyribonucleic acid level to body weight ratio |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
heart left ventricle DNA amount |
male |
98 days
| 4 |
|
|
5.0 |
ug/g |
0.5 |
1.0 |
spectrophotometry |
|
0.0 |
|
0 |
|
|
|
|
69036 |
1096 |
BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93 days
| 20 |
|
serial mean |
369.9 |
beats/min |
5.1 |
22.81 |
vascular indwelling catheter method |
left femoral artery |
10800.0 |
|
0 |
|
|
|
|
69519 |
151 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
3 |
|
|
114.33 |
U/l |
8.84 |
15.31 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60436 |
527 |
FHH-Lcatm1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
15 |
|
|
17.73 |
pg |
0.15 |
0.58 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60471 |
527 |
FHH-Ccr2m1Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
5 |
|
|
18.02 |
pg |
0.1 |
0.22 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60480 |
527 |
BN-Lcatm3Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
2 |
|
|
17.25 |
pg |
0.15 |
0.21 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60504 |
527 |
BN-Lcatm3Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
1 |
|
|
17.3 |
pg |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60507 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
5 |
|
|
18.16 |
pg |
0.17 |
0.39 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60526 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
mean corpuscular hemoglobin |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
5 |
|
|
17.78 |
pg |
0.22 |
0.5 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60529 |
527 |
SS-Sod3m1Mcwi |
serum total cholesterol level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
10 |
|
|
101.4 |
mg/dl |
9.38 |
29.66 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60534 |
527 |
SS-Ghsrm3Mcwi |
serum total cholesterol level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
2 |
|
|
107.0 |
mg/dl |
7.0 |
9.9 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60531 |
527 |
FHH-Adipoqm1Mcwi |
red blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
9 |
|
|
7.5 |
x 10E6 cells/ul |
0.09 |
0.26 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60542 |
527 |
SS |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
21 |
|
|
177.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70468 |
1438 |
SS.LEW-(D5Mco39-D5Mco57)/2Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11. |
arterial blood pressure trait |
male |
62 days-66 days |
0 |
|
|
221.0 |
mmHg |
6.3 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
|
|
70589 |
1482 |
BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) then controlled exposure to darkness (for 12 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
89 days-91 days |
20 |
|
serial mean |
96.0 |
mmHg |
2.7 |
12.07 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
69445 |
151 |
SS/JrTol |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Pillai R, et al., Physiol Genomics. 2013 Aug 15;45(16):729-36. doi: 10.1152/physiolgenomics.00077.2013. Epub 2013 Jun 11. |
arterial blood pressure trait |
male |
62 days-66 days |
0 |
|
|
220.0 |
mmHg |
5.6 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
restrained, 28 degrees C |
|
|
70581 |
1482 |
SS-Plcd3em7Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.36 |
g |
0.2 |
0.35 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44360 |
441 |
SS-Nppbem2Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
16 |
|
|
1.54 |
g |
0.03 |
0.13 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44371 |
441 |
SS-Nppaem4Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.38 |
g |
0.04 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44379 |
441 |
SS-Nppbem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.0 |
mmHg |
4.04 |
12.11 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44392 |
441 |
SS-Slc30a8em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
137.5 |
mmHg |
4.48 |
8.96 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44395 |
441 |
SS-Ulk3em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
129.0 |
mmHg |
6.25 |
10.82 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44419 |
441 |
SS-Aldh2em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
144.67 |
mmHg |
11.55 |
28.3 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44421 |
441 |
SS-Cdh13em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.57 |
mmHg |
5.49 |
14.51 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44437 |
441 |
SS-Stk39em2Mcwi-/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.68 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44461 |
441 |
SS-Mstnem1Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
13 |
|
|
1.43 |
g |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44459 |
441 |
SS-Mstnem3Mcwi-/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.55 |
g |
|
|
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44467 |
441 |
SS-Ulk3em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.58 |
g |
0.09 |
0.15 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44480 |
441 |
SS-Stk39em2Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
9 |
|
|
1.32 |
g |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44493 |
441 |
SS-Msraem3Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.53 |
g |
0.07 |
0.12 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44501 |
441 |
SS.LEW-(D18Chm59-D18Rat1)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
142.0 |
mmHg |
2.0 |
4.47 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84484 |
1438 |
SS.LEW-(D10Rat119-D10Mgh1)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hypertension. 2005 Dec;46(6):1300-8. Epub 2005 Nov 14. |
arterial blood pressure trait |
male |
56 days-59 days |
10 |
|
|
107.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
67877 |
830 |
SS.LEW-(D10Rat204-D10Rat9)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (2 %) (for 21 days) |
Charron S, et al., Hypertension. 2005 Dec;46(6):1300-8. Epub 2005 Nov 14. |
arterial blood pressure trait |
male |
56 days-59 days |
5 |
|
|
146.0 |
mmHg |
|
|
intra-aortic abdominal radiotelemetry |
|
86400.0 |
|
0 |
|
|
|
|
67888 |
830 |
SR/Hsd |
cubic root of body weight to nasoanal length ratio |
controlled sodium content diet (0.3 %) then fasting (for 16 hours) |
Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 |
body mass |
female |
180 days
| 14 |
|
|
306.0 |
g/mm x 10000 |
2.0 |
7.48 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
67894 |
204 |
SS.LEW-(D16Rat112-D16Chm60)/Ayd |
heart left atrium end-diastolic diameter |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left atrium diameter |
male |
77 days
| 14 |
|
|
3.29 |
mm |
0.12 |
0.46 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68311 |
542 |
SS/Jr |
heart isovolumetric relaxation time |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart muscle relaxation trait |
male |
77 days
| 40 |
|
|
20.1 |
ms |
0.41 |
2.57 |
continuous wave doppler ultrasound |
|
0.0 |
|
0 |
|
|
isovolumetric relaxation time |
|
68314 |
542 |
SS.LEW-(D18Chm41-D18Rat92)/Ayd |
heart left atrium fractional shortening |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left atrium diameter |
male |
77 days
| 8 |
(LADs - LADd)/ LADs x 100 |
|
38.1 |
% |
1.62 |
4.58 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
heart left atrium fractional shortening |
|
68324 |
542 |
SS/JrHsd |
heart weight to body weight ratio |
controlled sodium content diet (8 %) (for 84 days) |
Herrera VL, et al., Physiol Genomics. 2006 Aug 16;26(3):172-9. Epub 2006 May 23. |
heart mass |
female |
168 days
| 8 |
|
|
3.65 |
g/kg |
0.11 |
0.31 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
67868 |
810 |
SS.LEW-(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
6 |
|
|
151.0 |
mmHg |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70439 |
1438 |
SS.LEW-(D16Chm48-D16Chm60)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
7 |
|
|
134.0 |
mmHg |
5.0 |
13.23 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
70447 |
1438 |
SS-Chr 12BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (1 %) (for 77 days) |
Flister MJ, et al., Hypertension. 2012 Oct;60(4):942-8. doi: 10.1161/HYPERTENSIONAHA.112.198200. Epub 2012 Aug 6. |
arterial blood pressure trait |
male |
67 days-77 days |
10 |
|
serial mean |
127.0 |
mmHg |
1.0 |
3.16 |
intra-aortic abdominal radiotelemetry |
|
14400.0 |
|
0 |
|
abdominal aorta |
4 hrs for 3 consecutive days |
|
96862 |
1718 |
FHH-F10m2Mcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
male |
70 days-84 days |
16 |
|
|
3.81 |
g/dl |
0.06 |
0.22 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61920 |
527 |
BN/NHsdMcwi |
serum albumin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
male |
70 days-84 days |
44 |
|
|
3.89 |
g/dl |
0.03 |
0.23 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61961 |
527 |
FHH-Lcatm1Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
15 |
|
|
175.87 |
U/l |
20.14 |
78.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61977 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
3 |
|
|
87.33 |
U/l |
34.52 |
59.79 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61988 |
527 |
F344/NHsd |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
7 |
|
|
186.0 |
U/l |
21.39 |
56.59 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61991 |
527 |
BN-Lcatm3Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
70 days-84 days |
1 |
|
|
183.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62013 |
527 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
serum aspartate aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
70 days-84 days |
2 |
|
|
202.0 |
U/l |
44.0 |
62.23 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62029 |
527 |
SS-Cpt2m1Mcwi |
blood lymphocyte count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
70 days-84 days |
1 |
|
|
4.68 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62043 |
527 |
SS-Ulk4em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
172.5 |
mmHg |
13.73 |
27.45 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66633 |
717 |
SS-Tgfb1em3Mcwi+/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
3 |
|
|
1.09 |
g |
0.06 |
0.1 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67005 |
717 |
SR/Hsd |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) then 4-alpha-phorbol 12,13-didecanoate (2.5 mg/kg) |
Gao F and Wang DH, Hypertension. 2010 Apr;55(4):1018-25. Epub 2010 Mar 1. |
arterial blood pressure trait |
male |
35 days-56 days |
0 |
|
|
-39.0 |
mmHg |
1.0 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
DR strain is from Charles River Laboratory, Wilmington, MA |
67235 |
731 |
SR/Hsd |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.15 %) then ruthenium red (3 mg/kg) then 4-alpha-phorbol 12,13-didecanoate (2.5 mg/kg) |
Gao F and Wang DH, Hypertension. 2010 Apr;55(4):1018-25. Epub 2010 Mar 1. |
arterial blood pressure trait |
male |
35 days-56 days |
0 |
|
|
-5.0 |
mmHg |
3.0 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
DR strain is from Charles River Laboratory, Wilmington, MA |
67239 |
731 |
SS/HsdMcwiCrl |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.15 %) then ruthenium red (3 mg/kg) then 4-alpha-phorbol 12,13-didecanoate (2.5 mg/kg) |
Gao F and Wang DH, Hypertension. 2010 Apr;55(4):1018-25. Epub 2010 Mar 1. |
arterial blood pressure trait |
male |
35 days-56 days |
0 |
|
|
-5.0 |
mmHg |
2.0 |
|
tail cuff plethysmography |
|
0.0 |
|
0 |
|
|
|
DR strain is from Charles River Laboratory, Wilmington, MA |
67241 |
731 |
SS-Agtr1aem1Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
9 |
|
|
1.19 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44558 |
441 |
SS-Mstnem3Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
7 |
|
|
369.29 |
beats/min |
4.47 |
11.81 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44603 |
441 |
SS-Slc30a8em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
344.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44614 |
441 |
SS-Prokr1em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
389.17 |
beats/min |
12.11 |
29.66 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44630 |
441 |
SS-Cdh13em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
357.75 |
beats/min |
16.57 |
33.14 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44640 |
441 |
SS-Plcd3em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
13 |
|
|
356.0 |
beats/min |
5.5 |
19.85 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44654 |
441 |
SS-Plod1em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
362.7 |
beats/min |
7.75 |
25.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44656 |
441 |
SS-Aldh2em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
401.17 |
beats/min |
22.89 |
56.07 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44667 |
441 |
LEW |
peak aortic velocity |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
aorta blood flow trait |
male |
77 days
| 14 |
|
|
94.6 |
cm/s |
3.1 |
11.6 |
pulsed wave doppler ultrasound |
|
0.0 |
|
0 |
|
|
peak aortic velocity |
|
68241 |
542 |
SS.LEW-(D10Got112-Igfbp4)/Ayd |
heart left ventricle anterior wall thickness |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 35 days) |
Deng AY, et al., J Hypertens. 2008 Oct;26(10):1935-1943. |
heart left ventricle anterior wall thickness |
male |
77 days
| 5 |
|
|
0.15 |
mm |
0.0 |
0.01 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
68255 |
542 |
SS.LEW-(D2Uia5-D2Mit6)(D10Rat194-D10Chm243)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
6 |
|
|
183.0 |
mmHg |
9.0 |
22.05 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84497 |
1438 |
SS.LEW-(D10Chm10-D10Rat11)(D10Chm246-D10Chm257)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
151.0 |
mmHg |
4.0 |
8.94 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84486 |
1438 |
SS.LEW-(D1Chm64-D1Rat19)(D10Rat194-D10Chm243)(D10Chm10-D10Rat11)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 10 and 24 days) |
Chauvet C, et al., Hum Mol Genet. 2013 Nov 15;22(22):4451-9. doi: 10.1093/hmg/ddt294. Epub 2013 Jun 28. |
arterial blood pressure trait |
male |
66 days-80 days |
5 |
|
|
118.0 |
mmHg |
3.0 |
6.71 |
intra-aortic abdominal radiotelemetry |
abdominal aorta |
0.0 |
|
0 |
|
|
|
|
84502 |
1438 |
SS.SHR-(D9Mco72-D9Mco105)/Mco |
heart left ventricle end-systolic area |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) |
Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. |
heart left ventricle size trait |
not specified |
0 days
| 7 |
|
|
0.44 |
cm2 |
0.05 |
0.13 |
echocardiography |
|
0.0 |
|
0 |
|
|
|
|
69603 |
749 |
FHH/EurMcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
25 |
|
|
0.87 |
x 1000 cells/ul |
0.13 |
0.64 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60871 |
527 |
SS/JrHsdMcwi |
serum sodium level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
40 |
|
|
143.98 |
mmol/l |
0.37 |
2.33 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
60901 |
527 |
FHH-Tgfbr2m2Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
male |
70 days-84 days |
11 |
|
|
1.65 |
g/dl |
0.05 |
0.16 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60912 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum globulin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood globulin amount |
female |
70 days-84 days |
5 |
|
|
1.9 |
g/dl |
0.1 |
0.23 |
standard blood chemistry panel |
|
|
|
0 |
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
|
60928 |
527 |
WKY/NCrl |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
15 |
|
|
1.28 |
g/mg |
0.11 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56861 |
522 |
LEW/Crl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
23 |
|
|
99.43 |
% |
0.27 |
1.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56852 |
522 |
LE/BluGill |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
2.3 |
g/mg |
0.16 |
0.62 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56866 |
522 |
Crl:CD(SD) |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
98.22 |
% |
0.64 |
1.92 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56855 |
522 |
SS-Chr 18BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.1 |
umol/l |
0.02 |
0.06 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56874 |
522 |
GH/OmrMcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
0.1 |
umol/l |
0.04 |
0.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56880 |
522 |
SS-Chr 11BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
-6.84 |
null |
0.04 |
0.11 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56953 |
522 |
SS-Chr 18BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
18 |
|
|
-7.14 |
null |
0.05 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56958 |
522 |
BN/NHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
-6.67 |
null |
0.11 |
0.48 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56975 |
522 |
SS-Chr XBN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
-6.79 |
null |
0.07 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56977 |
522 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
2 |
|
|
26.5 |
mg/dl |
0.5 |
0.71 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60202 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
5 |
|
|
24.2 |
mg/dl |
2.54 |
5.67 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60208 |
527 |
FHH-Nr0b2m1Mcwi |
serum calcium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood calcium amount |
female |
70 days-84 days |
6 |
|
|
9.73 |
mg/dl |
0.12 |
0.29 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60213 |
527 |
SS/JrHsdMcwi |
total white blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
39 |
|
|
8.01 |
x 1000 cells/ul |
0.29 |
1.79 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60287 |
527 |
FHH-Tgfbr2m2Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
13 |
|
|
14.72 |
g/dl |
0.18 |
0.66 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60298 |
527 |
SS-Ghsrm3Mcwi |
total white blood cell count |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
1 |
|
|
7.1 |
x 1000 cells/ul |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60292 |
527 |
FHH-Nr0b2m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
6 |
|
|
13.62 |
g/dl |
0.16 |
0.39 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60295 |
527 |
FHH-F10m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
11 |
|
|
13.51 |
g/dl |
0.17 |
0.55 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60317 |
527 |
FHH-Nr4a1m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
11 |
|
|
14.21 |
g/dl |
0.14 |
0.46 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60325 |
527 |
SS-Mmp2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
/3 systolic pressure + 2/3 diastolic pressure |
|
139.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66472 |
717 |
SS-Nckap5em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
/3 systolic pressure + 2/3 diastolic pressure |
|
144.4 |
mmHg |
13.28 |
29.7 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66475 |
717 |
SS-Nox4em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
/3 systolic pressure + 2/3 diastolic pressure |
|
118.75 |
mmHg |
1.8 |
3.59 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66486 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
5 |
|
|
43.77 |
mg/d |
13.05 |
29.18 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66507 |
717 |
SS-Nckap5em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
7 |
|
|
112.23 |
mg/d |
36.1 |
95.51 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66518 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
12 |
|
|
37.54 |
mg/d |
4.94 |
17.12 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66526 |
717 |
SS-Nckap5em2Mcwi-/- |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
8 |
|
|
259.44 |
mg/d |
39.72 |
112.35 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66523 |
717 |
SS-Gpr183em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
349.5 |
beats/min |
11.5 |
16.26 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66585 |
717 |
SS-Mmp2em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
343.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66598 |
717 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
3 |
|
|
13.2 |
g/dl |
0.92 |
1.59 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60344 |
527 |
FHH-Tlr4m1Mcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
9 |
|
|
14.56 |
g/dl |
0.34 |
1.02 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60358 |
527 |
BN/NHsdMcwi |
blood hemoglobin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
43 |
|
|
14.87 |
g/dl |
0.11 |
0.74 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60363 |
527 |
FHH-Adipoqm1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
9 |
|
|
140.11 |
U/l |
18.98 |
56.94 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60388 |
527 |
FHH-Tgfbr2m2Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
10 |
|
|
171.8 |
U/l |
7.12 |
22.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60396 |
527 |
SS-Cpt2m1Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
1 |
|
|
31.8 |
g/dl |
|
|
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61859 |
527 |
FHH-Lcatm1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
0.02 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62737 |
528 |
FHH-Adipoqm2Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62734 |
528 |
BN-Tgfbr2m1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
2 |
|
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62748 |
528 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
2 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62742 |
528 |
FHH-Htr1am1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
12 |
|
|
0.03 |
umol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62756 |
528 |
FHH-Procm1Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
15 |
|
|
0.03 |
umol/l |
0.01 |
0.04 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62762 |
528 |
BN-Lcatm3Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
0.02 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62775 |
528 |
FHH-Adra1am1Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
70 days-84 days |
8 |
|
|
0.23 |
mg/dl |
0.03 |
0.07 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61047 |
527 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
2 |
|
|
0.25 |
mg/dl |
0.05 |
0.07 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61055 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
70 days-84 days |
2 |
|
|
0.4 |
mg/dl |
0.1 |
0.14 |
automated plasma creatinine analysis |
|
|
|
0 |
|
|
|
|
61052 |
527 |
FHH-Agtr1bm1Mcwi |
plasma anion gap |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
70 days-84 days |
14 |
|
|
25.5 |
mmol/l |
0.5 |
1.87 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61071 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
6 |
|
|
32.5 |
g/dl |
0.3 |
0.73 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61187 |
527 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
70 days-84 days |
3 |
|
|
31.73 |
g/dl |
0.42 |
0.72 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61184 |
527 |
FHH/EurMcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
158 |
|
|
33.18 |
g/dl |
0.07 |
0.93 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61190 |
527 |
F344-Inpp4bTn(sb-T2/Bart3)2.143Mcwi |
mean corpuscular hemoglobin concentration |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
70 days-84 days |
7 |
|
|
32.47 |
g/dl |
0.14 |
0.36 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61201 |
527 |
SS-Nppbem2Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
4 |
|
|
8.93 |
mEq/d |
1.6 |
3.19 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44204 |
441 |
SS-Prokr1em2Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
8 |
|
|
7.76 |
mEq/d |
0.89 |
2.52 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44225 |
441 |
SS-Aldh2em2Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
7 |
|
|
9.99 |
mEq/d |
1.19 |
3.15 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44231 |
441 |
SS-Plod1em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
5 |
|
|
8.04 |
mEq/d |
1.21 |
2.7 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44241 |
441 |
SS-Slc30a8em2Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
1 |
|
|
9.6 |
mEq/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44244 |
441 |
SS-Nppaem4Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
2 |
|
|
9.78 |
mEq/d |
0.49 |
0.69 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44255 |
441 |
SS-Nppbem4Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
9 |
|
|
36.09 |
mg/d |
5.74 |
17.23 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44268 |
441 |
SS-Plcd3em4Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
13 |
|
|
56.8 |
mg/d |
8.54 |
30.8 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44284 |
441 |
SS-Agtr1aem1Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
9 |
|
|
52.39 |
mg/d |
12.72 |
38.17 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44311 |
441 |
SS-Stk39em2Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
10 |
|
|
16.55 |
mg/d |
3.54 |
11.19 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44308 |
441 |
SS-Agtrapem8Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
2 |
|
|
18.39 |
mg/d |
6.69 |
9.46 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
44305 |
441 |
SS-Cyp1a1em5Mcwi+/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.32 |
g |
0.02 |
0.03 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
- |
44327 |
441 |
Hsd:SD |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
-6.98 |
null |
0.11 |
0.4 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Dyets upon arrival at MCW. For rats received from Harlan |
57194 |
522 |
FHH-Adipoqm2Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
15 |
|
|
194.2 |
g |
3.74 |
14.48 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62900 |
528 |
SS-Cpt2m1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
2 |
|
|
-7.5 |
null |
0.05 |
0.06 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
62894 |
528 |
SS-Cpt2m1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
5 |
|
|
-7.68 |
null |
0.09 |
0.2 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
62889 |
528 |
SS/JrHsdMcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
-7.25 |
null |
0.1 |
0.22 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62886 |
528 |
SS-Sod3m1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
13 |
|
|
-8.1 |
null |
0.03 |
0.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
62897 |
528 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
3 |
|
|
150.33 |
g |
0.67 |
1.15 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62911 |
528 |
FHH-F10m1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
7 |
|
|
188.57 |
g |
4.12 |
10.89 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62919 |
528 |
FHH-Htr1am1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
13 |
|
|
180.77 |
g |
3.57 |
12.87 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62922 |
528 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
5 |
|
|
173.8 |
g |
4.47 |
9.99 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62916 |
528 |
BN-Lcatm3Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
6 |
|
|
158.83 |
g |
3.63 |
8.89 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
62941 |
528 |
FHH-Nr4a1m1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
4 |
|
|
1.19 |
E-7mole |
0.57 |
1.13 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63024 |
528 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
2 |
|
|
2.93 |
E-7mole |
0.91 |
1.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63032 |
528 |
FHH-Adipoqm3Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
5 |
|
|
3.67 |
E-7mole |
1.0 |
2.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63037 |
528 |
FHH-Slc8a2m1Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
15 |
|
|
1.12 |
E-7mole |
0.18 |
0.71 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63045 |
528 |
FHH-Htr1am1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
13 |
|
|
5.27 |
g/dl |
0.06 |
0.22 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61242 |
527 |
BN-Tgfbr2m1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
7 |
|
|
5.73 |
g/dl |
0.06 |
0.16 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61234 |
527 |
FHH-Procm1Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
10 |
|
|
5.27 |
g/dl |
0.1 |
0.3 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61248 |
527 |
FHH-F10m2Mcwi |
serum total protein level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
female |
70 days-84 days |
12 |
|
|
5.3 |
g/dl |
0.09 |
0.3 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61253 |
527 |
FHH-Adipoqm3Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
5 |
|
|
6.06 |
mmol/l |
0.49 |
1.09 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61343 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
4 |
|
|
4.0 |
mmol/l |
0.22 |
0.43 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61360 |
527 |
BN/NHsdMcwi |
serum potassium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
43 |
|
|
4.8 |
mmol/l |
0.09 |
0.62 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61357 |
527 |
FHH-Adipoqm2Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
70 days-84 days |
12 |
|
|
4.16 |
x 1000 cells/ul |
0.27 |
0.94 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61363 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
total white blood cell count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
70 days-84 days |
2 |
|
|
5.2 |
x 1000 cells/ul |
0.5 |
0.71 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61395 |
527 |
GH/OmrMcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
1.1 |
E-7mole |
0.23 |
0.65 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54598 |
522 |
LE/BluGill |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
14 |
|
|
-7.41 |
null |
0.09 |
0.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
54748 |
522 |
FHH-Chr 5BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
82.78 |
% |
2.73 |
8.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54759 |
522 |
FHH-Chr 15BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
86.44 |
% |
3.85 |
11.54 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54772 |
522 |
FHH-Chr 12BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
16 |
|
|
60.88 |
% |
4.67 |
18.66 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54770 |
522 |
SS-Chr 16BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
-8.96 |
null |
0.17 |
0.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56022 |
522 |
FHH-Chr 1BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
-8.5 |
null |
0.12 |
0.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56032 |
522 |
SS-Chr 5BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
7 |
|
|
-7.35 |
null |
0.08 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56112 |
522 |
FHH-Chr 13BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
12 |
|
|
-8.2 |
null |
0.09 |
0.31 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56131 |
522 |
FHH-Chr 20BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
-7.77 |
null |
0.08 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56134 |
522 |
FHH-Chr 9BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
-8.39 |
null |
0.17 |
0.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56169 |
522 |
FHH/EurMcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
100.0 |
% |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56200 |
522 |
F344-Plcb3Tn(sb-T2/Bart3)2.69Mcwi |
serum chloride level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood chloride amount |
male |
70 days-84 days |
1 |
|
|
104.0 |
mmol/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62329 |
527 |
FHH-Adipoqm1Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
8 |
|
|
65.0 |
mg/dl |
2.52 |
7.13 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62356 |
527 |
FHH-Tgfbr2m2Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
11 |
|
|
62.0 |
mg/dl |
2.08 |
6.88 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62364 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
2 |
|
|
73.0 |
mg/dl |
12.0 |
16.97 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62389 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
4 |
|
|
74.5 |
mg/dl |
7.1 |
14.2 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62394 |
527 |
FHH-Ghsrm1Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
70 days-84 days |
15 |
|
|
61.67 |
mg/dl |
1.43 |
5.52 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62405 |
527 |
BN-Lcatm3Mcwi |
serum total cholesterol level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
70 days-84 days |
2 |
|
|
38.5 |
mg/dl |
1.5 |
2.12 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62400 |
527 |
SS-Cpt2m1Mcwi |
serum total protein level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood total protein amount |
male |
70 days-84 days |
6 |
|
|
5.78 |
g/dl |
0.08 |
0.19 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62438 |
527 |
SS-Cpt2m1Mcwi |
serum total bilirubin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
1 |
|
|
0.1 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62433 |
527 |
FHH-Adipoqm2Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
12 |
|
|
129.58 |
mg/dl |
10.37 |
35.91 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62449 |
527 |
FHH-Slc8a2m1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
12 |
|
|
122.0 |
mg/dl |
11.39 |
39.45 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62460 |
527 |
FHH-Nr0b2m1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
male |
70 days-84 days |
10 |
|
|
157.5 |
mg/dl |
9.05 |
28.62 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62463 |
527 |
F344-Plce1Tn(sb-T2/Bart3)2.146Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
5 |
|
|
137.6 |
mg/dl |
6.83 |
15.27 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62466 |
527 |
FHH-Ccr2m1Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
5 |
|
|
111.2 |
mg/dl |
14.76 |
33.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62468 |
527 |
FHH-Chr 11BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
75.22 |
% |
6.93 |
20.79 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54827 |
522 |
SS-Chr 4BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
10 |
|
|
79.2 |
% |
5.69 |
17.99 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54833 |
522 |
SS.BN-(D8Rat163-D8Rat81)/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
49.44 |
% |
5.26 |
15.77 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54838 |
522 |
BN/NHsdMcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
20 |
|
|
66.8 |
% |
3.88 |
17.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54841 |
522 |
FHH-Chr 1BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
18 |
|
|
41.5 |
% |
5.45 |
23.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54846 |
522 |
SS-Chr 18BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
8 |
|
|
29.13 |
% |
2.86 |
8.08 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54852 |
522 |
FHH/EurMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
33.6 |
% |
6.45 |
20.39 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54855 |
522 |
SHR/NCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
10 |
|
|
6.4 |
% |
3.45 |
10.9 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
54857 |
522 |
SS.BN-(D12Arb13-D12Rat79)/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
0.07 |
umol/l |
0.02 |
0.06 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54890 |
522 |
FHH-Chr 17BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54909 |
522 |
FHH-Chr 19BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
0.09 |
umol/l |
0.08 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54926 |
522 |
SS-Chr 13BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54940 |
522 |
FHH-Chr 4BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.02 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54950 |
522 |
FHH-Chr 11BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.01 |
umol/l |
0.0 |
0.0 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
54953 |
522 |
FHH/EurMcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
6 |
|
|
0.03 |
10E-7mol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Dyets |
56266 |
522 |
FHH/EurMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
5 |
|
|
32.2 |
% |
9.09 |
20.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56271 |
522 |
SS-Chr 16BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
30.44 |
% |
4.21 |
12.63 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56277 |
522 |
BN/NHsdMcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
6 |
|
|
54.5 |
% |
9.09 |
22.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56296 |
522 |
SS-Chr 2BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
15 |
|
|
34.6 |
% |
4.62 |
17.89 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56293 |
522 |
FHH-Chr 12BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
7 |
|
|
99.14 |
% |
0.7 |
1.86 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56313 |
522 |
GH/OmrMcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
5 |
|
|
99.2 |
% |
0.58 |
1.3 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56323 |
522 |
SS/JrHsdMcwi |
heart wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
47 |
|
|
1.13 |
g |
0.02 |
0.14 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63226 |
529 |
SS-Cpt2m1Mcwi |
body weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
body mass |
male |
70 days-84 days |
7 |
|
|
312.57 |
g |
2.61 |
6.9 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63235 |
529 |
SS-Klf4m3Mcwi |
heart right ventricle wet weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen General data |
heart right ventricle mass |
male |
70 days-84 days |
9 |
|
|
0.21 |
g |
0.01 |
0.02 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63249 |
529 |
SS-Hexim2em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.0 |
mmHg |
1.0 |
1.41 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43480 |
421 |
SS-Wdr72em2Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
7 |
|
|
126.17 |
mg/d |
17.74 |
46.93 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43509 |
421 |
SS-Hexim2em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
331.0 |
beats/min |
9.0 |
12.73 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43528 |
421 |
SS-Rasgrp3em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
10 |
|
|
336.4 |
beats/min |
12.53 |
39.62 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43523 |
421 |
SS-Hexim2em4Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
10.16 |
mg/d |
0.21 |
0.36 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43560 |
421 |
SS-Wdr72em2Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
8 |
|
|
7.72 |
mEq/d |
1.06 |
2.98 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43568 |
421 |
SS-Wdr72em2Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
7 |
|
|
10.72 |
mEq/d |
0.75 |
1.99 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43573 |
421 |
SS-Hexim2em4Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
7.24 |
mEq/d |
2.13 |
3.69 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43576 |
421 |
SS-Wdr72em2Mcwi-/- |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
7 |
|
|
6.96 |
mg/d |
1.24 |
3.28 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43584 |
421 |
SS-Wdr72em2Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.31 |
g |
0.03 |
0.08 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
43600 |
421 |
FHH-Tgfbr2m2Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
13 |
|
|
0.09 |
x 1000 cells/ul |
0.02 |
0.07 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61672 |
527 |
FHH-Htr1am1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
21 |
|
|
0.23 |
x 1000 cells/ul |
0.03 |
0.16 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61702 |
527 |
FHH-F10m2Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
16 |
|
|
0.19 |
x 1000 cells/ul |
0.04 |
0.14 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61696 |
527 |
FHH-Nr4a1m1Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
11 |
|
|
0.12 |
x 1000 cells/ul |
0.03 |
0.11 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61707 |
527 |
FHH/EurMcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
female |
70 days-84 days |
25 |
|
|
0.2 |
x 1000 cells/ul |
0.03 |
0.15 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61713 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
6 |
|
|
0.12 |
x 1000 cells/ul |
0.02 |
0.05 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61721 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
blood monocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
monocyte quantity |
male |
70 days-84 days |
4 |
|
|
0.16 |
x 1000 cells/ul |
0.02 |
0.03 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
61740 |
527 |
FHH-Ghsrm1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
10 |
|
|
0.95 |
g |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63378 |
529 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
2 |
|
|
0.57 |
g |
0.01 |
0.01 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63397 |
529 |
FHH-Adra1am1Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
9 |
|
|
0.91 |
g |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63394 |
529 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
kidney mass |
female |
70 days-84 days |
2 |
|
|
0.61 |
g |
0.0 |
0.0 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63400 |
529 |
FHH-Htr1am1Mcwi |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
heart mass |
male |
70 days-84 days |
22 |
|
|
0.95 |
g |
0.01 |
0.06 |
digital scale post excision weight measurement |
|
|
|
0 |
|
|
|
|
63441 |
529 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
7 |
|
|
23.64 |
cm |
0.39 |
1.03 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63507 |
529 |
FHH-Adipoqm1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
8 |
|
|
24.81 |
cm |
0.28 |
0.8 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63518 |
529 |
FHH-Ccr2m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
7 |
|
|
21.71 |
cm |
0.21 |
0.57 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63521 |
529 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
female |
70 days-84 days |
8 |
|
|
19.88 |
cm |
0.21 |
0.58 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63532 |
529 |
F344-Myo9aTn(sb-T2/Bart3)2.186Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
1 |
|
|
21.0 |
cm |
|
|
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63540 |
529 |
FHH-Slc8a2m1Mcwi |
body length, nose to rump |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body length |
male |
70 days-84 days |
15 |
|
|
24.2 |
cm |
0.14 |
0.53 |
in vivo ruler method |
|
|
|
0 |
|
|
|
|
63562 |
529 |
FHH-Lcatm1Mcwi |
body weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen General data |
body mass |
female |
70 days-84 days |
15 |
|
|
180.2 |
g |
4.47 |
17.32 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63594 |
529 |
SS-Adra2aem1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
6 |
|
|
358.83 |
beats/min |
9.8 |
24.0 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43675 |
421 |
SS-Ulk3em4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
15 |
|
|
379.53 |
beats/min |
4.76 |
18.45 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43683 |
421 |
SS-Ghsrm3Mcwi |
serum potassium level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
2 |
|
|
3.55 |
mmol/l |
0.15 |
0.21 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61751 |
527 |
SS-Klf4m3Mcwi |
serum potassium level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood potassium amount |
male |
70 days-84 days |
8 |
|
|
4.38 |
mmol/l |
0.29 |
0.82 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61756 |
527 |
SS-Cpt2m1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
6 |
|
|
31.5 |
mg/dl |
1.89 |
4.64 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61762 |
527 |
SS-Sod3m1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
10 |
|
|
25.5 |
mg/dl |
1.81 |
5.72 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61764 |
527 |
SS-Cpt2m1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
1 |
|
|
44.0 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61767 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
male |
70 days-84 days |
1 |
|
|
144.0 |
mmol/l |
|
|
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61775 |
527 |
FHH-Agtr1bm1Mcwi |
serum sodium level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood sodium amount |
female |
70 days-84 days |
14 |
|
|
140.21 |
mmol/l |
0.5 |
1.89 |
flame atomic emission spectrometry |
|
|
|
0 |
|
|
|
|
61786 |
527 |
LE/BluGill |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
14 |
|
|
29.36 |
% |
3.99 |
14.92 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
55006 |
522 |
SS-Chr 6BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
8 |
|
|
24.25 |
% |
4.97 |
14.05 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
55080 |
522 |
FHH-Chr 6BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
9 |
|
|
1.15 |
g/mg |
0.15 |
0.45 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57315 |
522 |
FHH-Chr 10BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.93 |
g/mg |
0.11 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57342 |
522 |
FHH-Chr 8BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
1.06 |
g/mg |
0.13 |
0.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57345 |
522 |
SS-Chr 20BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
1.48 |
g/mg |
0.05 |
0.15 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57364 |
522 |
SS-Chr 13BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
15 |
|
|
0.87 |
g/mg |
0.1 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57359 |
522 |
SS-Chr 11BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
10 |
|
|
0.81 |
g/mg |
0.07 |
0.21 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57372 |
522 |
FHH-Chr YBN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
11 |
|
|
0.79 |
g/mg |
0.08 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57370 |
522 |
SS-Chr XBN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
10 |
|
|
1.27 |
g/mg |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
57375 |
522 |
FHH-Chr 12BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
12 |
|
|
1.57 |
E-7mole |
0.18 |
0.63 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56494 |
522 |
FHH-Chr 2BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
1.57 |
E-7mole |
0.17 |
0.5 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56514 |
522 |
SS-Chr 16BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
11 |
|
|
2.8 |
E-7mole |
1.24 |
4.11 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56541 |
522 |
SS-Chr 3BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
9 |
|
|
1.53 |
E-7mole |
0.22 |
0.66 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56544 |
522 |
FHH-Chr 13BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
9 |
|
|
1.23 |
E-7mole |
0.17 |
0.51 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms and pups used in studies were fed Teklad |
56546 |
522 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
7 |
|
|
-8.19 |
null |
0.16 |
0.41 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63104 |
528 |
FHH-Adra1am1Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
-7.78 |
null |
0.12 |
0.34 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63109 |
528 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
-8.03 |
null |
0.07 |
0.16 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63120 |
528 |
BN/NHsdMcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
5 |
|
|
-8.13 |
null |
0.03 |
0.07 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
EC50 value is moles/liter |
|
63123 |
528 |
FHH-Ccr2m1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
6 |
|
|
1.66 |
g/mg |
0.13 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63145 |
528 |
FHH-Adra1am1Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 14 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70 days-84 days |
8 |
|
|
1.33 |
g/mg |
0.11 |
0.32 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63178 |
528 |
SS-Cpt2m1Mcwi |
body weight |
controlled sodium content diet (1 %) (for 14 days) |
PhysGen Vascular data |
body mass |
female |
70 days-84 days |
2 |
|
|
199.5 |
g |
5.5 |
7.78 |
whole body digital scale |
|
|
|
0 |
|
|
|
|
63200 |
528 |
SS-Ghsrm3Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (1 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
1 |
|
|
2.56 |
E-7mole |
|
|
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
63214 |
528 |
WKY/NCrl |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70 days-84 days |
9 |
|
|
0.04 |
umol/l |
0.01 |
0.02 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
57432 |
522 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
7 |
|
|
4.1 |
x 1000 cells/ul |
0.41 |
1.09 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62090 |
527 |
FHH-Tlr4m1Mcwi |
blood lymphocyte count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
70 days-84 days |
7 |
|
|
3.55 |
x 1000 cells/ul |
0.38 |
1.0 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62106 |
527 |
BN-Tgfbr2m1Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
7 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62136 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
70 days-84 days |
2 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62153 |
527 |
FHH-F10m2Mcwi |
serum total bilirubin level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
70 days-84 days |
12 |
|
|
0.18 |
mg/dl |
0.01 |
0.05 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62155 |
527 |
F344/NHsd |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
7 |
|
|
0.03 |
x 1000 cells/ul |
0.02 |
0.04 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62227 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
4 |
|
|
0.05 |
x 1000 cells/ul |
0.02 |
0.05 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62240 |
527 |
FHH-F10m1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
10 |
|
|
0.06 |
x 1000 cells/ul |
0.02 |
0.06 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62238 |
527 |
FHH-Ghsrm1Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
9 |
|
|
0.08 |
x 1000 cells/ul |
0.03 |
0.08 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62243 |
527 |
BN-Lcatm3Mcwi |
blood eosinophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
70 days-84 days |
2 |
|
|
0.17 |
x 1000 cells/ul |
0.17 |
0.24 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
62246 |
527 |
SS-Wdr72em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
342.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43721 |
441 |
SS-Plekha7em1Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
9 |
|
|
366.0 |
beats/min |
7.74 |
23.21 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43731 |
441 |
SS-Slc30a8em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
11 |
|
|
357.0 |
beats/min |
5.64 |
18.7 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43758 |
441 |
SS-Plcd3em7Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.78 |
mmHg |
4.69 |
14.06 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43801 |
441 |
SS-Plcd3em7Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
9 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
149.56 |
mmHg |
5.16 |
15.48 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43863 |
441 |
SS-Wdr72em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.0 |
mmHg |
3.0 |
4.24 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43871 |
441 |
SS-Cyp1a1em5Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
2 |
|
|
309.0 |
g |
16.0 |
22.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43895 |
441 |
SS-Cyp1a1em2Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
10 |
|
|
307.6 |
g |
5.1 |
16.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43892 |
441 |
SS-Nppaem4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.5 |
mmHg |
4.5 |
6.36 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
43884 |
441 |
SS-Cdh13em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
4 |
|
|
296.8 |
g |
12.8 |
25.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43900 |
441 |
SS-Ulk3em1Mcwi-/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
3 |
|
|
331.0 |
g |
13.1 |
22.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43903 |
441 |
SS-Tcf7l2em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
5 |
|
|
314.8 |
g |
7.0 |
15.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43905 |
441 |
SS-Wdr72em1Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
1 |
|
|
317.0 |
g |
|
|
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43908 |
441 |
SS-Cyp1a1em2Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
3 |
|
|
316.0 |
g |
13.5 |
23.4 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43911 |
441 |
F344/DuCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70 days-84 days |
18 |
|
|
58.44 |
% |
2.97 |
12.58 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56706 |
522 |
F344/DuCrl |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
18 |
|
|
53.28 |
% |
3.23 |
13.72 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
Moms were fed vendors standard diet, pups were fed Teklad upon arrival at MCW. For rats received from CRL and Harlan |
56711 |
522 |
SS.SR-(D13Mit9-D13Mit1)/Jr |
systolic blood pressure |
controlled sodium content diet (0.2 %) (for 10 days) then controlled sodium content diet (2 %) (between 41 and 44 days) |
Zhang QY, et al., Mamm Genome 1997 Sep;8(9):636-41 |
arterial blood pressure trait |
male |
81 days-84 days |
20 |
data obtained at three consistent sessions per day |
serial mean |
208.0 |
mmHg |
|
|
tail cuff plethysmography |
|
345600 |
|
0 |
|
|
|
|
65973 |
650 |
SS-Nox4em2Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.35 |
g |
0.05 |
0.12 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66244 |
717 |
SS-Ets1em1Mcwi-/+ |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
10 |
|
|
1.28 |
g |
0.07 |
0.22 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66247 |
717 |
F344-Elmod3Tn(sb-T2/Bart3)2.42Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
5 |
|
|
46.36 |
% |
0.45 |
1.01 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60630 |
527 |
F344-Brinp3Tn(sb-T2/Bart3)2.189Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
3 |
|
|
42.1 |
% |
1.48 |
2.57 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60646 |
527 |
FHH-Ccr2m1Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
70 days-84 days |
8 |
|
|
46.94 |
% |
1.66 |
4.7 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60652 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
4 |
|
|
45.23 |
% |
0.86 |
1.72 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60662 |
527 |
BN-Lcatm3Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
2 |
|
|
44.5 |
% |
0.4 |
0.57 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60668 |
527 |
FHH-Adipoqm3Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
6 |
|
|
42.88 |
% |
0.61 |
1.49 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60676 |
527 |
F344-Erbb4Tn(sb-T2/Bart3)2.208Mcwi |
hematocrit |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
70 days-84 days |
2 |
|
|
44.4 |
% |
0.4 |
0.57 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60687 |
527 |
SS-Cpt2m1Mcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
1 |
|
|
41.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60701 |
527 |
SS/JrHsdMcwi |
serum alkaline phosphatase activity level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
70 days-84 days |
17 |
|
|
56.53 |
U/l |
2.15 |
8.85 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60703 |
527 |
SS/JrHsdMcwi |
serum albumin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
male |
70 days-84 days |
41 |
|
|
3.4 |
g/dl |
0.06 |
0.37 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60717 |
527 |
SS-Klf4m3Mcwi |
serum albumin level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood albumin amount |
male |
70 days-84 days |
8 |
|
|
3.36 |
g/dl |
0.11 |
0.31 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60720 |
527 |
SS-Sod3m1Mcwi |
serum phosphate level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
10 |
|
|
9.0 |
mg/dl |
0.4 |
1.26 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60728 |
527 |
SS-Cpt2m1Mcwi |
serum phosphate level |
controlled sodium content diet (1 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
1 |
|
|
6.0 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60731 |
527 |
FHH-Adipoqm1Mcwi |
mean corpuscular volume |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
70 days-84 days |
9 |
|
|
54.91 |
fl |
0.57 |
1.72 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60736 |
527 |
FHH-Adipoqm1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
9 |
|
|
20.0 |
mg/dl |
2.58 |
7.75 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60142 |
527 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
4 |
|
|
19.75 |
mg/dl |
3.15 |
6.29 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60180 |
527 |
FHH-Ghsrm1Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
70 days-84 days |
15 |
|
|
17.07 |
mg/dl |
0.49 |
1.91 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60191 |
527 |
BN-Lcatm3Mcwi |
serum urea nitrogen level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
70 days-84 days |
2 |
|
|
28.0 |
mg/dl |
2.0 |
2.83 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
60186 |
527 |
FHH-Tgfbr2m2Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
14 |
|
|
46.14 |
U/l |
5.21 |
19.49 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61442 |
527 |
FHH-Lcatm1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
15 |
|
|
45.27 |
U/l |
8.34 |
32.3 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61445 |
527 |
BN-Tgfbr2m1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
3 |
|
|
37.67 |
U/l |
4.18 |
7.23 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61439 |
527 |
FHH-Ccr2m1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
8 |
|
|
50.63 |
U/l |
3.33 |
9.43 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61462 |
527 |
F344-Lims1Tn(sb-T2/Bart3)2.169Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
2 |
|
|
64.5 |
U/l |
22.5 |
31.82 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61467 |
527 |
BN-Lcatm3Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
2 |
|
|
106.5 |
U/l |
38.5 |
54.45 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61478 |
527 |
BN-Lcatm3Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
1 |
|
|
74.0 |
U/l |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61481 |
527 |
FHH-Adipoqm3Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
70 days-84 days |
6 |
|
|
41.83 |
U/l |
2.2 |
5.38 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61486 |
527 |
FHH-Tlr4m1Mcwi |
serum alanine aminotransferase activity level |
controlled sodium content diet (4 %) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
70 days-84 days |
7 |
|
|
50.14 |
U/l |
5.75 |
15.21 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61492 |
527 |
SS-Gpr183em3Mcwi-/- |
right kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.61 |
g |
0.07 |
0.19 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66257 |
717 |
SS-Nckap5em1Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
7 |
|
|
317.7 |
g |
10.6 |
28.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66276 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
5 |
|
|
279.4 |
g |
5.2 |
11.7 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66265 |
717 |
SS-Cybaem1Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
6 |
|
|
297.2 |
g |
8.7 |
21.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
66289 |
717 |
SS-Ulk4em3Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
396.5 |
beats/min |
6.99 |
13.99 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66332 |
717 |
SS-Acad10em2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
12 |
|
|
360.67 |
beats/min |
11.6 |
40.2 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66334 |
717 |
SS-Tgfb1em3Mcwi+/- |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
336.67 |
beats/min |
19.32 |
33.47 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66337 |
717 |
WKY/Bbb |
systolic blood pressure |
controlled sodium content diet |
Kreutz R, et al., Proc Natl Acad Sci U S A 1995 Sep 12;92(19):8778-82 |
arterial blood pressure trait |
not specified |
0 days
| 8 |
|
|
124.8 |
mmHg |
1.1 |
3.1 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
67196 |
116 |
SS.SR-(D3Arb14-D3Mco36)(D7Mco19-D7Mco7)/Mco |
heart wet weight |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 0 and 672 hours) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart mass |
male |
114 days-118 days |
6 |
|
|
1.78 |
g |
0.05 |
0.12 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65131 |
283 |
SS.LEW-(D7Rat73-D7Rat128)/Ayd |
mean arterial blood pressure |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (between 31 and 49 days) |
Crespo K, et al., J Hypertens. 2011 Mar;29(3):460-5. |
arterial blood pressure trait |
male |
66 days-73 days |
6 |
|
|
138.0 |
mmHg |
3.0 |
7.35 |
intra-aortic abdominal radiotelemetry |
|
0 |
|
0 |
|
|
|
|
65148 |
563 |
SS.SR-(D7Mco19-D7Mco7)/Jr |
heart weight to body weight ratio |
controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 0 and 672 hours) then controlled sodium content diet (4 %) (between 46 and 48 days) |
Cicila GT, et al., Hypertension. 2009 Apr;53(4):725-32. Epub 2009 Mar 2. |
heart mass |
male |
114 days-118 days |
3 |
|
|
5.09 |
g/kg |
0.4 |
0.69 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
65136 |
283 |
FHH-Ghsrm1Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
9 |
|
|
7.63 |
mg/dl |
0.3 |
0.9 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61567 |
527 |
BN-Lcatm3Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
1 |
|
|
6.7 |
mg/dl |
|
|
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61573 |
527 |
BN-Lcatm3Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
70 days-84 days |
2 |
|
|
6.85 |
mg/dl |
0.25 |
0.35 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61570 |
527 |
FHH-Tgfbr2m2Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
10 |
|
|
16.0 |
mmol/l |
0.83 |
2.62 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61606 |
527 |
F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
serum phosphate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
70 days-84 days |
5 |
|
|
7.58 |
mg/dl |
0.35 |
0.79 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61595 |
527 |
FHH-Procm1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
70 days-84 days |
10 |
|
|
13.3 |
mmol/l |
1.37 |
4.35 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61628 |
527 |
FHH-Ghsrm1Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
9 |
|
|
16.56 |
mmol/l |
0.63 |
1.88 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61639 |
527 |
F344-Fam19a2Tn(sb-T2/Bart3)2.184Mcwi |
serum bicarbonate level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
70 days-84 days |
2 |
|
|
23.0 |
mmol/l |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
61644 |
527 |
SS-Plekha7em4Mcwi-/- |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
13 |
|
|
309.6 |
g |
6.8 |
24.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43915 |
441 |
SS-Mstnem3Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
8 |
|
|
332.6 |
g |
2.2 |
6.2 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43924 |
441 |
SS-Aldh2em2Mcwi+/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
6 |
|
|
321.0 |
g |
4.8 |
11.8 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43927 |
441 |
SS-Tcf7l2em1Mcwi-/+ |
body weight |
controlled sodium content diet (4 %) (for 10 days) |
PhysGen Knockout data |
body mass |
male |
70 days-77 days |
2 |
|
|
339.5 |
g |
7.5 |
10.6 |
whole body digital scale |
|
|
|
0 |
|
|
|
- |
43937 |
441 |
SS-Stk39em2Mcwi+/+ |
urine total protein excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
total urine protein amount |
male |
70 days-77 days |
6 |
|
|
72.2 |
mg/d |
11.68 |
28.62 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
43953 |
441 |
SS-Slc30a8em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
341.5 |
beats/min |
14.87 |
29.74 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44024 |
441 |
SS-Mstnem3Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
1 |
|
|
377.0 |
beats/min |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44035 |
441 |
SS-Nppbem4Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
8 |
|
|
352.51 |
beats/min |
9.93 |
28.1 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44043 |
441 |
SS-Nppbem2Mcwi-/- |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
15 |
|
|
347.06 |
beats/min |
5.71 |
22.11 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44062 |
441 |
SS-Nppaem4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
343.5 |
beats/min |
9.5 |
13.44 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44070 |
441 |
SS-Plcd3em4Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
3 |
|
|
333.33 |
beats/min |
7.54 |
13.05 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44072 |
441 |
SS-Kcnq1em14Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
132.43 |
mmHg |
5.57 |
14.73 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44078 |
441 |
SS-Cyp1a1em5Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
129.5 |
mmHg |
6.5 |
9.19 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44080 |
441 |
SS-Prokr1em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
7 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
139.29 |
mmHg |
7.31 |
19.34 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44102 |
441 |
SS-Aldh2em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
154.5 |
mmHg |
11.34 |
27.78 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44112 |
441 |
SS-Wdr72em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
130.5 |
mmHg |
0.5 |
0.71 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
44118 |
441 |
SS-Ncf2em1Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
4 |
|
|
335.75 |
beats/min |
14.86 |
29.73 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66345 |
717 |
SS-Cybaem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
140.5 |
mmHg |
24.5 |
34.65 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66433 |
717 |
SS-Renem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 13 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
128.6 |
mmHg |
7.0 |
15.65 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66436 |
717 |
SS-Mthfrem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
/3 systolic pressure + 2/3 diastolic pressure |
|
151.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66455 |
717 |
SS-Ulk4em3Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
/3 systolic pressure + 2/3 diastolic pressure |
|
174.25 |
mmHg |
19.31 |
38.62 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66452 |
717 |
SS-Gpr183em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
8 |
/3 systolic pressure + 2/3 diastolic pressure |
|
151.5 |
mmHg |
7.87 |
22.26 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66460 |
717 |
SS-Nckap5em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
/3 systolic pressure + 2/3 diastolic pressure |
|
146.0 |
mmHg |
5.34 |
13.08 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66463 |
717 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 70 days) then controlled sodium content diet (8 %) (for 21 days) |
Hoffman MJ, et al., Hypertension. 2013 Sep;62(3):557-63. doi: 10.1161/HYPERTENSIONAHA.113.01708. Epub 2013 Jul 1. |
arterial blood pressure trait |
male |
91 days
| 12 |
|
serial mean |
182.0 |
mmHg |
6.0 |
20.78 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
0 |
|
|
|
|
98699 |
2141 |
F344-DccTn(sb-T2/Bart3)2.205Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
4 |
|
|
138.25 |
mg/dl |
24.59 |
49.18 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62486 |
527 |
F344-Stxbp5lTn(sb-T2/Bart3)2.202Mcwi |
serum glucose level |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
blood glucose amount |
female |
70 days-84 days |
2 |
|
|
171.5 |
mg/dl |
19.5 |
27.58 |
standard blood chemistry panel |
|
|
|
0 |
|
|
|
|
62508 |
527 |
FHH-Adipoqm2Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 14 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70 days-84 days |
15 |
|
|
66.87 |
% |
6.37 |
24.67 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
0 |
|
|
|
|
62590 |
528 |
SS-Klf4m3Mcwi |
blood eosinophil count |
controlled sodium content diet (1 %) (for 14 days) then fasting (between 16 and 1 hours) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
70 days-84 days |
8 |
|
|
0.1 |
x 1000 cells/ul |
0.04 |
0.1 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60822 |
527 |
F344-Trpc4Tn(sb-T2/Bart3)2.192Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
70 days-84 days |
2 |
|
|
0.56 |
x 1000 cells/ul |
0.07 |
0.09 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60838 |
527 |
FHH-Lcatm1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
70 days-84 days |
13 |
|
|
0.96 |
x 1000 cells/ul |
0.11 |
0.39 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60832 |
527 |
FHH-Agtr1bm1Mcwi |
blood neutrophil count |
controlled sodium content diet (4 %) (for 14 days) then fasting (for 16 hours) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
70 days-84 days |
15 |
|
|
1.21 |
x 1000 cells/ul |
0.09 |
0.33 |
automated blood cell counting method |
|
|
|
0 |
|
|
|
|
60835 |
527 |
SS/NEisSlc |
body weight |
controlled sodium content diet (8 %) (for 42 days) then 0.9% sodium chloride solution (0.3 ml) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
body mass |
male |
91 days
| 12 |
|
|
347.6 |
g |
6.85 |
23.73 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
100696 |
2519 |
SS/NEisSlc |
kidney weight |
controlled sodium content diet (0.3 %) (for 49 days) then controlled sodium content diet (8 %) (for 42 days) then cilazapril (10 mg/kg/d) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
kidney mass |
male |
91 days
| 6 |
|
|
1.38 |
g |
0.04 |
0.1 |
post excision weight measurement |
|
0.0 |
|
0 |
|
|
|
|
100704 |
2519 |
SS-Renem1Mcwi-/- |
timed urine volume |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
urine output |
male |
56 days
| 8 |
|
|
22.19 |
ml/d |
1.98 |
5.6 |
metabolic cage urine volume measurement method |
|
0.0 |
|
0 |
|
|
|
|
98315 |
2038 |
SS-Renem1Mcwi+/- |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
urine sodium amount |
male |
56 days
| 9 |
|
|
0.81 |
mEq/d |
0.08 |
0.24 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
98326 |
2038 |
SS-Renem1Mcwi+/- |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 35 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
total urine protein amount |
female |
56 days
| 9 |
|
|
55.45 |
mg/d |
5.64 |
16.92 |
urine total protein analysis |
|
0.0 |
|
0 |
|
|
|
|
98323 |
2038 |
SS-Renem1Mcwi-/- |
creatinine clearance to total kidney weight ratio |
controlled sodium content diet (0.4 %) (for 42 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
glomerular filtration trait |
female |
63 days
| 4 |
|
|
0.3 |
ml/min/g |
0.03 |
0.06 |
unspecified method |
|
0.0 |
|
0 |
|
|
|
|
98354 |
2038 |
SS/Jr |
heart rate |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 28 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
heart pumping trait |
male |
68 days-70 days |
8 |
|
serial mean |
397.0 |
beats/min |
9.01 |
25.48 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97979 |
1958 |
SS.BN-(D12Hmgc7-D12Hmgc6)/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (1 %) (between 42 and 49 days) |
Prisco SZ, et al., Hypertension. 2014 Jul 7. pii: HYPERTENSIONAHA.114.03550. |
arterial blood pressure trait |
male |
71 days-77 days |
6 |
|
|
110.0 |
mmHg |
1.0 |
2.45 |
intra-aortic abdominal radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
96806 |
1698 |
F344-Hsd11b2em1Jmul+/+ |
urine potassium level |
controlled sodium content diet (0.3 %) then controlled sodium content diet (3 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine potassium amount |
male |
168 days
| 4 |
|
|
1794.3 |
mmol/l |
174.4 |
348.8 |
urine potassium analysis |
|
0.0 |
|
0 |
|
|
|
|
105029 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
urine sodium level |
controlled sodium content diet (0.3 %) then controlled sodium content diet (3 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine sodium amount |
male |
168 days
| 4 |
|
|
17145.0 |
mmol/l |
2162.0 |
4324.0 |
urine sodium analysis |
|
0.0 |
|
0 |
|
|
|
|
105023 |
3008 |
F344-Hsd11b2em1Jmul+/+ |
urine sodium level to urine potassium level ratio |
controlled sodium content diet (0.3 %) then controlled sodium content diet (3 %) (between 7 and 10 days) |
Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. |
urine sodium amount |
male |
168 days
| 4 |
|
|
9.56 |
null |
0.54 |
1.08 |
urine electrolyte analysis |
|
0.0 |
|
0 |
|
|
|
|
105035 |
3008 |
SHR-Ndufc2em2Mcwi+/+ |
urine total protein excretion rate |
controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) |
Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. |
total urine protein amount |
not specified |
98 days
| 12 |
|
|
47.0 |
mg/d |
7.51 |
26.0 |
urine analysis |
|
0.0 |
|
0 |
|
|
|
|
97940 |
1938 |
SS-Plekha7em4Mcwi-/- |
renal cortex volume |
controlled sodium content diet (8 %) (for 28 days) |
Endres BT, et al., Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18. |
kidney cortex morphology trait |
male |
91 days
| 10 |
|
|
406.0 |
mm3 |
85.0 |
268.79 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
|
0 |
|
|
|
|
105749 |
3022 |
SR/NEisSlc |
percent change in mean arterial blood pressure |
controlled sodium content diet (0.3 %) (for 28 days) then tempol (4 mol/l) (between 0 and 0 hours) |
Fujita M, et al., Hypertension. 2007 Aug;50(2):360-7. Epub 2007 Jun 18. |
arterial blood pressure trait |
male |
63 days-70 days |
7 |
|
|
-14.1 |
% |
3.2 |
8.47 |
vascular fluid filled catheter |
|
0.0 |
|
0 |
|
|
|
|
102378 |
2687 |
SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
44 days-53 days |
11 |
|
serial mean |
122.0 |
mmHg |
2.0 |
6.63 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-P |
|
98482 |
2079 |
SS.BN-(D13Got42-D13Hmgc497)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
heart pumping trait |
male |
60 days-67 days |
7 |
|
serial mean |
372.0 |
beats/min |
11.0 |
29.1 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
intra-carotid radiotelemetry |
|
98615 |
2098 |
SS.BN-(D13Mit5-D13Rat32)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
heart pumping trait |
male |
60 days-67 days |
14 |
|
serial mean |
399.0 |
beats/min |
12.0 |
44.9 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
intra-carotid radiotelemetry |
|
98618 |
2098 |
SR/NEisSlc |
serum urea nitrogen level |
controlled sodium content diet (0.3 %) (for 91 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood urea nitrogen amount |
male |
91 days
| 6 |
|
|
19.2 |
mg/dl |
1.22 |
2.99 |
serum urea nitrogen analysis |
|
0.0 |
|
0 |
|
|
|
|
100674 |
2519 |
SS/NEisSlc |
serum creatinine level |
controlled sodium content diet (8 %) (for 42 days) then 0.9% sodium chloride solution (0.3 ml) (for 42 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood creatinine amount |
male |
91 days
| 12 |
|
|
0.73 |
mg/dl |
0.05 |
0.18 |
automated blood creatinine analysis |
|
0.0 |
|
0 |
|
|
|
|
100677 |
2519 |
SS-Mthfrem1Mcwi-/+ |
heart rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
heart pumping trait |
male |
58 days-67 days |
0 |
|
serial mean |
330.0 |
beats/min |
12.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98422 |
2059 |
SS-Mthfrem1Mcwi-/+ |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
|
serial mean |
152.0 |
mmHg |
6.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98415 |
2059 |
SS |
body weight |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
body mass |
male |
126 days
| 6 |
|
|
323.0 |
g |
5.72 |
14.0 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
103300 |
2803 |
SR |
heart left ventricle end-systolic diameter |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days) |
Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. |
heart left ventricle end-systolic diameter |
male |
126 days
| 6 |
|
|
4.9 |
mm |
0.2 |
0.5 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
103315 |
2803 |
SS/Jr |
mean arterial blood pressure |
controlled sodium content diet (0.3 %) (for 12 days) then controlled sodium content diet (2 %) (for 24 days) |
Nie Y, et al., Physiol Genomics. 2016 Jun;48(6):409-19. doi: 10.1152/physiolgenomics.00004.2016. Epub 2016 Apr 25. |
arterial blood pressure trait |
male |
68 days-70 days |
6 |
|
serial mean |
175.0 |
mmHg |
3.75 |
9.19 |
radiotelemetry |
|
0.0 |
|
0 |
|
|
|
|
97991 |
1958 |
SS |
conduction velocity |
controlled sodium content diet (6 %) (between 56 and 70 days) then pentobarbital (50 mg/kg) |
Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. |
heart electrical impulse conduction trait |
male |
98 days-132 days |
7 |
|
|
50.0 |
cm/min |
4.54 |
12.0 |
electrocardiography |
|
0.0 |
|
0 |
|
|
conduction velocity |
|
103391 |
2804 |
SR/Hsd |
plasma osmolality |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
|
301.3 |
umol/g |
4.4 |
10.78 |
osmometry |
|
0.0 |
|
0 |
|
|
|
|
102240 |
2682 |
SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
heart pumping trait |
male |
44 days-53 days |
11 |
|
serial mean |
395.0 |
beats/min |
5.0 |
16.58 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-O |
|
98516 |
2079 |
SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi |
heart rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
heart pumping trait |
male |
58 days-67 days |
11 |
|
serial mean |
366.0 |
beats/min |
6.0 |
19.9 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
strain 26-O |
|
98523 |
2079 |
SS-Clcn6em2Mcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
|
serial mean |
101.0 |
mmHg |
1.0 |
|
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98407 |
2059 |
SS/JrHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
14 |
|
serial mean |
185.0 |
mmHg |
5.0 |
18.71 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
|
|
98500 |
2079 |
SS/JrHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
arterial blood pressure trait |
male |
58 days-67 days |
14 |
|
serial mean |
141.0 |
mmHg |
4.0 |
14.97 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
carotid a. to thoracic aorta implant |
|
|
98507 |
2079 |
SR/NEisSlc |
body weight |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
body mass |
male |
126 days
| 8 |
|
|
449.0 |
g |
6.0 |
16.97 |
body weighing method |
|
0.0 |
|
0 |
|
|
|
|
102310 |
2684 |
SR/NEisSlc |
heart left ventricle fractional shortening |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
heart left ventricle end-diastolic diameter |
male |
126 days
| 8 |
|
|
52.6 |
% |
0.7 |
1.98 |
transthoracic echocardiography |
|
0.0 |
|
0 |
|
|
|
|
102316 |
2684 |
SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 20 and 29 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
41 days-50 days |
10 |
|
|
4.1 |
mg/d |
1.2 |
3.79 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-R |
|
98533 |
2079 |
SS-Renem1Mcwi+/+ |
heart rate |
controlled sodium content diet (0.4 %) (between 66 and 69 days) |
Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. |
heart pumping trait |
female |
66 days-69 days |
7 |
|
serial mean |
386.01 |
beats/min |
5.71 |
15.11 |
intra-aortic abdominal radiotelemetry |
|
32400.0 |
|
0 |
|
|
|
|
98394 |
2038 |
SS.BN-(D13Got42-D13Hmgc497)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
7 |
|
serial mean |
150.0 |
mmHg |
6.0 |
15.87 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-E |
|
98572 |
2098 |
SR/JrIpcv |
plasma triglyceride level |
controlled sodium content diet (0.3 %) |
Hojn¿ S, et al., Physiol Res. 2005;54(2):201-6. |
blood triglyceride amount |
male |
0 days
| 0 |
|
|
0.43 |
mmol/l |
0.11 |
|
plasma triglyceride analysis |
|
0.0 |
|
0 |
|
|
|
|
102401 |
2688 |
SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (0.4 %) (between 23 and 32 days) then controlled sodium content diet (8 %) (for 14 days) |
Cowley AW Jr, et al., Physiol Genomics. 2016 Jan;48(1):62-72. doi: 10.1152/physiolgenomics.00097.2015. Epub 2015 Nov 3. |
urine albumin amount |
male |
59 days-68 days |
11 |
|
|
161.0 |
mg/d |
21.0 |
69.65 |
urine microalbumin analysis |
|
86400.0 |
|
0 |
|
|
strain 26-P |
|
98538 |
2079 |
WKY/NHsd |
skin potassium level plus skin sodium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin mineral amount |
male |
0 days
| 7 |
|
|
0.18 |
null |
0.01 |
0.02 |
ex vivo analysis of atomic composition following dry ashing |
|
0.0 |
|
0 |
|
ashed skin |
skin na+k/h2o |
|
99145 |
2238 |
WKY/NHsd |
skin potassium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin potassium amount |
male |
0 days
| 8 |
|
|
69.0 |
mmol/l |
2.5 |
7.07 |
ex vivo analysis of atomic composition following dry ashing |
|
0.0 |
|
0 |
|
ashed skin |
skin k/h2o |
|
99158 |
2238 |
WKY/NHsd |
plasma potassium level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood potassium amount |
male |
0 days
| 7 |
|
|
4.2 |
mmol/l |
0.3 |
0.79 |
automated blood electrolyte analysis |
|
0.0 |
|
0 |
|
|
|
|
99165 |
2238 |
WKY/NHsd |
plasma chloride level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood chloride amount |
male |
0 days
| 8 |
|
|
109.1 |
mmol/l |
1.0 |
2.83 |
automated blood electrolyte analysis |
|
0.0 |
|
0 |
|
|
|
|
99170 |
2238 |
SS/NEisSlc |
serum potassium level |
controlled sodium content diet (0.3 %) (for 91 days) |
Otsuka F, et al., Am J Physiol. 1998 Jun;274(6 Pt 2):R1797-806. |
blood potassium amount |
male |
91 days
| 6 |
|
|
7.65 |
mmol/l |
0.29 |
0.71 |
automated serum potassium test |
|
0.0 |
|
0 |
|
|
|
|
100658 |
2519 |
SS.BN-(D13Got42-D13Hmgc354)/Mcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 46 and 50.8 days) then controlled sodium content diet (8 %) (for 13.4 days) |
Cowley AW, et al., Physiol Genomics. 2014 Jun 1;46(11):398-410. doi: 10.1152/physiolgenomics.00179.2013. Epub 2014 Apr 8. |
arterial blood pressure trait |
male |
60 days-67 days |
16 |
|
serial mean |
183.0 |
mmHg |
6.0 |
24.0 |
intra-aortic thoracic radiotelemetry via carotid cannulation |
|
10800.0 |
|
0 |
|
intra-carotid radiotelemetry |
strain 26-D |
|
98571 |
2098 |
SS/Jr |
heart wet weight |
controlled sodium content diet (2 %) (between 24 and 27 days) |
Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 |
heart mass |
not specified |
64 days-71 days |
46 |
|
|
1.23 |
g |
0.01 |
0.07 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
4 rats per cage, 2 SR/Jr 2 LEW/NCrl |
64743 |
222 |
SS/Jr |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
210.0 |
mmHg |
3.3 |
14.76 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65479 |
611 |
SS.LEW-(D1Rat211-D1Rat18)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
180.0 |
mmHg |
2.8 |
12.52 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65488 |
611 |
SS.LEW-(D1Mco4-D1Rat18)/Mco |
systolic blood pressure |
controlled sodium content diet (2 %) (between 24 and 28 days) |
Joe B, et al., J Hypertens 2003 Nov;21(11):2077-84. |
arterial blood pressure trait |
male |
63 days-70 days |
20 |
|
|
178.0 |
mmHg |
2.3 |
10.29 |
tail cuff plethysmography |
|
0 |
|
0 |
|
|
average of 4days |
|
65489 |
611 |
BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 30 days) and controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
91 days-93 days |
42 |
|
continuous mean |
109.0 |
mmHg |
3.0 |
19.44 |
vascular indwelling catheter method |
femoral artery |
259200.0 |
|
0 |
|
3 h per day |
increase |
|
66139 |
229 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
|
serial mean |
39.0 |
mmHg |
6.0 |
21.63 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
0 |
|
|
|
|
67302 |
151 |
SHR |
heart rate |
controlled sodium content diet (1 %) (for 14 days) |
Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. |
heart pumping trait |
male |
87 days
| 24 |
|
continuous mean |
380.0 |
beats/min |
8.0 |
39.19 |
vascular indwelling catheter method |
femoral artery |
1800 |
|
0 |
|
pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH) |
|
|
65346 |
306 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) then tactile electric shock exposure (2 %) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
14 |
|
serial mean |
16.0 |
mmHg |
3.0 |
11.22 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
66149 |
151 |
SS-Nox4em2Mcwi-/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
337.5 |
beats/min |
6.5 |
9.19 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66625 |
717 |
SS-Acad10em2Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
5 |
|
|
350.2 |
beats/min |
7.34 |
16.41 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66624 |
717 |
SS-Nckap5em3Mcwi+/+ |
heart rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart pumping trait |
male |
70 days-77 days |
2 |
|
|
349.0 |
beats/min |
3.0 |
4.24 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66621 |
717 |
SS-Tfdp2em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
143.0 |
mmHg |
3.0 |
4.24 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66640 |
717 |
SS-Nckap5em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
127.5 |
mmHg |
5.37 |
13.16 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66639 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
115.0 |
mmHg |
7.02 |
12.17 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66649 |
717 |
SS-Apoeem8Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
136.0 |
mmHg |
3.0 |
4.24 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66664 |
717 |
SS-Alms1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
134.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66667 |
717 |
SS-Bcas3em4Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
1 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
126.0 |
mmHg |
|
|
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66673 |
717 |
SS-Renem1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
121.5 |
mmHg |
5.89 |
14.43 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66679 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
5 |
|
|
7.9 |
mg/d |
0.52 |
1.17 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66690 |
717 |
SS-Nox4em2Mcwi-/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 11 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
122.0 |
mmHg |
1.0 |
1.41 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66687 |
717 |
SS-Acad10em2Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
13 |
|
|
10.9 |
mg/d |
0.23 |
0.83 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66697 |
717 |
SS-Tgfb1em3Mcwi+/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
12.27 |
mg/d |
0.06 |
0.1 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66700 |
717 |
SS-Apoeem7Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
10.08 |
mg/d |
0.43 |
0.74 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66713 |
717 |
SS-Rag1em1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
4 |
|
|
11.39 |
mg/d |
1.35 |
2.7 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66727 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi-/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
3 |
|
|
10.23 |
mg/d |
1.09 |
1.89 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66729 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
8.94 |
mg/d |
1.17 |
1.65 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66738 |
717 |
SS-Mas1em1Mcwi+/+ |
urine creatinine excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine creatinine amount |
male |
70 days-77 days |
2 |
|
|
12.28 |
mg/d |
1.63 |
2.31 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66746 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.14 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66751 |
717 |
SS-Tgfb1em3Mcwi+/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.5 |
g |
0.07 |
0.13 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66761 |
717 |
SS-Ncf2em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
5 |
|
|
1.44 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66769 |
717 |
SS-Gpr183em2Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
9 |
|
|
1.54 |
g |
0.05 |
0.14 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66764 |
717 |
SS-Mmp2em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
1 |
|
|
1.38 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66777 |
717 |
SS-Cybaem1Mcwi-/- |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
6 |
|
|
1.34 |
g |
0.03 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66775 |
717 |
SS-Apoeem7Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
3 |
|
|
1.44 |
g |
0.04 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66774 |
717 |
SS-Rag1em1Mcwi+/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
4 |
|
|
1.53 |
g |
0.07 |
0.13 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66788 |
717 |
SS-Mthfrem1Mcwi-/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
8 |
|
|
1.61 |
g |
0.08 |
0.23 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66807 |
717 |
SS-Nox4em2Mcwi-/+ |
left kidney wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
kidney mass |
male |
70 days-77 days |
2 |
|
|
1.25 |
g |
0.03 |
0.04 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
66810 |
717 |
SS-Ulk4em3Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
4 |
|
|
8.48 |
mEq/d |
1.31 |
2.63 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66818 |
717 |
SS-Acad10em2Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
13 |
|
|
9.57 |
mEq/d |
1.12 |
4.05 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66820 |
717 |
SS-Gpr183em2Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
9 |
|
|
8.82 |
mEq/d |
1.43 |
4.28 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66826 |
717 |
SS-Tfdp2em2Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
13.38 |
mEq/d |
1.65 |
2.86 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66825 |
717 |
SS.LEW-(D1Mco102-D1Mco129)/2Mco |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 36 and 40 days) |
Joe B, et al., Hum Mol Genet. 2009 Aug 1;18(15):2825-38. Epub 2009 May 7. |
arterial blood pressure trait |
male |
66 days-70 days |
20 |
|
serial mean |
176.0 |
mmHg |
2.2 |
9.84 |
tail cuff plethysmography |
|
345600 |
|
0 |
|
Rats warmed to 28 degrees C for measurement. |
|
|
65311 |
565 |
SS/JrHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92 days-94 days |
12 |
|
serial mean |
142.0 |
mmHg |
5.0 |
17.32 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
0 |
|
|
|
|
65467 |
151 |
SS/JrRkb |
single kidney wet weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
kidney mass |
male |
98 days
| 14 |
|
|
3.5 |
g/kg |
0.05 |
0.19 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
66086 |
669 |
SS-Chr 19SHR/Rkb |
single kidney wet weight to body weight ratio |
controlled sodium content diet (4 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
kidney mass |
male |
98 days
| 20 |
|
|
4.0 |
g/kg |
0.14 |
0.63 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
66089 |
669 |
SS/JrRkb |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
heart right ventricle mass |
male |
98 days
| 14 |
|
|
0.52 |
mg/g |
0.02 |
0.07 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
66090 |
669 |
SS-Chr 19SHR/Rkb |
heart right ventricle weight to body weight ratio |
controlled sodium content diet (0.2 %) (for 56 days) |
Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. |
heart right ventricle mass |
male |
98 days
| 20 |
|
|
0.51 |
mg/g |
0.01 |
0.04 |
post excision weight measurement |
|
0 |
|
0 |
|
|
|
|
66092 |
669 |
FHH-Chr 1BN-Sorcs1em1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
12 |
|
|
6.21 |
mEq/d |
0.8 |
2.78 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66832 |
717 |
SS-Nckap5em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
5 |
|
|
11.54 |
mEq/d |
1.15 |
2.58 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66842 |
717 |
SS-Alms1em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
1 |
|
|
6.26 |
mEq/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66851 |
717 |
SS-Ets1em1Mcwi+/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
4 |
|
|
7.37 |
mEq/d |
0.72 |
1.44 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66840 |
717 |
SS-Ets1em1Mcwi-/+ |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
10 |
|
|
10.15 |
mEq/d |
0.95 |
3.0 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66856 |
717 |
SS-Renem1Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
5 |
|
|
7.06 |
mEq/d |
1.41 |
3.15 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66863 |
717 |
SS-Nckap5em3Mcwi-/- |
urine sodium excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine sodium amount |
male |
70 days-77 days |
3 |
|
|
11.79 |
mEq/d |
0.69 |
1.2 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66864 |
717 |
SS-Mthfrem1Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
1 |
|
|
17.0 |
mg/d |
|
|
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66882 |
717 |
SS-Gpr183em2Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
2 |
|
|
60.18 |
mg/d |
6.81 |
9.62 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66891 |
717 |
FHH-Chr 1BN-Sorcs1em1Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
3 |
|
|
2.18 |
mg/d |
0.68 |
1.17 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66883 |
717 |
SS-Chr 5BN-Cyp4a2em1Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
3 |
|
|
85.45 |
mg/d |
5.57 |
9.64 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66895 |
717 |
SS-Apoeem8Mcwi+/+ |
urine albumin excretion rate |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
urine albumin amount |
male |
70 days-77 days |
2 |
|
|
27.98 |
mg/d |
4.63 |
6.55 |
automated urine analysis |
|
|
|
0 |
|
|
|
- |
66909 |
717 |
SS.SHR-(D13Rat63-D13Mit1)/Mco |
blood uric acid level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood uric acid amount |
male |
84 days
| 8 |
|
|
2.4 |
mg/dl |
0.12 |
0.34 |
automated blood analysis |
|
0 |
|
0 |
|
|
|
|
65786 |
246 |
SHR.SS-(D8Uia1-D8Rat90)/Mco |
blood uric acid level |
controlled sodium content diet (0.3 %) |
Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. |
blood uric acid amount |
male |
84 days
| 8 |
|
|
3.4 |
mg/dl |
0.29 |
0.82 |
automated blood analysis |
|
0 |
|
0 |
|
|
|
|
65788 |
246 |
SS-Alms1em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
151.2 |
mmHg |
7.61 |
17.02 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66937 |
717 |
SS-Gpr183em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
146.83 |
mmHg |
9.12 |
22.34 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66939 |
717 |
SS-Tfdp2em2Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.0 |
mmHg |
2.0 |
2.83 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66947 |
717 |
SS-Ets1em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
162.33 |
mmHg |
13.2 |
22.85 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66961 |
717 |
SS-Nckap5em1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
5 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
147.6 |
mmHg |
11.82 |
26.43 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66963 |
717 |
SS-Rag1em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
6 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
120.83 |
mmHg |
4.57 |
11.2 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66966 |
717 |
SS-Renem1Mcwi+/+ |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
4 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
156.5 |
mmHg |
17.87 |
35.74 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66976 |
717 |
SS-Tfdp2em2Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
3 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
142.0 |
mmHg |
12.58 |
21.79 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66980 |
717 |
FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- |
mean arterial blood pressure |
controlled sodium content diet (4 %) (for 12 days) |
PhysGen Knockout data |
arterial blood pressure trait |
male |
70 days-77 days |
2 |
1/3 systolic pressure + 2/3 diastolic pressure |
|
129.5 |
mmHg |
4.5 |
6.36 |
radiotelemetry |
carotid artery |
|
|
0 |
|
|
|
- |
66982 |
717 |
SS-Ube2q2em3Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
1 |
|
|
1.41 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67001 |
717 |
SS-Ets1em1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
4 |
|
|
1.11 |
g |
0.03 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67022 |
717 |
SS-Nox4em2Mcwi-/- |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
5 |
|
|
1.0 |
g |
0.03 |
0.06 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67036 |
717 |
SS-Apoeem8Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
2 |
|
|
1.19 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67031 |
717 |
SS-Alms1em1Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
70 days-77 days |
1 |
|
|
1.16 |
g |
|
|
post excision weight measurement |
|
|
|
0 |
|
|
|
- |
67034 |
717 |
SS-Rag1em2Mcwi+/+ |
heart wet weight |
controlled sodium content diet (4 %) (for 14 days) |
PhysGen Knockout data |
heart mass |
male |
|